Page 1

Un meilleur savoir pour une meilleure santĂŠ Better Knowledge for Better Health


Program at a glance 2013* Time/Date

Thursday 19 September

Friday 20 September

Saturday 21 September

Sunday 22 September

Monday 23 September

Internal Entity Business Meetings

Meetings

Meetings

Meetings

Meetings

Registration/Check-in

Poster set-up (P2)

Poster set-up (P3)

Poster set-up (P4)

Meet the Entities Poster set-up (P1)

0830-1000

Internal Entity Business Meetings

Opening Ceremony and Plenary I

Plenary II

Plenary III

1st Annual Cochrane Lecture (0845)

1000-1030

Break

Break & Meet the Entities poster viewing (P1)

Break

Break

Break

1030-1200

Internal Entity Business Meetings

Concurrent* Session A

Poster viewing (P2)

Poster viewing (P3)

Poster viewing (P4)

Lunch & Meet the Entities poster viewing (P1) (1300 - 1330)

Lunch

Lunch

Lunch

0700-0815

1200-1330

Lunch

Registration opens**

1330-1500

Internal Entity Business Meetings

Concurrent Session B

Concurrent Session D

Concurrent Session E

Concurrent Session G

1500-1530

Break

Registration closes

Break & Meet the Entities poster viewing (P1)

Break

Break

Break

1530-1700

Internal Entity Business Meetings

Concurrent Session C

Annual General Meeting

Concurrent Session F

Closing Plenary

Newcomers’ Session

1715-1830

Welcome Reception (1800)

Meetings

Meetings

Meetings

Colloquium Debriefing Meeting

Evening

Randomized Dinner

Free evening

20th Anniversary Gala

(1900)

Cocktails (1800) Dinner (1900)

Please note, the program is subject to change without notice. * Concurrent Sessions are workshops, oral sessions and special sessions that run concurrently. ** Items bolded on 19 September are relevant to all delegates; not bolded are restricted.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

2


BIENVENUE

Chères déléguées, Chers délégués, C’est très chaleureusement et avec la plus grande fierté et que nous vous souhaitons la bienvenue au 21ième Colloque International Cochrane. Neuf ans déjà se sont écoulés depuis que le Canada a eu le privilège d’accueillir le Colloque, et nous sommes enthousiasmés que cet honneur nous soit accordé de nouveau. Le Colloque de cette année promet de s’avérer une incroyable expérience d’apprentissage pour tous. À partir d’un nombre record de plus de 800 propositions d’ateliers et de résumés, nous avons préparé un programme stimulant et réfléchi comprenant 75 ateliers, 180 communications orales, et plus de 340 présentations par affiche; sans oublier les conférenciers invités de calibre international venus de partout sur le globe pour donner les conférences plénières quotidiennes. Depuis deux ans, nous avons travaillé avec ardeur à la préparation d’un Colloque et de célébrations du vingtième anniversaire dont vous vous souviendrez pour les vingt prochaines années. Le travail effectué depuis plus de deux décennies pour produire plus de 5500 revues systématiques et fournir les meilleures données pour le système de santé représente un effort colossal. Nous souhaitons vous rappeler, chers contributeurs, autant internes qu’externes, votre importance pour l’accomplissement de la mission et la vision de la Collaboration Cochrane. Durant le Colloque, nous espérons que vous pourrez prendre le temps de profiter de tout ce que la belle Ville de Québec a à offrir. Nous avons incorporé quelques merveilles de la Ville dans le programme, dont la Réception de bienvenue au Musée de la civilisation, situé dans l’un des nombreux sites historiques de la Ville, ainsi que le Souper-rencontre dans plusieurs des restaurants exceptionnels de la Ville de Québec, pour faire l’expérience de l’offre culinaire singulière qu’elle seule peut offrir. Enfin, nous anticipons avec joie de vous recevoir pour le Gala du 20ième anniversaire au cours duquel deux décennies d’intense travail, de résilience et de détermination culmineront en des heures de célébration. Nous souhaitons aussi remercier sincèrement tous ceux et celles au Centre Cochrane Canada, au Centre de recherche du CHU de Québec et à la Faculté de médecine de l’Université Laval qui, par leurs idées et suggestions audacieuses, ont fait en sorte que ce Colloque devienne l’évènement que vous vivrez cette semaine. Finalement, nous tenons à vous remercier tous de vous être joints à nous ici dans la belle Ville de Québec et au Canada pour célébrer cet anniversaire mémorable. Sincèrement, France Légaré François Rousseau Jeremy Grimshaw Co-présidents du Colloque, au nom du Comité organisateur du 21ième Colloque

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

3


Welcome

Dear Delegates, It is with the utmost warmth and pride that we welcome you to the 21st international Cochrane Colloquium. Nine years have passed since Canada last had the privilege of hosting the Colloquium and we are thrilled to have this honour bestowed upon us again. This year promises to be an incredible learning experience for everyone involved. From a record of over 800 workshop and abstract submissions we have carefully organized an enticing and thoughtful program of 75 workshops, 180 oral and more than 340 poster presentations; not to mention the worldclass speakers we have invited from all over the globe to deliver plenary presentations to you daily. We have been working diligently over the last two years to bring you a Colloquium and Anniversary celebration you will remember for the next 20. Working together for over two decades to produce more than 5500 systematic reviews and provide the best evidence for health care is no small feat. We want to remind you, the contributors, both internal and external, how important you are in achieving the mission and vision of The Cochrane Collaboration. While attending the Colloquium, we hope you will take the time to experience all that beautiful Québec City has to offer. We have interwoven some of the marvels of the city into our program, including a Welcome Reception at the Musée de la civilisation, located in one of the City’s many historic districts, and our Randomized Dinner taking place at many exceptional Québec City restaurants, allowing you to experience fine French fare. Finally, we look forward to hosting you at the 20th Anniversary Gala where two decades of hard work, resilience and determination will culminate in hours of celebration. We would like to extend our sincere thanks to those at the Canadian Cochrane Centre, the Research Center of CHU de Québec and Université Laval who were instrumental in turning this Colloquium from audacious thoughts and ideas into the event you will experience this week. And finally, we thank you for joining us here in Canada as we celebrate this monumental anniversary. Sincerely, France Légaré François Rousseau Jeremy Grimshaw Colloquium Co-Chairs, on behalf of the 21st Colloquium Organizing Committee

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

4


Table of contents Sponsors................................................................................................................................................................

6

Exhibitors...............................................................................................................................................................

8

Acknowledgements................................................................................................................................................

14

Colloquium Venue..................................................................................................................................................

18

Pre- and Post-Colloquium Events...........................................................................................................................

19

Prizes and Awards. ................................................................................................................................................

22

Social Program.......................................................................................................................................................

29

20th Anniversary....................................................................................................................................................

31

Colloquium Chairs..................................................................................................................................................

34

1st Annual Cochrane Lecture.................................................................................................................................

35

Plenary Speakers...................................................................................................................................................

35

Daily schedules Thursday 19 September.........................................................................................................................................

42

Friday 20 September.............................................................................................................................................

44

Saturday 21 September.........................................................................................................................................

62

Sunday 22 September...........................................................................................................................................

76

Monday 23 September..........................................................................................................................................

93

Cochrane Canada Annual Symposium...................................................................................................................

105

General Information...............................................................................................................................................

107

Local Attractions....................................................................................................................................................

110

Visitor Information.................................................................................................................................................

112

Map of QuĂŠbec City...............................................................................................................................................

115

CCQ Floor Plans.....................................................................................................................................................

116

India Colloquium....................................................................................................................................................

118

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

5


With thanks to our generous sponsors Platinum

GOLD

Canadian Cochrane Centre Centre canadien Cochrane

SILVER

Supporter

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

6


Newfound land & Labrador There are more varieties of English spoken in Newfoundland and Labrador than anywhere else in the world. Dating back four centuries, accents are flavoured by Western England and Southern Ireland. There’s also French and Aboriginal influences that have helped shape the province’s colourful language. Its isolation, given part of the province is an island, has preserved the multitude of dialects and traditions that have long since evolved in other countries. In addition to the various accents, the province has its own dictionary and encyclopedia. The Dictionary of Newfoundland English was first published in 1982 and contains hundreds of words and phrases you’ll find nowhere else.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

7


Exhibitors The Cochrane Collaboration cochrane.org The Cochrane Collaboration is an international network of more than 31,000 people from over 120 countries. We work together to help healthcare practitioners, policy-makers and consumers make well-informed decisions about health care by producing Cochrane Systematic Reviews of healthcare evidence and the largest collection of records of randomised controlled trials in the world, published online in The Cochrane Library. Our work is internationally recognised as the benchmark for high quality information about the effectiveness of health care. As a non-governmental and not-for-profit organisation, we operate to minimise bias and remain free from commercial influences, and offer training and guidance to our growing network of contributors. Each year a different Cochrane centre hosts the Collaboration’s Colloquium and this year we are delighted to be celebrating our 20th anniversary in beautiful Québec City, courtesy of the Canadian Cochrane Centre and Université Laval. If you’re already a contributor or are new to Cochrane, please visit our exhibition space, the Cochrane Exchange, to meet Cochrane staff, find out how to get involved in the organisation, book one-to-one training in using Cochrane’s Review Manager software or building your Cochrane website, learn about Cochrane initiatives and projects, and more!

The Cochrane Collaboration Anniversary Merchandise Booth anniversary.cochrane.org The Anniversary Public Relations Working Group will be on-site to deliver the promotional merchandise ordered in advance of the Colloquium to help celebrate the 20th Anniversary of The Cochrane Collaboration. Come by our booth to pick up your order and please bring Canadian cash (exact change) for your purchase.

2014 Cochrane Colloquium - Hyderabad, India Cochrane South Asia is privileged to host the 22nd Cochrane Colloquium in Hyderabad in India. 2014 heralds the 21st anniversary of The Cochrane Collaboration’s pioneering global initiative. We celebrate Cochrane’s rite of passage into its prime with a Colloquium that we hope will challenge, stimulate, and empower us to face our responsibilities as global leaders in research synthesis for better health. The 2014 Cochrane Colloquium will focus on ‘Evidence-Informed Public Health: Opportunities and Challenges;’ an apt theme for the setting of the Colloquium in India, and South Asia. We hope that September 2014 will see history, geography, altruism, pragmatism, and good science meld seamlessly to help improve the health of the millions of people around the world. The 400-year-old city of Hyderabad, built by the Qutub Shahi kings, is steeped in a rich historical, cultural, and architectural heritage, and is also home to the glistening towers of many global IT giants. Blending the ancient and the modern in perfect harmony, Hyderabad, the jewel of the Deccan, offers you a life-changing experience of the vibrant democracy that is incredible India, like no other Indian city can. Hyderabad offers you a world-class conference venue and hotel in the Novotel Hyderabad International Convention Centre. In addition, there are over 25 other hotels, serviced apartments and guest houses in the vicinity. Swagatham! We welcome you warmly to the planet called India, the land of a thousand Gods, where every guest is treated like a god. See you in Hyderabad!

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

8


Exhibitors con’t. Canadian Agency for Drugs and Technologies in Health (CADTH) cadth.ca Decisions about which medical devices and drugs to use are crucial to the quality and sustainability of health care in Canada. Access to evidence-based information is key to making informed decisions that harness the benefits of technology while getting the best value from every health dollar. The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent producer and broker of health technology assessments. It provides decision-makers with the evidence, analysis, advice, and recommendations they require to make informed decisions in health care. Funded by Canada’s federal, provincial, and territorial governments, CADTH delivers timely, evidence-based information to health care leaders about the effectiveness and efficiency of health technologies. Through its wide variety of services and products, CADTH delivers information that Canada’s health care decision-makers can rely on.

CIHR Institute of Musculoskeletal Health and Arthritis cihr-irsc.gc.ca The CIHR Institute of Musculoskeletal Health and Arthritis (IMHA) funds research and knowledge translation activities which focus on any of these six research focus areas: arthritis, bone, muscle, skin, oral health and musculoskeletal rehabilitation. IMHA works with its Institute Advisory Board to identify research priority areas which are reviewed on an annual basis. Programs and projects are developed, implemented and evaluated by staff based in Ottawa working in concert with staff at the host institution, which is currently the University of Manitoba where IMHA’s current Scientific Director, Dr Hani El-Gabalaway is based. IMHA is proud to work with partners in the non-governmental sector as well as consumer representatives who sit on some of our Institute Advisory Board committees. Our “research ambassadors” represent IMHA in various ways and they provide insights into the research needs and challenges affecting patients affected by the disease areas touching IMHA. In consultation with our various stakeholders, IMHA is currently developing a new strategic plan identifying future directions for the 2014-2019 timeframe.

EBSCO Health | Dynamed ebscohost.com EBSCO Health, part of EBSCO Information Services, is a leading provider of clinical decision support solutions, healthcare business intelligence, and medical research information for the healthcare industry. Our mission is to provide the global healthcare community with the information they need to make informed decisions. EBSCO Health users include librarians, nurses, physicians, administrators, and trainees in medicine, nursing, and allied health. Flagship products include CINAHL®, DynaMed™, Nursing Reference Center™, clinical eBooks and eJournals, EBSCO Discovery Service™, licensed databases (such as MEDLINE®), plus EBSCONET®. EBSCO databases are powered by EBSCOhost®, the premier electronic resource favored by libraries around the world.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

9


Exhibitors con’t. EMBASE elsevier.com/online-tools/embase Embase from Elsevier Life Science Solutions is the most comprehensive international database for biomedical researchers. It enables you to track and retrieve precise information on drugs and diseases from pre-clinical studies to searches on critical toxicological information. Embase supports Evidence Based Medicine by delivering a better basis for decision making to you and your organization. With over 25 million indexed records and more than 7600 current, mostly peer-reviewed journals, Embase quickly and accurately delivers the answers you need. It gives you comprehensive, authoritative, reliable coverage of all relevant and scientifically valid biomedical literature. Information managers, regulatory specialists, clinicians, medical librarians, educators and students use Embase for its breadth and depth of data. Embase can help you with everything from clinical trials research to pharmacovigilance.

EPPI-Centre eppi.ioe.ac.uk/cms The Evidence for Policy and Practice Information and Co-ordinating Centre (EPPI-Centre) is part of the Social Science Research Unit at the Institute of Education, University of London. Since 1993, we have been at the forefront of carrying out systematic reviews and developing review methods in social science and public policy. We are dedicated to making reliable research findings accessible to the people who need them, and supporting the use of evidence in policy, practice or personal decisions. The EPPI-Centre offers support and expertise to those undertaking systematic reviews and those who are interested in finding out about or using research evidence.

Health Evidence healthevidence.org Health Evidence is a service and research organization involved in knowledge translation among Canada’s public health decision makers. Health Evidence helps the public health workforce and policy makers search for, interpret, and apply research evidence to their local context. They began with the launch of the healthevidence.org registry of reviews in March 2005. This registry continues to provide free, user-friendly access to a searchable database of over 3100 relevant, quality-appraised systematic reviews that evaluate the effectiveness of public health interventions and facilitates evidence-informed public health decision making. Health Evidence further expanded in 2007 to offer a suite of training and consultation services – including workshops, webinars and Knowledge Broker services – that are tailored to the needs of public health practitioners and their organizations. For more information on these services and to search the registry of reviews, visit healthevidence.org.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

10


Exhibitors con’t.

National Collaborating Centre for Methods and Tools nccmt.ca The National Collaborating Centre for Methods and Tools (NCCMT) is one of six National Collaborating Centres for Public Health in Canada. The NCCMT provides leadership and expertise in working with public health professionals to move evidence into practice. We believe that using evidence to inform public health practice and policy in Canada can improve our public health system and, ultimately, the health of all Canadians. We help you to find and use innovative, high quality, up-to-date methods and tools that support you in moving evidence into practice.

National Institute for Health Research nihr.ac.uk • netscc.ac.uk/systematic_reviews The National Institute for Health Research (NIHR) is a large, multi-faceted and nationally distributed UK based organization. Together, NIHR people, facilities and systems represent the most integrated clinical research system in the world, driving research from bench to bedside for the benefit of patients. The NIHR is making sure that the UK health service has access to the best possible evidence to inform decisions and choices by commissioning systematic reviews and by building capacity for their conduct and supporting the development of methods. The NIHR Systematic Reviews (SR) Programme supports the following organisations: • UK Cochrane Centre (UKCC) • Cochrane Review Groups • Centre for Reviews and Dissemination (CRD) • Health Technology Assessment Review (TAR) teams The SR Programme also supports and commissions reviews that explicitly address key questions faced by front line professionals and by National Health Service (NHS) decision-making bodies and other policy customers in the UK. Each part of the Programme works to ensure that the knowledge they produce is rigorous, accessible, and can be used by professionals and policy-makers to make informed decisions about the treatment and care the NHS provides.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

11


Exhibitors con’t. Wolters Kluwer Health | Ovid wolterskluwerhealth.com Ovid, part of Wolters Kluwer Health, is a global information solutions provider offering medical, scientific, and academic communities customizable solutions of high-quality core and niche content fully integrated with their institutional holdings. Clinicians, professionals, students, and researchers benefit from Ovid’s best-in-class content, technology tools, and services. OvidSP, our industry-leading online search and discovery platform, continues to break barriers to transform the research community. OvidSP’s unique tools and features are designed to maximize search precision and efficiency, and simplify and speed analysis and workflow—all in a simple, integrated and easy-to-use system. Ovid is used by the world’s leading colleges and universities; medical schools; academic research libraries and library consortia; hospitals and healthcare systems; pharmaceutical, engineering and biotechnology companies; and HMOs and clinical practices. Ovid offers tremendous depth and breadth of content published by the world’s leading publishers, covering a wide range of core and niche scientific, medical, and healthcare disciplines: • More than 4000 ebooks, 100 book collections, archive collections of critical historical material, publisher collections, and topical collections • O  ver 1300 premium, peer-reviewed journals with no embargoes! Plus 70 journal collections, archive collections and packages based on publisher or subject • Over 100 bibliographic and full-text databases

Wiley | The Cochrane Library wiley.com Wiley is the leading society publisher. Our scientific, technical, medical and scholarly business publishes on behalf of more societies and membership associations than anybody else, and offers libraries and individuals 1250 online journals, thousands of books and e-books, reviews, reference works, databases, and more. For more information, visit wiley.com, or our online resource onlinelibrary.wiley.com. Wiley is proud to publish The Cochrane Library on behalf of The Cochrane Collaboration. The Cochrane Library is the single most reliable source for evidence on the effects of health care. World-leading Cochrane Systematic Reviews provide high-quality, independent evidence to inform healthcare decision-making. In celebration of this year’s Cochrane Colloquium, Wiley is pleased to provide free access to The Cochrane Library throughout all of Canada. Complimentary Canadian access will be available from September through November 2013. Learn more at thecochranelibrary.com.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

12


ia Nova Scot Nova Scotia’s Bay of Fundy is home to the most extreme tidal environment on earth. The highest tides in the world are found within the Bay’s Minas Basin. One hundred and sixty billion tonnes of water flows in and out of the Bay of Fundy every 12.5 hours. That’s enough to fill the entire Grand Canyon! It’s more than the combined flow of all the freshwater rivers in the world, and at its peak, the Fundy tide can reach as high as a five-story building. *The entirety of the Bay of Fundy is located between Nova Scotia and New Brunswick.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

13


Acknowledgements Canadian Institutes of Health Research The Canadian Institutes of Health Research (CIHR), Cochrane Canada’s primary funder, has awarded the 21st Cochrane Colloquium $25,000 as part of its Dissemination Events Grant competition. Cochrane Canada graciously acknowledges CIHR for its support. The purpose of the CIHR Dissemination Events Grant is to support events/ activities that contribute to the dissemination, exchange and uptake of research evidence. It is funded by CIHR’s Knowledge Translation Branch.

Developing Country Stipends The Cochrane Collaboration has dedicated funds to support the attendance of Collaboration contributors from developing countries at Colloquia for many years. This year we have provided financial support to 23 individuals from 12 countries to attend the Colloquium. We are grateful to The Cochrane Collaboration, BMJ Publishing, The Lancet Global Health, the Global Health Research Initiative (GHRI), and the Austrian Branch of the German Cochrane Centre (through the RTI-UNC Evidence-based Practice Center) for their generous support in making this initiative possible. The BMJ is delighted to support the work of The Cochrane Collaboration again this year and, in particular, to help delegates attending from low- and middle-income countries. - Fiona Godlee, Editor in Chief

The Lancet is delighted to announce the launch of The Lancet Global Health, a new gold open access journal. The Lancet has long been a champion of global health research and this new online only journal follows this tradition by publishing high-quality original research, commentary, correspondence and blogs with direct relevance to practitioners and communities in low- and middle-income countries. For more information on this new journal and all of The Lancet’s journals please visit thelancet.com.

The Global Health Research Initiative is a partnership of Canadian government agencies who are working together with researchers and decision-makers around the world to tackle global health challenges. The Initiative promotes collaborations and shared learning across disciplines and sectors within and between lowand middle-income countries and Canada.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

14


Acknowledgements con’t. Consumer Stipends The Cochrane Collaboration is committed to the active involvement of consumers and consumer advocates in the preparation and dissemination of Cochrane Reviews and furthering the goals of the Collaboration. Consumer stipends enable consumers to attend Colloquia and share their valuable experience and contribute to the evidence process. This year we have supported the attendance of 14 consumers from seven countries. Funding was generously provided by The Cochrane Collaboration, the Cochrane Consumer Network, along with continued funding from the Canadian Cochrane Centre and the UK Cochrane Centre to support the attendance of Canadian and UK consumers.

Additional Funding 3ie offered five bursaries for citizens of low- and middle-income countries to attend the 21st Cochrane Colloquium. 3ie funds impact evaluations and systematic reviews that generate high-quality evidence on what works in development and why, and at what cost. The core mission is to improve lives through impact evaluation by increasing the use of evidence to inform policy and increase development effectiveness.

Special thanks Many individuals and organizations have been instrumental in preparing and executing the 21st Cochrane Colloquium. This would not have been possible without the invaluable support we have received. We would like to thank:

thank you

• Canadian Cochrane Centre staff; the Vice-Dean of Education and Continuing Professional Development, Faculté de médecine, Université Laval; and Lisa McGovern and Brigitte Boyle, in particular, for their tremendous organizational skills and dedication to this endeavor;

• Wiley-Blackwell for providing ongoing support and their work in layout and design of this Colloquium program;

• Martin Janczyk and Juliane Ried for their ongoing website support; and

• everyone who contributed to the Scientific Program by submitting workshop proposals, and oral and poster abstracts.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

15


Acknowledgements con’t. Committees Canadian Organizing Committee François Rousseau (Chair)* Julie Bourque* Brigitte Boyle* Jeremy Grimshaw* Carole Guérin*

Yves Labelle Lisa McGovern* France Légaré Jordi Pardo Pardo Pierre Paquin*

Michel Rouleau Mary Ellen Schaafsma* Nadine Tremblay

Louis Dufresne Ian Graham Sally Green France Légaré Stuart MacLeod Pierre Ongolo-Zogo Zulma Ortiz Philippe Ravaud

John-Arne Rottingen François Rousseau Silvana Simi Jean Slutsky Tom Walley Howard White

Jeremy Grimshaw Gill Gyte David Henry Sophie Hill Clara Juandó Terry Klassen John Lavis Mona Nasser Sandy Oliver Ian Schemilt

Ian Shrier Mildred Solomon Lesley Stewart Nadine Tremblay Prathap Tharyan David Tovey Luke Vale Liz Waters Mingming Zhang

*Core Planning Team

International Advisory Committee Jeremy Grimshaw (Chair) Reiner Banken Renaldo Battista Rénald Bergeron Howard Bergman Zulfiqar Bhutta Luis Gabriel Cuervo Kay Dickersin

Scientific Committee France Légaré (Chair) Gerd Antes Hilda Bastian Isabelle Boutron Bernard Burnand Martin Burton Esther Coren Pierre Dagenais Leonila (Inday) Dans Marie-Pierre Gagnon

Consumer Stipend Committee Catherine McIlwain (Co-Chair) Eileen Vilis (Co-Chair) Liz Whamond Mingming Zhang

Developing Country Stipend Committee Jordi Pardo Pardo (Co-Chair) Sridharan Ramaratnam (Co-Chair) Joy Oliver

Giordano Perez Gaxiola Ludovic Reveiz Maria Regina Torloni

Stipend Management and Support Team Claire Allen Tom Cracknell Juliane Ried Rachel Sayers

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

16


Prince Ed ward Isla nd Lucy Maud Montgomery, author of Anne of Green Gables, was a native of Prince Edward Island. The book has sold millions of copies worldwide and celebrated 100 years of publication in 2008. Tourists from all over the world visit the island every year to visit the many historic sites related to the book.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

17


Colloquium Venue The 21st Cochrane Colloquium takes place at the Québec City Convention Centre 1000, boulevard René-Lévesque Est Québec (Qc) G1R 5T8 convention.qc.ca/en Conveniently located in the heart of Québec City, the Centre is the perfect place for conventions, trade shows and meetings. The Convention Centre is just 15 minutes from the international airport in the heart of downtown and just steps away from accommodation, dining and sightseeing. It’s no wonder Québec City is one of Canada’s top convention destinations.

Transportation • T axi: Taxis are available from the Québec City Jean Lesage International Airport to downtown Québec City for a flat rate of $34.25 CAD. • B  us: Public transit runs throughout downtown to Québec City’s main tourist attractions and shopping districts. Bus tickets are $3.00 (exact change) or $7.00 for a day pass. The concierge desk at the Québec City Convention Centre has information on bus routes and schedules.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

18


Pre- and Post-Colloquium events Wednesday 14 August 2013 Welcome to the Cochrane Colloquium! Tips and Tricks for Newcomers webinar (French) Online 1200-1300 EDT ccc.cochrane.org/cochrane-canada-live-webinars

Thursday 15 August 2013 Welcome to the Cochrane Colloquium! Tips and Tricks for Newcomers webinar (English) Online 1200-1300 EDT ccc.cochrane.org/cochrane-canada-live-webinars

Tuesday 17 September 2013 #CochraneTech Symposium TRYP Hotel Pur, Québec City 0900-1700 tech.cochrane.org

Thursday 19 September 2013 Summary of Findings and Assessment of Quality of Evidence: GRADE Workshop for editorial teams Québec City Convention Centre, Adelaide 302 B 0900-1700 Contact: Holger Schünemann, chairceb@mcmaster.ca

Tuesday 24 September 2013

Cochrane Methods Symposium 1811-A, Ferdinand-Vandry pavilion, Faculté de médecine, Université Laval, Québec 0900-1600 Contact: Maria Burgess, mburgess@cochrane.org

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

19


wick New Bruns Moncton, New Brunswick is home to Magnetic Hill. The Magnetic Hill is an example of a gravity hill – a type of optical illusion created by rising and descending terrain. It was first noticed in the early 1930s that at one point near the base of the ridge when driving south, motorists were required to accelerate in order to prevent rolling backward (i.e. what appears to be uphill). The novelty became known as “Magnetic Hill” and was an amusing local attraction for residents and visitors to try. When a car is placed in neutral it will begin to roll backwards, apparently uphill. Observers will also note that water in the adjacent drainage ditches also seemingly runs “uphill”.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

20


Prizes and Awards Several prizes are awarded annually to Collaboration contributors. Awards are presented throughout the Colloquium.

Anne Anderson Award Award presentation will take place during The Cochrane Collaboration’s Annual General Meeting, 21 September 2013

Anne Anderson Anne Anderson was a contributor to the stream of thinking and effort that gave birth to evidence-based health care. A clinically qualified reproductive physiologist, Anne had an active interest in women’s health, co-editing the first edition of Women’s Problems in General Practice (1983) with Ann McPherson. Anne also contributed to Effectiveness and Satisfaction in Antenatal Care (1982), edited by Murray Enkin and Iain Chalmers, and discussed, with Marc Keirse and Iain Chalmers, the possibility of co-editing a companion volume on elective birth. However, her premature death from breast cancer in 1983 ended her involvement. Anne Anderson was 46 years old when she died. Iain Chalmers, Murray Enkin and Marc Keirse went on to publish Effective Care in Pregnancy and Childbirth (ECPC) in 1989, dedicating the book in part to Anne. ECPC, through its systematic approach to assessing research literature, is widely acknowledged to have led to the development of a similar project for all of medicine and health: The Cochrane Collaboration.

Anne Anderson Award In the footsteps of Anne Anderson, many outstanding women continue to contribute and inspire other women to improve health knowledge for the good of their communities. Often these women are quiet achievers who might not otherwise be recognized. The goal of the Anne Anderson Award is to recognize and stimulate individuals contributing to the enhancement of women’s visibility and participation in the Cochrane leadership. The award is given to a member of The Cochrane Collaboration who has contributed meaningfully to the promotion of women as leaders and contributors to the organization. The establishment of the Award was approved in principle by The Cochrane Collaboration Steering Group in 2010, and was awarded for the first time in 2011. At its meeting in Split in March 2011, The Cochrane Collaboration Steering Group agreed to contribute GBP 1000 from core funds, per year, for three years towards the newly established Anne Anderson Award. Additional donations may be made via the ‘Donate now!’ button on cochrane.org , earmarked ‘The Cochrane Collaboration Anne Anderson Award’. The cash award is designated by the recipient to assist a woman from a low-resource setting with her Cochrane Collaboration activities. Past or current active female members of The Cochrane Collaboration are eligible for the award. Recipients are selected based on the following criteria: • emotional and cognitive intelligence; • personal qualities; • serving as an inspiration to others; • team building; • evidence of cumulative accomplishment; • leadership and mentorship. • originality and independence of thought, Consideration is also given in the selection process to: • the nominee’s contribution to, or enhancement of women’s visibility within the Collaboration; • participation in The Cochrane Collaboration and other leadership, and other accomplishments within the context of The Cochrane Collaboration.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

Chair Lisa Bero, 2013 Anne Anderson Award selection committee

Previous recipients 2012 - The Award was not made in 2012

2011 - Caroline Crowther, Cochrane Pregnancy and Childbirth Group Fundraising Walk to benefit the Anne Anderson Award Please join us in raising funds for the Anne Anderson Award.

Time: Meet at the Convention Centre entrance at 1800, Saturday 21 September The ‘Walk’ organizers are requesting a $10 donation, and participants can also help additionally by being ‘sponsored’ for the walk by their friends and colleagues (suggested sponsorship $5). The walk will be a distance of three to five kilometres through scenic Québec City and will occur rain or shine (no refunds!). To participate, please go to the Cochrane Anniversary Merchandise Booth in the Ottawa Room 200 C during breaks to sign-up and provide your donation to the Anne Anderson representative there. For more information or to participate, please contact Kay Dickerson at kdicers@jhsph.edu.

21


Prizes and Awards con’t. Thomas C Chalmers Award Award presentation will take place during the Closing Plenary, 23 September 2013

Thomas C Chalmers, MD The Thomas C Chalmers Award was established with individual donations to celebrate and recognize Tom’s interests, and was awarded for the first time at the 2nd Cochrane Colloquium in Hamilton, Canada in 1994. The Award is given at each Cochrane Colloquium to the principal author of both the best oral and the best poster presentation addressing methodological issues related to systematic reviews given by an early career investigator. The presentations must demonstrate originality of thought, high quality science, relevance to the advancement of the science of systematic reviews, and clarity of presentation. Presentations are judged by the Thomas C Chalmers Award Committee during the course of the Colloquium, and the two recipients receive a certificate and USD 500 each. The Cochrane Operations Unit has administered the Award since 2005.

Eligibility criteria To be considered eligible for the award, for either an oral or a poster presentation, the first author must be an early career investigator and the presenter at the Colloquium.

Assessment criteria Eligible oral and poster presentations must demonstrate: • originality of thought; • high quality science; • relevance for the advancement of the science of systematic reviews; and • clarity of presentation.

Chair Yemisi Takwoingi, 2013 Thomas C Chalmers Award Committee

Previous recipients 2012 - Page MJ, McKenzie JE, Green

SE, Forbes A. Types of selective inclusion and reporting bias in randomised trials and systematic reviews of randomised trials [presentation].

2012 - O’Mara-Eves AJ, Brunton G, Thomas J, Kavanagh J, Oliver S. Systematic methods for identifying evidence for broad review questions: looking beyond titles and abstracts [poster]. 2011 - Huckvale K. Screen2Go: a pilot smartphone app for citation screening [presentation]. 2011 - Mhaskar R, Magazin A, Soares H, Kumar A, Djulbegovic B. True methodological quality of trials is not reflected in their reporting [presentation]. A complete list of previous recipients is available here.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

22


Prizes and Awards con’t. Chris Silagy Prize Prize presentation will take place during The Cochrane Collaboration’s Annual General Meeting, 21 September 2013

Chris Silagy, AO, MD Chris Silagy (1960-2001) was the founding Director of the Australasian Cochrane Centre, a former Chair of The Cochrane Collaboration Steering Group, and instrumental in the development and success of The Cochrane Collaboration. Chris was energetic, positive and inspiring. Before his death in December 2001, Chris expressed a wish for a fund to be established and to be held by the Monash Foundation. Chris initiated this fund with his own contribution, and requested donations be made to it instead of flowers or other tributes after his death. Chris requested that this fund be used to recognize contributions to The Cochrane Collaboration in ways that are often insufficiently recognized; for example, providing administration, management, Colloquium organization, communication and motivation - in short, the ‘glue’ that helps keep The Cochrane Collaboration together. The establishment and perpetuation of the Prize was approved by The Cochrane Collaboration Steering Group in April 2002.

Previous recipients 2012 - Jordi Pardo Pardo, Musculoskeletal Review Group

2011 - Martin Janczyk and Juliane Ried, German Cochrane Centre A complete list of previous recipients is available here.

Chris Silagy Prize The Chris Silagy Prize is awarded at every Cochrane Colloquium to an individual who has made an ‘extraordinary’ contribution to the work of The Cochrane Collaboration. The Prize consists of AUD 1000 (drawn from the Chris Silagy Memorial Fund), a certificate which includes the words “for an extraordinary contribution to the work of The Cochrane Collaboration”, and expenses associated with attending the Colloquium (to be met by The Cochrane Collaboration). Potential recipients of the Chris Silagy Prize are required to have: • made an extraordinary contribution to The Cochrane Collaboration; • made a contribution that exceeds the expectations of their employment; • made a contribution to The Cochrane Collaboration that would not be recognized outside the scope of this Prize; • been identified by their peers as consistently contributing to a spirit of collaboration.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

23


Prizes and Awards con’t. Bill Silverman Prize Prize presentation will take place during The Cochrane Collaboration’s Annual General Meeting, 21 September 2013

William Silverman, MD William (Bill) Silverman (1924-2004) was one of the founders of American neonatal medicine. He was honoured repeatedly as one of the pioneers in his specialty; however, he often evoked somewhat contradictory responses amongst his colleagues because he was in the habit of raising troubling questions about the scientific basis and ethics of his and their practices. Like many of the people who have helped establish The Cochrane Collaboration, Bill Silverman could be regarded as a ‘troublemaker’. As he reiterated frequently, however, criticism is a form of troublemaking that can help drive progress. Furthermore, criticism should not be limited to examining the work of others, but should also include self-criticism.

Bill Silverman Prize The Bill Silverman Prize acknowledges explicitly the value of criticism of The Cochrane Collaboration, with a view to helping improve its work, and thus achieve its aim of helping people make well-informed decisions about health care by providing the best possible evidence on the effects of healthcare interventions. The establishment of the Prize was approved by The Cochrane Collaboration Steering Group in 2007 and awarded for the first time in early 2008. The criteria for the Prize are that the publication or presentation has evaluated any aspect of the preparation, maintenance or dissemination of Cochrane Reviews or the work of The Cochrane Collaboration more generally, and: • was of high quality; • was accompanied by constructive suggestions on how the relevant aspects of the work of The Cochrane Collaboration could be improved; and • has had, or is likely to have, a positive impact on the scientific quality, relevance and use of Cochrane Reviews. The Prize comprises a certificate and USD 1000 to the corresponding author of the selected publication or presentation.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

Bill Silverman Prize Committee The Prize Committee comprises five members, at least three of whom do not have an active role within any Cochrane entity. Members of the Committee for 2013 include: David Moher (internal Co-Chair) Bill Summerskill (external Co-Chair) David Atkins Sarah Donegan Mona Nasser

Previous recipients 2012 - Nasser M, Welch V, Tugwell

P, Ueffing E, Doyle J, Waters E. Ensuring relevance for Cochrane Reviews: evaluating processes and methods for prioritising topics for Cochrane Reviews. Journal of Clinical Epidemiology, Jan 2012.

2011 - Donegan S, Williamson P, Gamble C, Tudur-Smith C. Indirect comparisons: a review of reporting and methodological quality. PLoS ONE 2010 5(11):e11054, doi:10.1371/journal.pone.0011054. A complete list of previous recipients is available here.

24


Prizes and Awards con’t. Kenneth Warren Prize Prize presentation will take place during The Cochrane Collaboration’s Annual General Meeting, 21 September 2013

Kenneth Warren, MD Kenneth Warren (1929-1996) was a larger-than-life man who was a source of encouragement and support for many young people, particularly those living in developing countries. He was very influential in drawing attention to the ‘great neglected diseases’ that plague people in the poorer parts of the world. He was one of the first people to draw attention to the need for valid summaries of key research studies and the way electronic media could be used to disseminate results of health research relevant to people in developing countries. Ken was an enthusiastic supporter of the pilot work in pregnancy and childbirth that led to the creation of The Cochrane Collaboration, and, with Fred Mosteller, he co-organized the meeting at the New York Academy of Sciences at which the vision for The Cochrane Collaboration was first made public.

Kenneth Warren Prize The Kenneth Warren Prize has been established with individual and institutional donations (see cochrane.org for details) to celebrate and recognize Ken’s interests. It was awarded for the first time at the 8th Cochrane Colloquium in Cape Town, South Africa, 2000. The Prize is awarded annually to the principal author who is a national living in a developing country of a published Cochrane Review which is judged to be both of high methodological quality and relevant to health problems in developing countries.

2013 Selection panel Nandi Siegfried, South Africa (Chair) Prince Christopher, India Zohra Lassi, Pakistan Don Mathanga, Malawi

Previous recipients 2012 - Don Mathanga, Malawi: Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women

2011 - Zohra Lassi, Pakistan: Community based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes A complete list of previous recipients is available here.

The Prize for any given year is open to the principal author of a review published in the Cochrane Database of Systematic Reviews in The Cochrane Library, in Issues 4-12 of the previous year and issues 1-3 of the current year. In response to the call for nominations, authors may either self-select their review(s) based on quality and relevance, and Review Group editorial teams and other members of The Cochrane Collaboration may also nominate specific reviews. The judgement is made by a panel comprised entirely of nationals of developing countries. The Prize recipient receives a certificate and USD 1000. Travel, accommodation and conference registration costs of the Prize recipient and Chair of the selection panel are also met to enable attendance at the Cochrane Colloquium to receive and present the Prize.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

25


Prizes and Awards con’t. PAHO – Iberoamerican Cochrane Network Award 2013 Award presentation will take place during Plenary III, 22 September 2013 The Pan American Health Organization (PAHO), with the Iberoamerican Cochrane Network, created this award to recognize systematic reviews and protocols that contribute to the advancement of the Health Agenda for the Americas 2008-2017, agreed by the Governments of the Americas in 2007. The prize aims to inspire Cochrane authors, reviewers, and other young researchers to develop systematic reviews that contribute to informed decisions in priority topics for the health systems in the Americas. This year’s theme is Prevention of chronic non-communicable diseases through healthy lifestyles. Its objective is to promote research on healthy lifestyles as a means of preventing non-communicable diseases. The prize will be awarded to a systematic review and protocol that answers questions about prevention of chronic non-communicable diseases that are relevant to the health systems in Latin America and the Caribbean (LAC). The award recognizes the authors of a systematic review and protocol that have been judged based on their importance and usefulness to health systems in LAC and are of the highest quality. The recipients of the award will be recognized at the Colloquium, and one of the authors will receive free registration, to be decided by the author team and the conference organizers. Eligible works must: • be written by Iberoamerican authors (or residents) living in LAC, affiliated with a Latin American and Caribbean Institution; and • be of high methodological quality: present a structured summary and recommendations that are concrete and applicable.

Previous recipients 2012 - Auckland The prize was not offered in 2012

2011 - Madrid Systematic Review: • Not awarded/there was no winner. Protocol: Three protocols received honorary mention: • Gutiérrez-Aguado A, Fiesta F, Solari L, Suárez V • López-Alcalde J, Dancer S, Martí-Carvajal AJ, Conterno LO, Guevara-Eslava M, Mateos-Mazón M, Gracia J, Solá I • Martí-Carvajal AJ, Cruciani M

2010 - Keystone Systematic Review: • González U, Pinart M, Rengifo-Pardo M, Macaya A, Alvar J, Tweed JA Protocol: Two protocols were awarded the prize. • Sguassero Y, Booker D, Dennis JA, Orellano A and Abalos E • Peñaloza B, Rada G, Pantoja T, Bustíos G and Herrea C

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

26 27


Québec Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

La Ville de Québec est la Capitale du Québec et, après Montréal, la deuxième ville en importance de la province. Le Vieux-Québec est la seule ville fortifiée au nord du Mexique, dont les fortifications existent encore aujourd’hui. Le VieuxQuébec a d’ailleurs été déclaré joyau mondial de l’UNESCO en 1985, en tant qu’«Arrondissement historique du Vieux-Québec». Autant dans la Haute que la Basse-Ville, au-dessus et au pied du Cap Diamant, on dénombre pas moins de 11 styles architecturaux distincts, allant de l’architecture classique française (1608-1700), au néo-classicisme (1790-1820) et au style international (1930-1965). Le Vieux-Québec est jouxté par les plaines d’Abraham, qui furent le site d’une bataille entre les troupes anglaises et françaises en septembre 1759 et qui eut un impact significatif 27 sur l’avenir de l’Amérique du Nord.


Québec Québec City is the capital of Québec and, after Montreal, the second largest city in the province. Québec’s Old Town (Vieux-Québec) is the only North American fortified city north of Mexico whose walls still exist. It was declared a UNESCO World Heritage Site in 1985, as the “Historic District of Old Québec”. In Québec’s Upper and Lower Towns, above and below the cliff, you can find at least 11 architectural styles, ranging from Classical Revival (1790-1820) to International Style (1930-1965). The area is also home to the Plains of Abraham, where a pivotal battle between the French and English in 1759 shaped the future of North America.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

28


Social Program Welcome Reception Musée de la civilisation Thursday 19 September 2013, 1800 The 21st Colloquium organizing committee invites you to kick off our celebration of two decades of Cochrane history while exploring millions of years of human history at the Musée de la civilisation. Join us at our Welcome Reception and navigate three of the museum’s exhibits as our 20th Anniversary gift to you. This delightful reception will allow you to connect with old friends and new, while bringing an energizing start to the Colloquium with beverages and hors d’oeuvre for you to enjoy while you mix and mingle. The Musée de la civilisation is located in the heart of a historic district and links the past, present and future. While remaining strongly rooted in the reality of Québec, it projects a new, attentive and dynamic outlook on the human experience in its whole, and on civilizations from the world over. Visitors enter into a world of discovery and exploration with the museum calling upon all of their senses, speaking to both the heart and the mind. The three exhibits open for exploration are: • Game Story • People of Québec . . . then and Now • Paris on stage. 1889-1914 Participants must be registered for this event. Tickets will be emailed to registrants prior to the Colloquium. Tickets must be printed and shown at the door to gain entry. Visit mcq.org for more information on these exhibits.

Randomized Dinner Friday 20 September 2013, 1900 As Cochranites you can never get enough of methods, stats, numbers and tables, so, why not make them a part of dinner? Join the Collaboration’s Randomized Dinner and feast at a fine Québec City restaurant with a group of other randomly assigned participants. Get to know Cochranites from around the world who you may have met in passing while rushing to attend (or teach!) a workshop or seminar. Create new linkages and network with colleagues and new friends who share an interest in evidence-based health care. At a randomly assigned restaurant, you will receive a choice of two or three pre-set, threecourse menus, including a complimentary alcoholic beverage. Take a step out on your own with this unique opportunity to embrace randomization with guaranteed positive results. Participants must be registered for this event. Assigned restaurants will be displayed on each registrant’s ticket. Tickets will be provided upon Colloquium check-in.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

29


Social Program con’t. 20th Anniversary Gala Hyderabad 400 A Sunday 22 September 2013 Cocktail hour begins at 1800; dinner begins promptly at 1900 Shine those dancing shoes, loosen up your legs and prepare to tantalize your taste buds for A Night with Cochrane: The Cochrane Collaboration’s 20th Anniversary Gala Extravaganza. We are prepared to deliver a night you will never forget, complete with a live performance that will reach new heights. Relive special moments as we celebrate two decades of success in evidence-based health and health care. Taste Québec’s delicacies and embrace its culture while dancing the night away in one of the beautifully decorated banquet rooms at the Centre des congrès de Québec. Help 20 years of Cochrane go out with a bang by coming together for a monumental celebration of Cochrane’s coming of age. Participants must be registered for the Gala and present their tickets at the door to gain access. Tickets will be provided upon Colloquium check-in. * The dress code for this event is business formal, though guests are welcomed and encouraged to dress in cocktail/semi-formal attire.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

30 30


20th Anniversary The Cochrane Collaboration celebrates its 20th Anniversary anniversary.cochrane.org The Cochrane Collaboration proudly celebrates two decades of working together to provide the best evidence for health care. We invite you to participate in several initiatives we have created to help commemorate this monumental event.

Archie’s Jukebox – the perfect playlist

A memorable evening consists of great people, delicious food and, of course, an amazing soundtrack. Your song submissions have formed part of the 20th Anniversary Gala’s playlist. Listen for your selections as you dance and celebrate.

Blast from the Past

The Colloquium Organizers thought they would give delegates a Blast from the Past by naming the venue rooms after various cities which have hosted Colloquia over the past 20 years. Enjoy reminiscing as you enter cities from across the globe.

Cochrane Anniversary Trivial Pursuit Challenge

If the intellectual rigour of systematic review methodology is making your brain hurt, but you still fancy a little light Cochrane-related brain stimulation, what better way to limber up than by participating in the Cochrane Anniversary Trivial Pursuit Challenge? You will find in your delegate bags a Trivial Pursuit button badge, set of questions and game instructions to thoroughly test your knowledge of Cochrane past and present. Could there be an Entertainment question about Cochrane Methods? (yes - it’s possible!). A Literature question about Wiley? (more plausible, perhaps). History, Geography, Science and Sport (yes, really) will also be covered. Some questions are easy, some fiendish, but we hope they will encourage you to talk to new and familiar colleagues across the Collaboration, view and listen to the multi-media displays, visit exhibition stands such as Cochrane Exchange, and pay close attention to the inspiring plenary presentations where the answers may lie.

Cochrane Dance-Off

Dance off

Watch Cochrane entities show off their skills in the first Cochrane dance circle. Entities will be represented by individuals and troupes during the dance portion of the Gala. Don’t miss your colleagues out on the dance floor!

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

31


20th Anniversary con’t. Entryway Poster Display

As you enter the Québec City Convention Centre and make your way through the Welcome Arch you will encounter poster boards adorning information to help celebrate 20 years of Cochrane. There will be photo collages, murals of publications, and an “In the News” poster, to name a few. Please come and take in this information as you enjoy your coffee break!

Merchandise Booth

The Anniversary Public Relations Working Group will be on-site to deliver the promotional merchandise ordered in advance of the Colloquium to help celebrate the 20th Anniversary of The Cochrane Collaboration. Come by our booth to pick up your order, and please bring Canadian cash for your purchase. Please bring exact change.

“Most likely to” Board

In some countries, each high school year is commemorated with a “yearbook” which tells the tale of the year gone by and highlights special events and groups or teams who contributed to school spirit. Each student’s picture is featured, often, with the caption: “Most likely to . . .” as voted by the rest of their peers. Titles can range from silly suggestions such as, “Most likely to take over the world” to more serious submissions such as, “Most likely to run a large corporation”. We invite you to participate in Cochrane’s “Most likely to” Board (in the main entry hall) and add your own take on the claim to fame for the Cochranites we’ve featured. Suggestions will be provided – or come with your own!

Record a Message

You may see our wandering videographer, Richard Davis, with our own Jini Hetherington from time to time stopping to see if you would like to record a very short message of congratulations to The Cochrane Collaboration on celebrating its 20th Anniversary. Many of these clips will be pieced together and played on the plenary room (Québec 200 AB) screens as you enter to find your seat. Arrive at the plenary sessions 10 minutes early to enjoy the show!

Tapestry

Thirty-three individual contributions have created a beautiful Cochrane tapestry representing the Collaboration, entities, and different parts of the world. Over a third of all entities contributed to this endeavor. The tapestry is nearly 25 feet long and is displayed in Foyer 2 (outside of the plenary room). The Collaboration will continue to add contributions to the tapestry, and it can be borrowed to display at future Cochrane meetings or conferences. Be sure to take the time to view this work of art created by you and your colleagues.

The Cochrane Story

Each level of the Convention Centre features wall-mounted LCD screens. Not only will these screens direct you to various rooms, but some have been designated to tell you the Cochrane Story. Look up each day to learn something new about the last 20 years of Cochrane!

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

32


Ontario The Province of Ontario is approximately 1,076,395 square kilometres/415,598 square miles. It is: larger than France and Spain, combined; almost 1/3 the size of India; more than 3 times the size of Germany;

more than 3.5 times the size of Italy; more than 1/10 the size of Canada; more than 4 times the size of the UK; more than 8.25 times the size of England;

more than 15 times the size of Ireland; and about the same size of the US states Texas & Montana, combined. Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

33


Colloquium Co-Chairs Dr France Légaré, BSc Arch, MD, PhD, CCFP, FCFP Canada Research Chair in Implementation of Shared Decision Making in Primary Care Professor, Department of Family Medicine and Emergency Medicine, Université Laval Researcher, Centre Hospitalier Universitaire de Québec (CHUQ)

Trained as an architect first, France has been a family physician in Québec since 1990. She is a Full Professor with the Department of Family Medicine and Emergency Medicine at Université Laval and acts as its Research Director. Since 1 June 2006, she has held a Tier 2 Canada Research Chair in Implementation of Shared Decision Making in Primary Care. France leads the ‘’Knowledge Transfer and Health Technology Assessment’’ theme for the Population Health and Optimal Health Practices Research Unit, CHU de Québec Research Centre. She has been the Canadian Cochrane Centre Regional Site Representative at Université Laval since 1999. Her research program aims at providing healthcare professionals and patients with the needed tools to optimize decision-making in the context of primary care (shared decision-making).

Dr François Rousseau, BSc, MD, MSc, FRCPC FQR-S/MSSS/CHUQ Research Chair in Health Technology Assessment and Evidence Based Laboratory Medicine Professor, Department of Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval Researcher, Centre de recherche du CHU de Québec

Dr François Rousseau is a medical biochemist subspecialized in molecular genetics. He obtained a BSc in medicine (1983), a MD in medicine (1984) and a MSc in Molecular Ontogeny (1987), all from Université Laval. He completed a post-doctoral fellowship in Human Molecular Genetics at Université Louis-Pasteur in Strasbourg (1989-1991), where he contributed to the discovery of the fragile-X syndrome gene, the most frequent cause of inherited mental retardation. His research focuses on the translation of discoveries stemming from the Human Genome Project into the health care system. He is an expert member of several national and international committees on diagnostic tests, including for the Québec Health Technology Assessment Agency (INESSS). He is the designated principal investigator of the CIHR-funded Canadian APOGEE-Net/CanGeneTest research consortium on health services research in genetics that focuses on transferring clinically useful and cost-effective genetic innovations to the health care system. He has over 110 peer reviewed publications.

Dr Jeremy Grimshaw, MBCHB, PHD, FRCGP, FCAHS Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake Senior Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute Full Professor, Department of Medicine, University of Ottawa Co-Chair, The Cochrane Collaboration Steering Group Director, Canadian Cochrane Centre

Dr Jeremy Grimshaw received a MBChB (MD equivalent) from the University of Edinburgh, UK. He trained as a family physician prior to undertaking a PhD in health services research at the University of Aberdeen. He moved to Canada in 2002. His research focuses on the evaluation of interventions to disseminate and implement evidence-based practice. Dr Grimshaw is a Senior Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute, a Full Professor in the Department of Medicine, University of Ottawa, and a Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake. He is Co-Chair of The Cochrane Collaboration Steering Group, Director of the Canadian Cochrane Centre and Co-ordinating Editor of the Cochrane Effective Practice and Organisation of Care Review Group. He is also the Principal Investigator of Knowledge Translation Canada (KT CANADA), a Canadian Institute of Health Research and Canada Foundation for Innovation funded interdisciplinary network of over 50 knowledge translation researchers from six academic health science centres in four provinces. He has over 400 peer reviewed publications.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

34


1st Annual Cochrane Lecture 0845

Sir Iain Chalmers, DSc

Coordinator, James Lind Initiative

Iain Chalmers practised as a clinician for seven years in the UK and the Gaza Strip before becoming a full time health services researcher. Between 1978 and 1992 he was founding director of the National Perinatal Epidemiology Unit. Between 1992 and 2002, he was founding director of the UK Cochrane Centre, which convened the meeting at which The Cochrane Collaboration was inaugurated. Since 2003, he has coordinated the James Lind Initiative to promote public and professional acknowledgement of the need to address uncertainties about the effects of treatments. Between 2003 and 2013 the James Lind Initiative established the UK Database of Uncertainties about the Effects of Treatments and the James Lind Alliance, a framework to enable patients and clinicians to identify shared priorities for research. The James Lind Initiative is currently responsible for editing Testing Treatments interactive – English and The James Lind Library. Iain Chalmers was knighted in 2000 for services to health care.

Speaker Ready Room We encourage speakers to bring their CDs/USB keys to the Speaker Ready Room (Vienna 201 A) one hour, or a day, before their presentation to avoid delays. This allows speakers to test presentations and make final adjustments, if necessary. A computer technician will be present to transfer presentations to the appropriate computer. This allows for presentations to be ready for use at the appropriate time. We suggest you arrive at least 10 minutes prior to meet your session moderator to ensure your presentation goes smoothly.

Plenary Speakers Dr Alan Bernstein, OC, PhD, FRSC President and Chief Executive Officer, Canadian Institute for Advanced Research

Dr Alan Bernstein is the President and CEO of CIFAR (the Canadian Institute for Advanced Research), whose mission is to connect the world’s best minds through global research networks that address important and complex challenges facing humanity. An internationally known biomedical scientist, Dr Bernstein was the executive director of the Global HIV Vaccine Enterprise, an international alliance of researchers and funders charged with accelerating the search for an HIV vaccine, from 2008-2011. Previously, he served as the founding president of the Canadian Institutes of Health Research (2000-2007), Canada’s federal agency for the support of health research. In that capacity, he led the transformation of health research in Canada. After receiving his PhD from the University of Toronto, and following postdoctoral work in London, Dr Bernstein joined the Ontario Cancer Institute (1974-1985). In 1985, he was appointed to the new Samuel Lunenfeld Research Institute in Toronto, was named Associate Director in 1988 and then Director of Research (1994-2000). Author of over 225 scientific publications, Dr Bernstein has made extensive contributions to the study of stem cells, hematopoiesis and cancer. He chairs or is a member of advisory and review boards in Canada, the US, UK, Italy and Australia. Dr Bernstein has received numerous awards and honourary degrees for his contributions to science, including the 2008 Gairdner Wightman Award. He is a Senior Fellow of both Massey College and the Munk School of Global Affairs, and is an Officer of the Order of Canada.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

35


Plenary Speakers con’t. Lisa A Bero, PhD Professor, University of California, San Francisco Director, San Francisco Branch US Cochrane Center

Lisa A Bero is a pharmacologist who studies how science is translated into clinical practice and health policy. She has developed and validated methods for assessing bias in the design, conduct and dissemination of research on pharmaceuticals, tobacco and chemicals. Dr Bero has also conducted analyses to examine the dissemination and policy implications of research evidence. Her international activities include advisor to the World Health Organization Department of Essential Medicines and Pharmaceutical Policies, member of the WHO Essential Medicines Committee and member of the Pan American Health Organization Advisory Committee on Health Research. She is Director of the San Francisco Branch of the United States Cochrane Center and the World Health Organization Collaborating Centre on Pharmaceutical Research and Science Policy. She was an elected member of The Cochrane Collaboration Steering Group for 12 years and serves on several national and international committees related to conflicts of interest and research, such as the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education and Practice.

David Bornstein Author, How to Change the World: Social Entrepreneurs and the Power of New Ideas (Oxford University Press) Journalist, The New York Times

David Bornstein is a journalist and author who focuses on social innovation. He co-authors the Fixes column in The New York Times Opinionator section, which explores and analyzes potential solutions to major social problems. He is the co-founder of the Solutions Journalism Network, which supports journalists who report on constructive responses to social problems, and the founder of Dowser, a media site for young journalists who cover social innovation. His books include How to Change the World: Social Entrepreneurs and the Power of New Ideas, The Price of a Dream: The Story of the Grameen Bank, and Social Entrepreneurship: What Everyone Needs to Know. He is currently completing a book on social innovation in the US and Canada. He lives in New York.

Dr Catherine L Cook, MD, MSc, CCFP, FCFP Associate Dean, First Nations, Métis and Inuit Health

Dr Catherine Lousie Cook graduated from the University of Manitoba’s Faculty of Medicine in 1987, certified in Family Medicine in 1989 and received her Masters of Science in 2003 through the Department of Community Health Sciences, U of MB. With a joint position as Vice-President of Population and Aboriginal Health for the Winnipeg Regional Health Authority, and Associate Dean of First Nations, Metis and Inuit Health at the University of Manitoba’s Faculty of Medicine, Dr Cook plays an important role in shaping the nature and scope of Aboriginal health care and research in Manitoba. Dr Cook practiced as a family physician in remote northern nursing stations for several years before focussing on public health practice and administration. She has held positions of Associate Director of the JA Hildes Northern Medical Unit, Regional Director of Health Programs for First Nations and Inuit Health, Manitoba Region, Regional Medical Officer of Health for the Nor-Man and Winnipeg Regional Health Authorities, Director for the Centre for Aboriginal Health Education and Co-Director of the Manitoba First Nations Centre for Aboriginal Health Research, and the Co-Chair of the ‘Changes for Children’ Implementation Team – a process for systemic change within the child welfare system in Manitoba stemming from the AJI-CWI Initiative and a series of reviews of the child welfare system.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

Continued next page

36


Plenary Speakers con’t. Dr Catherine L Cook, con’t. In 2000, Dr Cook joined the Winnipeg Regional Health Authority and played a leading role in developing its Aboriginal Health Strategy and also served as a special advisor to the Minister of Health during the H1H1 influenza outbreak in 2009. She is the Manitoba lead for the Networks Environment for Aboriginal Health Research (NEAHR), which will build capacity, obtain information about Aboriginal health and help build a critical mass of Aboriginal doctors, nurses, specialists and researchers who understand the challenges and needs of Canada’s First Nation, Metis and Inuit people. In 2011, Dr Cook received the May Cohen Gender Equity and Diversity Award from the Associations of Faculties of Medicine in Canada, and has recently received the 2013 Health Administration Award from Doctors Manitoba. Dr Cook participates on several national boards and committees, and has been actively engaged in board and committee membership throughout her career.

Dr Tim Evans, DPhil, MD Director, Health Nutrition and Population, World Bank

Timothy G Evans is the Director, Health, Nutrition and Population at the World Bank. Dr Evans has been active in the international health arena for more than 20 years. Before joining the World Bank, he was the Dean of the James P Grant School of Public Health of BRAC University in Bangladesh. Previously, he served as Assistant Director General at the World Health Organization, heading the Evidence, Information, Research and Policy Clusters, where he oversaw the production of the annual World Health Report. Dr Evans has been a leader in advancing global health equity and health systems performance throughout his career, notably through his work with the Rockefeller Foundation and the Harvard School of Public Health and with his contributions to the development of innovative partnerships, including the Global Alliance on Vaccines and Immunization, INDEPTH and Health Metrics networks, the Global Health Workforce Alliance and the World Alliance for Patient Safety. Dr Evans earned his DPhil in agricultural economics at Oxford, and pursued medical and postgraduate studies at McMaster and Harvard Universities.

Dr Luiz Augusto Cassanha Galvão Acting Assistant Director, Pan American Health Organization

Dr Galvão, a Brazilian national, received his medical degree in Brazil in 1977 and a Master’s Degree in Public Health with specialization in environmental epidemiology from the Escola Nacional de Saúde Pública Sérgio Arouca of Fundação Oswaldo Cruz (FIOCRUZ). Dr Galvão began his professional career in 1979 at the Instituto de Saúde da Bahia in Brazil. Later, he became Coordinator of the Center for Studies on Workers’ Health and Human Ecology (CESTEH) of FIOCRUZ. His professional career includes extensive teaching experience and a vast number of technical publications. He was president of the Brazilian Society of Toxicology and is an active member of several professional associations. Dr Galvão’s career at PAHO started in 1991 as Environmental Epidemiologist of the Pan American Center for Human Ecology and Health (ECO). In 1994 he was appointed Regional Advisor on Environmental Quality and in July 2001 Coordinator of the Environmental Quality Program until February 2003. In March 2003, he was appointed Area Manager of the Sustainable Development and Environmental Health Area. As of 1 July 2013, he was appointed Chief of the Special Program on Sustainable Development and Health Equity. The Special Program on Sustainable Development and Health Equity deals with many relevant risks for public health in the Region of the Americas, such as: Violence, Workers’ Health, Environmental Health, Health Promotion, Climate Change, Local Development, Consumers’ Health, Human Security, Social Determinants of Health, Toxicology, and Millennium Development Goals. Dr Galvao is acting as PAHO Assistant Director since 29 July 2013.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

37


Plenary Speakers con’t. Lorraine Johnson, JD, MBA Co-Chair, Consumers United for Evidence-Based Healthcare (CUE) Steering Committee Executive Director, LymeDisease.org

Lorraine Johnson is the Co-Chair of the steering committee of Consumers United for Evidence-Based Healthcare (CUE), a national coalition of approximately 40 consumer advocacy organizations. CUE was organized in 2003 when the US Cochrane Centre invited advocacy groups to join a consumer advocate-scientist partnership to improve the consumers’ ability to engage in and demand high quality healthcare. She serves as a consumer peer reviewer for The Cochrane Collaboration’s evidence-based protocols and reviews. She is also a member of the international Cochrane Consumer Network and presented to this group at a Cochrane Colloquium on the topic of “Evidence-Based Medicine: Evidence, Evidence Gaps and the Role of Stakeholders”. She is the Chief Executive Officer of LymeDisease.org (LDo), a US national non-profit that publishes the only print journal dedicated to Lyme disease, maintains a national network of state-based internet groups, and funds research. She has published over 40 publications in peer reviewed journals regarding medico-legal and ethical aspects of Lyme disease and evidence-based health care. She has spoken at universities, before state legislatures, the US Centers for Diseases Control, at the Canadian government consensus hearings on Lyme disease, before medical societies, at the IDSA guideline review hearing and at The Cochrane Collaboration (Cochrane Consumer Network). She is a director and an officer of the International Lyme and Associated Diseases Society. She is also a member of the patient research grant reviewer panel for the US Patient Centered Outcomes Research Institute.

Dr John N Lavis, MD, PhD Director, McMaster Health Forum Associate Director, Centre for Health Economics and Policy Analysis Professor, Department of Clinical Epidemiology and Biostatistics and the Department of Political Science, McMaster University Adjunct Professor of Global Health, Department of Global Health and Population, Harvard School of Public Health

John N Lavis’ principal research interests include knowledge transfer and exchange in public policymaking environments and the politics of health systems. He led the creation and oversees the continuous updating of Health Systems Evidence, the world’s most comprehensive, free access point for high-quality evidence about how to strengthen or reform health systems, or how to get cost-effective programs, services and drugs to those who need them. He directs the Program in Policy Decision-Making and oversees the Policy Liaison Office of the Canadian Cochrane Centre. He teaches an undergraduate course on the politics of health systems for the Bachelor of Health Sciences (Honours) program at McMaster University, a simulations course in the same program, and the doctoral seminar for the PhD in Health Policy program. He teaches a week-long module on ‘Using and supporting the use of research-based evidence in healthcare organizations and systems’ for Canada’s Executive Training for Research Application (EXTRA) program and runs one-day and two-day workshops on using research evidence for governments and international agencies. He is Co-Chair of the World Health Organization (WHO)sponsored Evidence-Informed Policy Network (EVIPNet) Global Steering Group, President of the Pan American Health Organization (PAHO) Advisory Committee on Health Research, and a member of the WHO Advisory Committee on Health Research. John holds an MD from Queen’s University, an MSc from the London School of Economics, and a PhD from Harvard University.

Dr France Légaré, BSc Arch, MD, PhD, CCFP, FCFP Canada Research Chair in Implementation of Shared Decision Making in Primary Care Professor, Department of Family Medicine and Emergency Medicine, Université Laval Researcher, Centre Hospitalier Universitaire de Québec (CHUQ)

Trained as an architect first, France has been a family physician in Québec since 1990. She is a full professor with the Department of Family Medicine and Emergency Medicine at Université Laval and acts as its Research Director. Since 1 June 2006, she has held a Tier 2 Canada Research Chair in Implementation of Shared Decision Making in Primary Care. France leads the ‘’Knowledge Transfer and Health Technology Assessment’’ theme for the Population Health and Optimal Health Practices Research Unit, CHU de Québec Research Centre. She has been the Canadian Cochrane Centre Regional Site Representative at Université Laval since 1999. Her research program aims at providing healthcare professionals and patients with the needed tools to optimize decision-making in the context of primary care (shared decision-making). Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

38


Plenary Speakers con’t. Chris Mavergames, MLIS Director of Web Development, The Cochrane Collaboration

Chris Mavergames leads Cochrane’s Web Team in the development and maintenance of Cochrane’s web presences; this includes more than 120 organizational, entity, and special project websites, as well as social media and other technology and knowledge management initiatives. He is also Co-Chair of the Cochrane Linked Data Project Board and has led Cochrane’s exploration into using linked data and semantic technologies to enhance the production and dissemination of Cochrane evidence since its inception in 2011. Chris’ background is in information science and knowledge management with an MLIS degree from Long Island University in New York, US. He has more than 12 years’ experience working with XML and related technologies, database management systems, web development technologies, metadata schema and controlled vocabularies and, most recently, linked data technologies. Chris began his career at CNN and Time Inc., in the relatively early days of digital and online publishing. He went on to become Director of Multimedia Resources at the New York City College of Technology, and then spent a year working on a digitisation project at the British Library, St. Pancras, London. Chris joined The Cochrane Collaboration in 2006 and took over leadership of the Web Team in 2009. In addition to his work with the Web Team, he is an author in the Cochrane Airways Group and a member of the Information Retrieval Methods Group.

Dr Andrew D Oxman, MD, MSc Researcher, Global Health Unit, Norwegian Knowledge Center for the Health Services

Andy Oxman works as a health services researcher in the Global Health Unit at the Norwegian Knowledge Centre for the Health Services. His research over the past three decades has focused on ways of helping people make informed choices about healthcare. His current research focuses primarily on supporting the use of research evidence to inform healthcare decisions in low- and middle-income countries. Andy completed his medical training in the US in 1979. After that he worked as a general practitioner in northern Norway. He was at McMaster University in Canada from 1984 to 1994 before moving back to Norway. He was an editor of the Cochrane Reviewers’ Handbook (currently Cochrane Handbook for Systematic Reviews of Interventions) from 1993 to 2003 and chair of The Cochrane Collaboration Steering Group from 1998 to 2000. He has been an editor for the Cochrane Effective Practice and Organisation of Care Group since 1994.

Dr Jimmy Volmink, DCH, MPH, MD, PhD Dean, Faculty of Medicine and Health Sciences, Stellenbosch University Director, South African Cochrane Centre

Jimmy Volmink is Dean of the Faculty of Medicine and Health Sciences, Stellenbosch University and Director of the South African Cochrane Centre, SA Medical Research Council. Previous appointments include GlaxoWellcome Chair of Primary Health Care, University of Cape Town and Director of Research and Analysis, Global Health Council, Washington DC. He is a member of committees and advisory boards of a large number of health and scientific organizations. In 2005 he was Guest Editor of the British Medical Journal Special Issue on Africa. He has a special interest in the evaluation of interventions for chronic diseases, including TB, HIV and cardiovascular disease, and in translating evidence into policy and practice.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

39


Plenary Speakers con’t. Professor Thomas J Walley, MB, BCh, MD, FRCPI, FRCP, CBE Director, NIHR Evaluation, Trials and Studies and Director of the HTA Programme Professor, Health Services Research, Institute of Psychology, Health and Society, University of Liverpool

Professor Thomas J Walley qualified in medicine in Dublin in 1980. He was appointed consultant physician in the Royal Liverpool University Hospital in 1991, and Professor of Clinical Pharmacology in Liverpool University in 1994. He is a Fellow of the Royal Colleges of Physicians of London and of Ireland, and of the British Pharmacological Society. Tom Walley has been Director of the HTA programme since January 2004. He also has responsibility for other NIHR programmes including the Health Service & Delivery Research programme, the Public Health Research programme, the Reviews Programme, and the MRC/NIHR funded Efficacy and Mechanisms Evaluations programme. He formerly headed a research group at Liverpool University, focusing on drug prescribing, pharmaceutical policy, and clinical effectiveness and cost-effectiveness. In June 2008, he was awarded a CBE by the Queen for his services to medicine.

Mark G Wilson, MA, DIP JOUR, M PHIL, MM, FCMI Chief Executive Officer, The Cochrane Collaboration

Mark started work as The Cochrane Collaboration’s new Chief Executive Officer in November 2012. He has extensive leadership experience at the highest levels in international humanitarian and development organizations, including the International Federation of Red Cross and Red Crescent Societies, where he was Chef de Cabinet, Senior Advisor to the Secretary General and the organisation’s Head of Planning. Previously he had been Head of Delegation in Mozambique; managed the Federation’s humanitarian operations in former Yugoslavia from 1996 to 2000; and in charge of the Federation’s Appeals & Reports for Africa and Europe from 1994 to 1996. From 2004 to 2012 Mark was Executive Director of Panos London and Chair of the worldwide Panos Network of Institutes, which he helped to establish. Panos aims to ensure information and communication is effectively used to foster public debate, pluralism and democracy amongst poor and marginalized communities around the world. Mark is a member of the Royal Institute of International Affairs and the International Institute for Strategic Studies, and a Fellow of the Chartered Management Institute in the UK. He holds Masters Degrees from universities in the UK and Canada in International Politics; Soviet and East European Studies; Journalism; and Management. As a former journalist in London and Hong Kong, and Communications Director of the Swiss-based Business Council for Sustainable Development, he is an experienced commentator on international economics, business and politics.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

40


Manitoba Photo: Roof of Manitoba Legislative Building Photo taken by en:User:Zef, 4 June 2007 Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

The Golden Boy is arguably Manitoba’s most known symbol. It is a 17-foot statue of a messenger boy holding a sheaf of golden grain in one hand and a torch in the other, embodying the spirit of enterprise and eternal youth. The figure was sculpted by Georges Gardet of Paris in 1918, and its journey from France to Manitoba was anything but easy. The foundry where it was casted was bombed during World War I, though somehow the Golden Boy emerged unharmed. It was then put on a ship, which was commandeered for the transport of troops before it had a chance to set out to sea. It wasn’t until the war was over that the statue made it to Halifax, where it was then shipped to Manitoba. The Golden Boy was finally erected on top of the Legislative Building of Manitoba on 21 November 1919. 41


This program book will not be available in print as part of our effort to reduce our environmental footprint and capitalize on the various technologies available. It will be available electronically only, online at colloquium.cochrane.org, on the USB flash drive provided to all delegates at the Colloquium and as an app for download at eventmobi.com/cochrane2013. Please print any pages you want copies of before coming to the event. Paper copies will not be available on-site.

Indicates simultaneous translation available; English-French

Internal Cochrane Business Meetings

All day:

(see separate schedule provided)

1200-1530

Registration/check-in

Fourth level, main hallway

1530-1700

Newcomers’ Session

Amsterdam 303 A

This session is for you if you are new to The Cochrane Collaboration and you are unsure what it is, how it works and how to get involved. The history and structure of the Collaboration will be discussed briefly during this informal session. You will also receive tips on how to navigate the Colloquium and which sessions are most suitable for you.

1800-2100

Welcome Reception

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

M usée de la civilisation 85 Rue Dalhousie

42

Thursday 19 September

Thursday 19 September


Nunavut Though Nunavut is the largest landmass in Canada, there is only one paved road in the entire Territory, located in the capital city of Iqaluit. Cars can travel within individual communities in Nunavut, but there are no roads connecting the communities to each other or connecting them to southern Canada. The most popular way to travel is by small plane, boat, or in the winter months, skidoo.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

43


0700

Registration/Check-in Opens

0700-0815

Meetings Meeting

Restriction (If any)

Room

Cochrane ENT/AAOHNS Cochrane Scholars

Closed

São Paulo 205 B

Consumers and Communication Group Editors’ Meeting - Part 1

Closed

Amsterdam 303 A

DECIDE: coverage decisions about medical tests

Closed

Adelaide 302 B

Evidence to policy in graduate programs

Closed

Melbourne 204 B

Managing Editors’ Executive - Part 1

Closed

Rome 304 A

Neonatal Review Group Annual Meeting

Open

Barcelona 204 A

Relative risk, odds ratio and hazard ratio — how to report these effect measures

Open

Cape Town 304 B

Training Working Group

Closed

Dublin 205 A

Trials Search Co-ordinators’ Executive Meeting — Part 1

Closed

Madrid 207

Poster Set-up 1: Meet the Entities

Ottawa 200 C

0830-1000

Opening Ceremony and Plenary I

Québec 200 AB

Welcome and Opening Remarks

21st Cochrane Colloquium Co-Chairs: Jeremy Grimshaw and François Rousseau Dr Alain Beaudet President Canadian Institutes of Health Research

Sophie D’Amours Vice Rector Research and Innovation Université Laval

Rénald Bergeron

Dean Faculty of Medicine Université Laval

Rémi Quirion

Chief Scientist Fonds de recherche du Québec

0700-0815

friday 20 September

Friday 20 September

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

44


Better knowledge for better health: Effectiveness and Efficiency

The learning objectives of this plenary session are to ensure participants:

1.

2. Acquire an understanding of the history of The Cochrane Collaboration and its contribution to evidence-based decisions in health care.

3. Identify future opportunities for The Cochrane Collaboration to support evidence informed health care and health systems.

 ffectiveness and Efficiency, published in 1972, is a landmark publication that has E had a major influence on health services research and the thinking about health systems globally. In it, Archie Cochrane argued “all effective treatments should be free”, and for robust research to support health system decisions about what care to provide and how to provide it. In this plenary, speakers will reflect on the relevance of Cochrane’s arguments 40 years on, how The Cochrane Collaboration has contributed to better knowledge globally and what still needs to be done.

Chairs: Alain Beaudet and France Légaré

Speakers: Professor Thomas J Walley, MB, BCh, MD, FRCPI, FRCP, CBE

0830-1000

friday 20 September

Friday 20 September con’t.

Recognize the role of evidence to support health care decision-making.

Director, NIHR Evaluation, Trials and Studies and Director of the HTA Programme Professor, Health Services Research, Institute of Psychology, Health and Society, University of Liverpool Effectiveness and efficiency: better knowledge for better health

Lisa Bero, PhD Professor, University of California, San Francisco Director, San Francisco Branch US Cochrane Center Cochrane Reviews travel the world . . . but evidence can only take you so far

Dr Andrew D Oxman, MD, MSc Researcher, Global Health Unit, Norwegian Knowledge Center for the Health Services From there to here, the first 20 years of The Cochrane Collaboration

1000-1030

Refreshment Break; Meet the Entities poster viewing and Exhibitors

Meet the Entities Poster Session; Friday 20 September 2013; all-day

The Meet the Entities session is a tradition within the Colloquium. It is an opportunity for delegates to meet and visit entity representatives, obtain information and make linkages with each entity.

In light of Cochrane’s 20th Anniversary, this poster session is an opportunity for these Cochrane entities to highlight their best work: what they are most proud of; what had the most impact; and how they have contributed to better evidenceinformed health care around the globe.

Entity representatives will be at their posters to talk to you during breaks and the last half hour of lunch today.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

Ottawa 200 C

45


Entity

friday 20 September

Friday 20 September con’t. poster number

Centres and Branches Australasian Cochrane Centre............................................................................................................................................... Bahrain Branch, UK Cochrane Centre .................................................................................................................................... Belgian Branch, Dutch Cochrane Centre ................................................................................................................................ Brazilian Cochrane Centre..................................................................................................................................................... Caribbean Branch, US Cochrane Centre................................................................................................................................ Canadian Cochrane Centre.................................................................................................................................................... Croatian Branch, Italian Cochrane Centre.............................................................................................................................. Dutch Cochrane Centre......................................................................................................................................................... French Cochrane Centre........................................................................................................................................................ German Cochrane Centre...................................................................................................................................................... Iberoamerican Cochrane Centre............................................................................................................................................ Italian Cochrane Centre......................................................................................................................................................... New Zealand Branch, Australasian Cochrane Centre ............................................................................................................. Nigerian Branch, South African Cochrane Centre.................................................................................................................. Nordic Cochrane Centre........................................................................................................................................................ Norwegian Branch, Nordic Cochrane Centre ......................................................................................................................... South African Cochrane Centre............................................................................................................................................. South Asian Cochrane Network and Centre . ......................................................................................................................... UK Cochrane Centre.............................................................................................................................................................. US Cochrane Center..............................................................................................................................................................

01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20

Review Groups Acute Respiratory Infections Review Group........................................................................................................................... Airways Review Group............................................................................................................................................................ Anaesthesia Review Group..................................................................................................................................................... Back Review Group................................................................................................................................................................ Bone, Joint and Muscle Trauma Review Group....................................................................................................................... Breast Cancer Review Group.................................................................................................................................................. Childhood Cancer Review Group............................................................................................................................................ Colorectal Cancer Review Group............................................................................................................................................ Consumers and Communication Review Group..................................................................................................................... Cystic Fibrosis and Genetic Disorders Review Group............................................................................................................. Dementia and Cognitive Improvement Review Group............................................................................................................ Depression, Anxiety and Neurosis Review Group................................................................................................................... Developmental, Psychosocial and Learning Problems Review Group..................................................................................... Drugs and Alcohol Review Group........................................................................................................................................... Ear, Nose and Throat Disorders Review Group....................................................................................................................... Effective Practice and Organisation of Care Review Group.................................................................................................... Epilepsy Review Group........................................................................................................................................................... Eyes and Vision Review Group............................................................................................................................................... Fertility Regulation Review Group.......................................................................................................................................... Gynaecological Cancer Review Group.................................................................................................................................... Heart Review Group............................................................................................................................................................... Hepato-Biliary Review Group.................................................................................................................................................. Hypertension Review Group................................................................................................................................................... Inflammatory Bowel Disease and Functional Bowel Disorders Review Group........................................................................ Incontinence Review Group...................................................................................................................................................

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45

46


Entity

friday 20 September

Friday 20 September con’t. poster number

Review Groups, con’t. Infectious Diseases Review Group......................................................................................................................................... Injuries Review Group............................................................................................................................................................ Lung Cancer Review Group.................................................................................................................................................... Menstrual Disorders and Subfertility Review Group............................................................................................................... Metabolic and Endocrine Disorders Review Group................................................................................................................. Multiple Sclerosis and Rare Diseases of the Central Nervous System Review Group............................................................. Musculoskeletal Review Group.............................................................................................................................................. Neonatal Review Group.......................................................................................................................................................... Neuromuscular Disease Review Group.................................................................................................................................. Occupational Safety and Health Review Group...................................................................................................................... Oral Health Review Group...................................................................................................................................................... Pain, Palliative and Supportive Care Review Group................................................................................................................ Peripheral Vascular Diseases Review Group.......................................................................................................................... Pregnancy and Childbirth Review Group................................................................................................................................ Prostatic Diseases and Urologic Cancers Review Group........................................................................................................ Public Health Review Group................................................................................................................................................... Renal Review Group............................................................................................................................................................... Sexually Transmitted Infections Review Group....................................................................................................................... Skin Review Group................................................................................................................................................................. Stroke Review Group.............................................................................................................................................................. Tobacco Addiction Review Group........................................................................................................................................... Upper Gastrointestinal and Pancreatic Diseases Review Group............................................................................................. Wounds Review Group...........................................................................................................................................................

46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68

Methods Groups Adverse Effects Methods Group............................................................................................................................................. Agenda and Priority Setting Methods Group.......................................................................................................................... Applicability and Recommendations Methods Group............................................................................................................. Bias Methods Group............................................................................................................................................................... Campbell and Cochrane Equity Methods Group..................................................................................................................... Comparing Multiple Interventions Methods Group................................................................................................................. Individual Patient Data Meta-analysis Methods Group........................................................................................................... Information Retrieval Methods Group.................................................................................................................................... Non-Randomised Studies Methods Group............................................................................................................................. Prognosis Methods Group...................................................................................................................................................... Prospective Meta-Analysis Methods Group............................................................................................................................ Qualitative and Implementation Methods Group....................................................................................................................

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

69 70 71 72 73 74 75 76 77 78 79 80

47


Entity

friday 20 September

Friday 20 September con’t. poster number

Fields and Networks Child Health Field................................................................................................................................................................... Complementary Medicine Field............................................................................................................................................. Consumer Network................................................................................................................................................................ Health Care of Older People Field.......................................................................................................................................... Neurological Field.................................................................................................................................................................. Nursing Care Field................................................................................................................................................................. Pre-hospital and Emergency Health Field............................................................................................................................... Primary Health Care Field......................................................................................................................................................

81 82 83 84 85 86 87 88

Other Cochrane groups Evidence Aid.......................................................................................................................................................................... 89 Information Management System team................................................................................................................................. 90 Training Working Group. ........................................................................................................................................................ 91

1030-1200 Concurrent Session A 1030-1200

Special Sessions Special Session 1.01 Wikipedia meets Cochrane: working to get better evidence into mass use Bastian H, Heilman J, Tharyan P

Baltimore 303 B

Special Session 1.02 Chair: Henry D Preventing Overdiagnosis – can Cochrane and systematic reviews help? Henry D, Moynihan R, Moons K

Stavanger 203

1030-1200

Oral Sessions

Online tools for dissemination and communication

Oral Session O1.01

Oxford 301 A

Moderator: Krista Connell

1. The Cochrane Library for iPad – a new platform for dissemination Stewart G

2. Engaging with the next generation of “Cochranites” through an international web-based community Millward H, Burton M

3. Using the Cochrane Community site to support Cochrane work Mavergames C, Owens N

4.

Translating Cochrane Reviews to lay people through the web: the IN-DEEP project Colombo C, Hill S, Filippini G, Mosconi P, Synnot A, Summers M, Osborne R, Hawkins M, Shapland S, Confalonieri P, Traversa S, Baroni I

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

48


Oral Session O1.02

Publication/reporting bias

friday 20 September

Friday 20 September con’t. Singapore 206 A

Moderator: Grigorios Leontiadis 1.

Epidemiology and publication of discontinued randomized trials – the DISCO study Kasenda B, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl J, Stegert M, Briel M

2.

Understanding the process and impact of within-study selective reporting bias for harm outcomes (ORBIT II – Outcome Reporting Bias in Trials) Saini P, Gamble C, Loke Y, Altman D, Williamson P, Kirkham J

3.

A selection model to explore whether publication bias is more likely in two-arm and placebo-controlled trials rather than in multi-arm and head-to-head studies Mavridis D, Welton NJ, Sutton A, Salanti G

4. Extent of publication bias in cohorts of studies approved by research ethics committees and included in trial registries Schmucker C, von Elm E, Schwarzer G, Schell L, Bluemle A, Meerpohl J

Oral Session O1.03

Statistical methods - Intention-to-treat

Keystone 206 B

Moderator: Alain Mayhew 1.

The impact of modified intention-to-treat reporting randomised trials in meta-analyses Montedori A, Schünemann H, Cozzolino F, Orso M, Luchetta L, Germani A, Amici S, Folletti I, Menculini G, De Florio R, Abraha I

2.

Ethics of randomised controlled trials challenged: the selective cross-over in trials assessing efficacy of therapies for breast cancer patients Balduzzi S, Miglio R, Petracci E, Guarneri V, Moja L, D’Amico R

3. Treatment effects from the patient perspective: Understanding the alternatives to intention-to-treat analyses Shrier I

Oral Session O1.04

Hamilton 301 B

Conflicts of Interest

Moderator: Finola Delamare

1. Association between personal financial conflicts of interest and recommendation of medical interventions: systematic review Lundh A, Jørgensen AW, Bero L

2.

Identifying and Managing Nonfinancial Conflicts of Interest for Systematic Reviews Viswanathan M, Carey T, Belinson S, Chang S, Graham E, Guise J, Ip S, Maglione M, McCrory D, McPheeters M, Newberry S, Sista P, White M

3. Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline Akl E, El-Hachem P, Abou-Haidar H, Neumann I, Schünemann H, Guyatt G

4. The influence of pharmaceutical companies on guidelines — two examples from Germany Schott G, Dünnweber C, Mühlbauer B, Niebling W, Pachl H, Ludwig W

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

49


Oral Session O1.05

Searching and information retrieval - Session 1

friday 20 September

Friday 20 September con’t. Amsterdam 303 A

Moderator: Julie Glanville

1. Effective searching of LILACS database for systematic reviews Glujovsky D, Ciapponi A

2. Data cleaning in the Cochrane Register of Studies Foxlee R, Noel-Storr A, Dooley G, Littlewood A, Salzwedel D

3. Peer review of literature search strategies: does it make a difference? Spry C, Mierzwinski-Urban M, Rabb D

4.

Development of high-performing population search filters is feasible and their use warranted in systematic reviews and clinical practice guidelines Iansavichus A, Hildebrand A, Haynes B, Garg A

Oral Session O1.06

Investigating bias - Session 1

Lyon 202

Moderator: Lesley Stewart 1.

Addressing missing participant data for continuous outcomes assessed with different instruments: a guide for systematic review authors Ebrahim S, Johnston B, Akl E, Mustafa R, Sun X, Walter S, Heels-Ansdell D, Alonso-Coello P, Guyatt G

2. Prediction study risk of bias assessment tool (PROBAST) Wolff R, Whiting P, Mallett S, Riley R, Westwood M, Kleijnen J, Moons K

3.

Exploring mechanisms of publication bias in systematic reviews of diagnostic test accuracy van Enst WA, Naaktgeboren C, Ochodo EA, Leeflang MM, Reitsma JB, de Groot J, Bossuyt PMM, Moons CGM, Scholten RJPM, Hooft L

4. What is the probability of discovering breakthrough interventions in industry versus publicly sponsored randomized controlled trials Kumar A, Miladinovic B, Reljic T, Mhaskar R, Wao H, Djulbegovic B

Oral Session O1.07

Québec 200 AB

Accessing and disseminating Cochrane evidence

Moderator: Marina Davoli

1. Impact of translations on access to Cochrane Reviews Stewart G, Ried J, Hives D, Janczyk M, Becker L

2. Issues in developing and disseminating summaries of Cochrane Reviews for specific external audiences Mahan KM, Pearson A

3. Cochrane goes green and gold: overview and impact of open access options for Cochrane Reviews Pentesco-Gilbert D, Maclehose H, Urqhuart B

4. Why should we translate Cochrane Reviews into French? Mbuagbaw L, Ongolo-Zogo P

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

50


1030-1200

friday 20 September

Friday 20 September con’t. Workshops 1.01 [Consumer Stream] Making sense of scientific evidence: how consumers can contribute to Cochrane Reviews – Part 1 Facilitators: Gyte G, Horey D, Crowe S

Rome 304 A

1.02 Establishing a Cochrane roadmap to data models for asking relevant clinical questions and finding the best answers individually for each patient Facilitators: Kunnamo I, Mavergames C, Brandt L, Rada G

Cape Town 304 B

1.03 [DTA Stream] Introduction to diagnostic test accuracy (DTA) reviews Facilitators: Leeflang M

Adelaide 302 B

1.04 Closing the gap between ‘mean effect size’ and data desired by decision-makers - exploring heterogeneity in complex interventions Facilitators: Ivers N, Grimshaw J, Tricco A, Trikalinos T, Straus S

Barcelona 204 A

1.06 Planning and conducting a Priority Setting Exercise for a Cochrane entity Facilitators: Nasser M, Crowe S, Wilson E, Welch V, Ueffing E, Li T

São Paulo 205 B

1.07 Comparing multiple treatments: Intervention review or overview – Part 1 Facilitators: Li T

Dublin 205 A

1.08 How to include economics in Cochrane Review protocols: background, objectives, outcome measures and types of studies – Part 1 Facilitators: Shemilt I

Freiburg 205 C

1.09 Calculation and interpretation of the number needed to treat (NNT) Facilitators: Bender R

Madrid 207

1.10 [Core] Using the new online GRADEpro to create Summary of Findings Tables Facilitators: Schünemann H ***In computer lab; no need for personal laptops

Oslo 302 A

*[Consumer stream] = workshops that are particularly aimed at consumers [DTA stream] = suite of workshops all related to diagnostic test accuracy (DTA) [Core] = basic training workshops likely to be relevant to authors conducting a Cochrane intervention review; not advanced methods, or new methods still under discussion & development

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

51


1200-1330

Lunch Break

1200-1330

Meeting Meeting

Heart Review Group 1300-1330

Auckland 400 B

Restriction (If any)

Room

Barcelona 204 A

Open

Meet the Entities poster viewing

Ottawa 200 C

1330-1500 Concurrent Session B 1330-1500

Special Sessions Special Session1 .03 Chairs: Santesso N, Mustafa R, Guyatt G Systematic Reviews and Guideline development Chandler J, Chang S, Dickersin K, Glenton C, Lewin S, Labrecque M, Norris S, Qaseem A, Santesso N, Tonelli M, Schünemann H

Baltimore 303 B

Special Session 1.04 Chair: Noyes J Getting to grips with complexity in complex interventions Jane Noyes, Petticrew M, Lewin S, Thomson H

Stavanger 203

Special Session 1.05 Using Cochrane Reviews in policy agenda setting, choice and implementation Lavis J, Dagenais P, Ouimet M

Singapore 206 A

1330-1500

Oral Sessions

International Approaches

Oral Session O1.08

Oxford 301 A

Moderator: Isabelle Boutron

1.

2. Translating Cochrane Abstracts and Plain Language Summaries from Traditional to Simplified Chinese: Feasibility assessment and user survey Wang Y, Tang X, Jiang Y, Zeng H, Lei X

3.

Policy Buddies: baseline assessment of the institutional capacity for evidence-informed decisions in provincial health departments in South Africa Young T, Zani B, Dudley L, Ongolo-Zogo P, Naude CE, Garner P

Development of user-friendly evidence summaries for the rational use of essential medicines and other complex drugs in the Americas Solà I, Rigau D, Selva A, Osorio D, Posso M, Pardo H, Sanabria AJ, Roqué M, Porrás A, Bonfill X

4. IRIS – a tool for prioritising guidance development at the European Centre for Disease Prevention and Control (ECDC) de Carvalho Gomes H, Jansen A, Kramarz P, Giesecke J

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

52

friday 20 September

Friday 20 September con’t.


Oral Session O1.09

friday 20 September

Friday 20 September con’t. Hamilton 301 B

Knowledge Translation and Communicating the Evidence — Session 1

Moderator: Stuart Macleod

1. Workforce training in evidence-informed decision-making Waters E, Armstrong R, Pettman T, Doyle J, Burford B

2.

Dietitian’s perspectives of systematically reviewed interventions enhancing adherence to dietary advice for preventing and managing chronic diseases in adults: a Delphi study Desroches S, Bissonnette-Maheux V, Lapointe A, Deschênes S, Légaré F, Gravel K, Thirsk J

3. Communicating Cochrane Reviews: experiences with a Review Specific Dissemination Strategy Jones B, Stephani A, Hinds P, Smith H, Garner P

4. Hitting the right target - disseminating Cochrane Review findings for greatest impact Jones K, Doyle J, Pettman T, Armstrong R, Waters E Oral Session O1.10 Outcomes Moderator: Jennifer O’Neill 1.

Lyon 202

Searching for black swans: critically assessing surrogate markers in Cochrane Reviews Tejani AM, Wright JM, Musini V, Bassett K, Perry T, Mintzes B, Jauca C, Hinch M

2. Variation in outcome measure usage across Cochrane Systematic Reviews related to three common eye conditions Saldanha I, Wang X, Li T, Dickersin K

3. Effect sizes in child health and association with unreported outcomes Hartling L, Fernandes R, Dryden D, Vandermeer B

4. Making results of patient-reported outcomes interpretable Guyatt G, Patrick D Oral Session O1.11 Moved to 21 Saturday Qualitative evidence 1330-1500 Moderator: Karen New 1.

Integrating findings from a Cochrane Systematic Review of effectiveness and a Cochrane qualitative evidence synthesis: methods and lessons learnt Glenton C, Lewin S, Colvin C, Carlsen B, Noyes J, Swartz A, Rashidian A

2. Assessing how much certainty to place in findings from qualitative evidence syntheses: the CerQual approach Lewin S, Glenton C, Munthe-Kaas H, Carlsen B, Colvin C, Noyes J, Rashidian A

3. Using qualitative research to explore heterogeneity in a Cochrane Review Glenton C, Carlsen B, Flottorp S, Jamtvedt G

4. Enhancing transparency in reporting the synthesis of qualitative research: the ENTREQ statement - discussion and debate McInnes E, Tong A, Flemming K, Oliver S, Craig J

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

53


Oral Session O1.12

1. Estimating a test’s accuracy using tailored meta-analysis — the potential of setting-specific data in aiding study selection Willis B, Hyde C

2. Reporting and methods in systematic reviews of comparative accuracy Takwoingi Y, Riley R, Deeks J

3. Why do diagnostic tests differ in performance between different settings? Willis B, Hyde C

friday 20 September

Friday 20 September con’t. Keystone 206 B

Diagnostic Test Accuracy Review Methods Moderator: Jon Deeks

4.

Enhancing the acceptance and implementation of GRADE summary of findings tables for evidence about diagnostic tests Mustafa RA, Wiercioch W, Brozek JL, Lelgemann M, Buehler D, Garg AX, Bossuyt P, Schünemann HJ, FTDDUTG

Oral Session O1.13 Evidence Packaging Moderator: Hilda Bastian

1. Evidence packaging to support public deliberation Lavis J, Abelson J

2. Comparison of alternative evidence summary and presentation formats in clinical guideline development: a mixed-method study Opiyo N, Shepperd S, Musila N, Allen E, Nyamai R, Fretheim A, English M

3. A systematic review of the use of narrative storytelling and visual arts-based approaches as knowledge translation tools in healthcare Scott SD, Brett-MacLean P, Archibald M, Albrecht L, Flynn R, Hartling L

4.

Québec 200 AB

Cochrane vignettes: use of Cochrane Reviews in a Cochrane Learning continuing medical education program Moja L, Becker L, Bjerre LM, Chande N, Grad R, Kwag K, Leontiadis GI, Lewin G, Moayyedi P, Ni Ogain O, Pentesco-Gilbert D, Pussegoda K, Sapko MT, Schaafsma ME, Tugwell P, Ueffing E, Urquhart B, Tovey D, Grimshaw J

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

54


1330-1500

Workshops

1.11 [Consumer Stream] Making sense of scientific evidence: how consumers can contribute to Cochrane Reviews – Part 2 Facilitators: Gyte G, Horey D, Crowe S

Madrid 207

1.12 Searching for studies for inclusion in Cochrane Reviews Facilitators: Lefebvre C, Glanville J

Amsterdam 303 A

1.13 Understanding, appraising and reporting systematic reviews that use individual participant data Facilitators: Tierney J, Stewart L, Rovers M

Rome 304 A

1.14 [DTA Stream] Developing search strategies for systematic reviews of diagnostic test accuracy (DTA) (restricted) Facilitators: Glanville J, Noel-Storr A, Mitchell R

Cape Town 304 B

1.15 Training for Managing Editors - Part 1 (restricted) Facilitators: Shah A

Adelaide 302 B

1.16 Introducing theory into systematic reviews: a discussion workshop Facilitators: Cargo M, Harris J, Jagosh J, Pearson M, Greenhalgh J

Melbourne 204 B

1.17 Comparing multiple treatments: Statistical methods for network meta-analysis – Part 2 Facilitators: Salanti G, Mavridis D, Chaimani A, Higgins J

Dublin 205 A

1.18 How to include economics in Cochrane Review protocols: searches, risk of bias and methodological quality, data collection and analysis – Part 2 Facilitators: Shemilt I

Barcelona 204 A

1.19 PROBAST: An opportunity to pilot test a new risk of bias tool for prediction modelling studies Facilitators: Wolff R, Moons K, Mallett S, Whiting P, Kleijnen J

São Paulo 205 B

1.20 Assessing the risk of selection bias in a systematic review which includes non-randomised studies (NRS) Facilitators: Shea B

Freiburg 205 C

1.21 [Core] RevMan 5.2 for Cochrane Intervention review authors – How using all the new features can make life easier Facilitators: Pienaar E ***In computer lab; no need for personal laptops

Oslo 302 A

friday 20 September

Friday 20 September con’t.

*[Consumer stream] = workshops that are particularly aimed at consumers [DTA stream] = suite of workshops all related to diagnostic test accuracy (DTA) [Core] = basic training workshops likely to be relevant to authors conducting a Cochrane intervention review; not advanced methods, or new methods still under discussion & development

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

55


1500-1530

Refreshment Break; Meet the Entities posters viewing; and Exhibitors

friday 20 September

Friday 20 September con’t. Ottawa 200C

1530-1700 Concurrent Session C 1530-1700

Special Sessions Special Session 1.06 Chairs: Ritskes-Hoitinga M, Leenaars M Synergy of systematic reviews of animal and clinical studies: towards evidence-based translational medicine Rovers M, Hooijmans C, Ritskes-Hoitinga M, Sena E

1530-1700

Oral Sessions

Cochrane structure and processes

Oral Session O1.14

Amsterdam 303 A

Oxford 301 A

Moderator: Cindy Farquar

1. Starting a new review group: tribulations without trials Grant R, Hart M, Quinn G, Jess C

2. The Cochrane Collaboration ‘in the making’: an Actor-Network perspective Hannes K, Decuypere M

3. The complex and challenging role of Cochrane Fields: moving Cochrane evidence into practice Thomson D, Pearson A, Mahan K, Wieland S, Gallagher C, McIlwain C

4.

Improving the efficiency of updating Cochrane Reviews: a joint pilot project of the McMaster PLUS database team and the Musculoskeletal Review Group Pardo Pardo J, Lawson J, Rader T, Parrish R, Cotoi C, Tugwell P, Haynes B, Iorio A

Oral Session O1.15

Tools for Review Authors

Hamilton 301 B

Moderator: Joao Costa

1. Superfilters Website: A searching tool for review authors Wilczynski N, Cotoi C, Haynes R

2. Epistemonikos: a comprehensive, systematic, collaborative and multilingual database for evidence-based health care Rada G, Capurro D, Rivera S, Peña J, Claro JC, Soto M, Neumann I, Pérez D

3. Shortening the pipeline: the use of data mining to link new trials to Cochrane Reviews McDonald S, Thomas J, Wallace S, Elliott J

4.

Surveillance System Assessing the Need for Updating Systematic Reviews Ahmadzai N, Newberry SJ, Maglione M, Tsertsvadze A, Ansari MT, Hempel S, Motala A, Tsouros S, Garritty C, Schneider Chafen J, Shanman R, Skidmore B, Moher D, Shekelle PG

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

56


Oral Session O1.16

friday 20 September

Friday 20 September con’t. Baltimore 303 B

New tools of dissemination

Moderator: Zbys Fedorowicz

1. Searching a database of knowledge translation resources for public health: The Registry of Methods and Tools Dobbins M

2. DynaMed summaries and Cochrane Reviews: a Dynamic Collaboration! Alper B, Fedorowicz Z, van Zuuren E

3. Making Cochrane Reviews more clinically accessible: the new Cochrane Clinical Answers derivative product Pettersen K

4. Development and Evaluation of a Point-of-care Tool for Providers Based on a Meta-Analysis and Clinical Practice Guideline Furlan A, Flannery J 5.

The Healthcare Knowledge Integrity Framework: A conceptual map of the synergy, mediators, and threats to integrity within the healthcare research/practice continuum Galipeau J, Shamseer L, Moher D

Oral Session O1.17

Methods for improving review efficiency

Stavanger 203

Moderator: Sandy Oliver

1. Systematic Review Data Repository (SRDR): Beyond Old School Data Abstraction Hadar N

2. Enhancing the efficiency of the systematic review process for evidence-based medicine Crawford C, Jonas W

3.

Many hands make light work – or do they? Results of two pilot studies looking at the effects of crowdsourcing Noel-Storr A, Struthers C, Cullum S, McShane R, Creavin S, Davis D, Huckvale K

4. A cloud computing database for data extraction in a Cochrane Review Stordal B, Kapros E, Busschots S, Lawlor D, Doherty B, Smith L, Hennessy B, O’Mathúna D

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

57


Oral Session O1.18

friday 20 September

Friday 20 September con’t. Lyon 202

Complexity

Moderator: Jill Hayden

1.

Methods for configurational synthesis: extensions to traditional meta-analysis for addressing intervention complexity and contextual variation in reviews O’Mara-Eves A, Thomas J

2. Key domains of context and implementation and their assessment in systematic reviews of complex health interventions Pfadenhauer LM, Rehfuess EA

3. Systematic reviews on multimorbidity: methodological challenges Menear M, Fournier L

Oral Session O1.19

Keystone 206 B

Investigating bias - Session 2

Moderator: Vanessa Jordan

1. Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomized trials: a cross-sectional review Hopewell S, Boutron I, Altman DG, Ravaud P

2.

Reporting, dealing with, and judging risk of bias associated with missing participant data in systematic reviews: a methodological survey Akl E, Johnston B, Carrasco A, Brignardello Petersen R, Neumann I, Sun X, Briel M, Busse J, Granados C, Iorio A, Irfan A, Martinez L, Mustafa R, Ramírez A, Solà I, Martínez García L, Selva A, Sanabria AJ, Zazueta OE, Vernooij R, Tikkinen K, Ebrahim S, Vandvik P, Guyatt G, Alonso Coello P

3. 4.

Do prominent biomedical journals have methods for detecting outcome reporting bias? (survey of the top 30 journals by impact factor) Huan N, Tejani AM, Egan G, Chua S Reporting of industry-funded trial outcome data: a comparison of journal publications with confidential individual patient data and clinical study reports Rodgers M, Brown J, Heirs M, Higgins J, Mannion R, Simmonds M, Stewart L

Oral Session O1.20

Québec 200 AB

Using Cochrane Systematic Reviews

Moderator: Martin Burton

1. Towards an optimal use of the Cochrane Systematic Review to support decision-making in a hospital setting Rhainds M

2.

3. The use of Cochrane evidence and guidance in World Health Organization guidelines Hartling L, Thomson D, Sommerville M, Bero L

4.

Using Cochrane Systematic Reviews in real life - experiences from teaching health science students and professionals to access and utilize Cochrane Reviews Kwok C, Lawrence K, Musini V, Perry T, Tejani A

20 ways to move Cochrane evidence into practice: A celebration of 20 years of disseminating Cochrane’s research to the world — and how you can use what we’ve done! Thomson D, Mahan K, Pearson A, Wieland LS

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

58


1530-1700

friday 20 September

Friday 20 September con’t. Workshops 1.22 Realist review: an introductory workshop Facilitators: Cargo M, Harris J, Jagosh J, Pearson M, Greenhalgh J

Adelaide 302 B

1.23 Search strategies and data sources for adverse effects reviews Facilitators: Golder S, Zorzela L

Rome 304 A

1.24 [DTA Stream] Systematic reviews of diagnostic accuracy studies. Assessment of methodological quality. Facilitators: Leeflang M

Melbourne 204 B

1.25 Sharing evidence through Twitter Facilitators: Chapman S, Millward H

Cape Town 304 B

1.26 [Core] Introduction to meta-analysis: Basic ideas for novices – Part 1 Facilitators: Beyene J

Barcelona 204 A

1.27 Core outcome measures for randomised controlled trials and Cochrane Reviews Facilitators: Gargon E, Williamson P

Dublin 205 A

1.28 Extending the assessment of outcome reporting bias to harms Facilitators: Kirkham J, Saini P, Dwan K, Williamson P

São Paulo 205 B

1.29 Assessing the risk of within-study selective reporting in a systematic review which includes non-randomised studies (NRS) Facilitators: Shea B

Freiburg 205 C

1.30 [Consumer Stream] The stats café (today’s special: statistics for the terrified) Facilitators: Trivella M, Hopewell S, Takwoingi Y, Radar T, Vilis E

Madrid 207

1.31 [Core] Navigating The Cochrane Library Facilitators: Stewart G ***PARTICIPANTS: Please bring your laptops to this session

Singapore 206 A

1.32 EROS dialogues with RevMan: data extraction, quality assessment and more Facilitators: Glujovsky D, Ciapponi A ***In computer lab; no need for personal laptops

Oslo 302 A

*[Consumer stream] = workshops that are particularly aimed at consumers [DTA stream] = suite of workshops all related to diagnostic test accuracy (DTA) [Core] = basic training workshops likely to be relevant to authors conducting a Cochrane intervention review; not advanced methods, or new methods still under discussion & development

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

59


1715-1830

Meetings Meeting

1900

friday 20 September

Friday 20 September con’t. Restriction (If any)

Room

CCDAN Meeting for Authors and Editors

Open

Madrid 207

Central Executive Team

Closed

Baltimore 303 B

Child Health Field Annual Meeting

Open

Dublin 205 A

Comparing Multiple Interventions Methods Group

Open

Keystone 206 B

Consumers Network (CCNET) Annual Meeting

Open

Cape Town 304 B

Equity Methods Group Open Meeting

Open

Adelaide 302 B

Gynaecological and Orphan Cancer Group Editorial Board

Closed

Singapore 206 A

Individual Participant Data (IPD) Meta-analysis Methods Group Meeting

Closed

Stavanger 203

Menstrual Disorders and Subfertility Meeting for Group Members

Open

Amsterdam 303 A

Nursing Care Field Annual General Meeting

Open

Hamilton 301 B

Occupational Safety and Health Review Group Meeting

Open

Rome 304 A

Pain, Palliative and Supportive Care Review Group Editorial Meeting

Closed

Barcelona 204 A

Pregnancy and Childbirth Review Group Meeting

Open

São Paulo 205 B

PRO Methods Group Business Meeting

Open

Lyon 202

Qualitative and Implementation Methods Group

Open

Melbourne 204 B

Risk of Bias Tool Extension for Non-Randomised Studies: CRG Network Meeting

Closed

Oxford 301 A

Screening and Diagnostic Tests Methods Group Meeting

Open

Freiburg 205 C

Randomized Dinner (ticket holders only)

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

Please make your way to the restaurant indicated on your ticket by 1900.

60


wan Saskatche Cree is the most commonly spoken Aboriginal language in Saskatchewan, with about 20,000 Skatchei Cree-speakers. This makes it the second most common language after English. Cree bands make up over half of the 74 First Nations in Saskatchewan.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

61


0700-1700

Registration/Information Desk Open

0700-0815

Meetings Meeting

Restriction (If any)

saturday 21 September

Saturday 21 September

Room

A3 (Lean) methodology for improving the diagnosis and treatment of cancer

Open

Rome 304 A

Anaesthesia Review Group Meeting

Open

Barcelona 204 A

ARI Group Editors Meeting

Open

Dublin 205 A

Individual participant data meta-analysis for anticoagulation in patients with cancer

Closed

Amsterdam 303 A

Methods Editors Meeting

Closed

Cape Town 304 B

MIF Risk of Bias Tool Non-Randomised Studies Project Methods Meeting

Closed

Freiburg 205 C

Prognosis Methods Group Meeting

Open

São Paulo 205 B

Public Health Review Group Editorial Meeting

Closed

Madrid 207

Rapid Reviews Methods Discussion

Open

Adelaide 302 B

Review Exchange (REx): a new approach to collaboration on the production of Cochrane Reviews

Open

Melbourne 204 B

US Contributors Meeting

Closed

Lyon 202

0700-0815

Poster Set-up 2

Ottawa 200 C

0830-1000

Plenary II: Better knowledge for better health: knowledge users’ perspectives

Québec 200 AB

The learning objectives of this plenary session are to ensure participants:

1.

2. Illustrate different approaches to making systematic review evidence available to knowledge users.

3. Discuss opportunities for The Cochrane Collaboration to better address the information needs of different decision-maker groups.

The Cochrane Collaboration aims to serve the needs of diverse knowledge users including health system policy-makers and managers, health care professionals, and consumers and carers. This plenary will consider the different knowledge needs of these diverse audiences, different approaches to making systematic review evidence accessible to these diverse audiences and opportunities for The Cochrane Collaboration to better address their knowledge needs.

Distinguish the information needs of different types of knowledge users in health care.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

62


Chairs: Sally Green and Lawrence Mbuagbaw

Speakers: Dr John N Lavis, MD, PhD

saturday 21 September

Saturday 21 September con’t.

Director, McMaster Health Forum Associate Director, Centre for Health Economics and Policy Analysis Professor, Department of Clinical Epidemiology and Biostatistics and the Department of Political Science, McMaster University Adjunct Professor of Global Health, Department of Global Health and Population, Harvard School of Public Health Knowledge for health system managers and policy makers

Dr Jimmy Volmink, BSc, MBChB, DCH, MPH, DPhil Dean, Faculty of Medicine and Health Sciences, Stellenbosch University Director, South African Cochrane Centre Knowledge for healthcare professionals

Dr France Légaré, BSc Arch, MD, PhD, CCFP, FCFP Canada Research Chair in Implementation of Shared Decision Making in Primary Care Professor, Department of Family Medicine and Emergency Medicine, Université Laval Researcher, Centre Hospitalier Universitaire de Québec (CHUQ) Promoting shared decision-making for better decisions and health

Lorraine Johnson, JD, MBA

Co-Chair, Consumers United for Evidence-Based Healthcare (CUE) Steering Committee Executive Director, LymeDisease.org The intersection between evidence-based and patient-centered healthcare

1000-1030

Refreshment Break and Exhibitors

Ottawa 200 C

1030-1200

Poster Viewing 2

Ottawa 200 C

P2.001 Evidence meets the media: working with science journalists in South Africa Schoonees A, Naude CE, Lombard MJ, Young T

P2.002 New marketing and communication strategies of the Brazilian Cochrane Centre Fioretti BTDS, Carvalho MR, Riera R, Torloni MR, Martimbianco ALC, Grande AJ, Porfirio GJM, Costa MB, Torres MFS, Silva V, Costa CS, Macedo CR, Silva EMK, Puga MEDS, Melnik T, Atallah AN

P2.003 Consumer involvement in the Cochrane Musculoskeletal Group Gunderson J, Fyfe C, Lyddiatt A, Walsh M, Rader T, Ghogomu E, Maxwell L, Pardo J

P2.004 Critical outcomes in a Cochrane Systematic Review: Patients’ perspective Omar MI, Lam T, MacLennan S

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

63


P2.005 The Cochrane Library publicity programme – promoting Cochrane evidence worldwide Urquhart B, Beal J P2.006 The ‘Implications for Practice’ of empty reviews: An analysis of Cochrane Systematic Reviews with no included studies Yaffe J, Shepard L, Hopewell S, Montgomery P

P2.016 Implementing the extended risk of bias tool for non-randomised studies: feedback from the Cochrane Epilepsy Group Pulman J, Marson T

P2.007 A Crib Sheet for Cochrane Review Authors’ Use of Trial Registries Abrams A, Pienaar E, Kredo T P2.008 Illuminating review results using systematic evidence mapping Coren E, Hossain R, Pardo Pardo J, Kavanagh J

 2.018 Factors related to biases of randomized P controlled trials published from Japan Yoneoka D, Ota E, Hisashige A, Nomura S, Miyamoto K, Segawa M, Kanda M, Wariki W, Shibuya K

P2.009 Registered paediatric trials worldwide: frequency, location and focus Joseph D, Caldwell P, Craig J  2.010 The Therapeutic Drug Management P Program: A collaborative initiative of teaching hospitals Dupont C, Michel M, Pelletier É, Turgeon M, Varin F, Deschênes L, Farand P, Froment D, Gaudreault P, Rajan R  2.011 Shaping HTA to meet new regulatory and P pricing evidence requirements in the UK Sutton AJ, Abrams KR P2.012 The potential of text mining to reduce screening workload in systematic reviews: a retrospective evaluation Thomas J, O’Mara-Eves A, McNaught J, Ananiadou S  2.013 Turning a scientific procedure into an P online participative tool Chalon PX, Vlayen J, Mertens R P2.014 The Evolution of Technology for Cochrane Thomas J, Mavergames C, Dooley G, Elliott J  2.015 An innovative tool for incorporating risk P of bias ratings into the GRADE assessment Marin T, Furlan A

 2.017 The effectiveness of interventions for P reducing publication bias Van Noord M, Thaler K, Nussbaumer B, Kien C, Gartlehner G

 2.019 Assessment of risk of bias due to P blinding for objective and subjective outcomes: An exploratory study of Cochrane Reviews Okwundu C, Durãao S, Motaze V P2.020 Risk of bias in pediatric critical care randomized controlled trials: a systematic review Duffett M, Choong K, Cupido C, Hartling L, Menon K, Thebane L, Cook DJ P2.021 Outcome domains reported by Chinese randomized controlled trials of postoperative analgesia for children Sun R, Zhang HJ, Zhao WY, Tian JH, Yang KH P2.022 Suspected publication bias regarding efficacy of psychoeducative interventions on burden experienced by caregivers of people with dementia Ballesteros J, González-Fraile E, Santos B, Solá I P2.023 Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Risk of Bias Tool in physical therapy trials Armijo-Olivo S, Ospina M, Jorge F, Humam S, Annabritt C, Dion P, Greta C P2.024 Selective reporting: a proxy or a more direct indicator of our confidence in the summary estimates? Rutjes AW

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

saturday 21 September

Saturday 21 September con’t.



64


P2.025 Systematic Review of the Empirical Evidence of the Selective Reporting of Analyses Dwan K, Williamson PR, Gamble C, Higgins J, Sterne J, Altman DG, Clarke M, Kirkham JJ  2.026 Comparing apples and oranges? P A Bayesian meta-regression of effect estimates from non-randomized studies and randomized controlled trials Sandhu L, Tomlinson G, Kennedy ED, Wei AC, Baxter NN, Urbach DR P2.027 Glaucoma drug trials: Why 349 trials and 130 unique interventions? Li T, Wormald R, Dickersin K  2.028 Are all Cochrane Reviews born equal? P Statistical methods in Cochrane Reviews (could be improved) Pantoja T, Claro JC, Moreno G  2.029 Using QUADAS-2 in systematic reviews P of diagnostic test accuracy studies: survey of users’ experience Zhelev Z, Hunt H, Hyde C, Davenport C, Leeflang M  2.030 Challenges in conducting a systematic P review of diagnostic test accuracy of genetic test: an example of the genetic diagnosis of familial hypercholesterolaemia Sharma P, Mowatt G, Boachie C, Stewart F, Miedzybrodzka Z, Simpson W, Boyers D, Kilonzo M, McNamee P

saturday 21 September

Saturday 21 September con’t.  2.035 The Quality Survey of Campbell P Systematic Reviews using AMSTAR Bai Z, Chang J, Feng Y P2.036 Poor interpretation of quality assessment results in diagnostic accuracy reviews Ochodo E, van Enst A, Naaktgeboren C, Leeflang M, Hooft L, de Groot J, Reitsma J, Moons K, Bossuyt P P2.037 Using AMSTAR to assess methodological quality of systematic reviews/ Meta-analysis of animal studies in China Gou Y, Shi L, Jin A, Xiong H, Huang X P2.038 Quality of systematic reviews of diagnostic test accuracy on Alzheimer´s disease dementia and other dementias Arevalo-Rodriguez I, Segura O, Solà I, Sánchez E, Bonfill X, Alonso-Coello P  2.039 Reporting and methodological quality of P systematic reviews of interventions published in Chinese surgical journals Ge L, Zeng QL, Liang L, Li YR, Ma JC, Liu YC, Tian JH P2.040 The Quality of Economic Studies in Respiratory Diseases in China by QHES tool Zhuo M, Zhao L, He Y, Zhang X, Liu F, Jiang H, Tian J

P2.031 Inter-rater reliability of the QUADAS-2 for assessing screening accuracy studies Guo B

P2.041 Navigating the rough waters of knowledge translation (KT) research: Effective search strategies for systematic reviews with a KT focus Chojecki D, Boruff J

P2.032 Direct versus indirect comparisons in systematic reviews of test accuracy studies: An IPD case study in ovarian reserve testing Wang J, Bossuyt P, Geskus R, Leeflang M

P2.042 Where to look for studies to include in EPOC reviews Johansen M, Paulsen E, Mathisen M, Odgaard-Jensen J

P2.033 How do authors investigate selective publication in diagnostic test accuracy reviews? vanEnst WA, Ochodo EA, Leeflang MM, Scholten RJPM, Hooft L

P2.043 Finding evidence from developing countries: the use of regional databases and other search sources Bangpan M, Dickson K, Stansfield C, Tripney J, Vigurs C, Stewart R, Oliver S

P2.034 Search methods for diagnostic test accuracy reviews in dementia: an overview of a programme grant Noel-Storr A

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

65


 2.044 Investigating the use of the McMaster P Premium LiteratUre Service (PLUS) as a method to efficiently update systematic reviews Athale A, Iorio A P2.045 MAPA: a live meta-analysis with customized tables in a live map Ciapponi A, Glujovsky D, GarcíaMartí S, Bardach A P2.046 Filtering for findability in systematic review search strategies Hagstrom C, Cunningham H P2.047 Comprehensive overview of conduct and reporting of cross-sectional studies on STROBE Statement in public health field of China Ding G, Li H, Yao Q, Li X, Bai Z, Yang K  2.048 Search filter accuracy to LILACS (via P iAHx 2.6-5 interface) for retrieving Randomized Controlled Trials by Brazilian Cochrane Centre Puga MES, Silva V, Soares BGDO, Atallah Î P2.049 Electronic culling of the clinical research literature: Filters to reduce the burden of handsearching Wilczynski N, McKibbon A, Haynes B  2.050 To improve the efficiency of database P searches for the identification of reports of RCTs used in NICE guidelines Alderson P, Ashe J, Beckles Z, Boynton J, Glover S, Hasler E, Lai R, Stockton S P2.051 On beyond Endnote: doing more with search results Witteman W P2.053 The development of highly sensitive retrieval strategy for cluster randomized controlled trial Chen Y, Yao L, Wang M, Wei D, Wang Q, Yang K P2.054 Is there a potential of umbrella reviews to inform guideline development? Bekkering GE, Emmers E, Hannes K

saturday 21 September

Saturday 21 September con’t. P2.055 Analysis of clinical guidelines developed based on evidence in China Wei ML, Liu M P2.056 Use and quality of Cochrane Reviews used in knee and hip osteoarthritis clinical practice guidelines Paterson G, Toupin April K, Ueffing E, Benkhalti Jandu M, McGowan J, Welch V, Wells G, Towheed T, Altman R, Tugwell P, Hochberg M  2.057 Changing Physician Practice Patterns: P Methods for Implementing Clinical Research and Guidelines Mostofian F, Ruban C, Simunovic N, Bhandari M  2.058 Optimal use of GRADE in Cochrane P Reviews to inform clinical practice guidelines Neumann I, Santesso N, Akl EA, Vandvik PO, Alonso-Coello P, Agoritsas T, Elias P, Mustafa R, Schünemann H, Guyatt GH P2.059 The use of GRADE methods in World Health Organization (WHO) public health guidelines: distributions of strength of recommendations and confidence in estimates of effect Alexander PE, Norris S, Brito JP, Stoltzfus RJ, Bero L, Djulbegovic B, Neumann I, Montori VM, Guyatt G P2.060 Does journal endorsement of reporting guidelines impact the completeness of reporting of health research? A systematic review Stevens A, Shamseer L, Weinstein E, Yazdi F, Turner L, Thielman J, Altman D, HIrst A, Hoey J, Palepu A, Simera I, Schulz K, Moher D  2.061 PEN - The Global Resource for Nutrition P Knowledge Translation Armour B, Byron A, Kellie S, Murray B, Thirsk J P2.062 The Challenges of Moving Evidence to Practice Holly C, Salmond S P2.063 The growing role and impact of Evidence Aid: its 10-year vision Kayabu B, Clarke M

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

66


 2.064 Exercise for lower limb osteoarthritis: P systematic review incorporating trial sequential analysis and network meta-analysis Uthman O, van der Windt D, Jordan J, Dziedzic K, Healey E, Peat G, Foster N

P2.074 The utility of systematic reviews for informing agri-food public health policy: a survey of Canadian policy-makers Rajic A, Young I, Sargeant J, Papadopoulos A, McEwen S

P2.065 Network meta-analysis of multiple outcome measures with extrapolation of effects across networks Achana F, Cooper N, Bujkiewicz S, Kendrick D, Sutton A

P2.075 Evidence-based approaches for evidence dissemination in Cameroon Mbuagbaw L, Ongolo-Zogo P

P2.066 Closing the research-practice gap using integrated knowledge translation: a practical webinar series Vilis E, Bradley C P2.067 A case study on the reporting of effect size estimates in breast cancer trials Willson M, Ghersi D, Askie L P2.068 Legal Issues in Health Technology Assessment: A Case Study Blouin M, Coulombe M, Rhainds M  2.069 Trying to introduce systematic P comparisons between randomized and non-randomized studies into the surgery field: a case report Wang Q, Shi C, Tian J, Yang K P2.070 Enabling engagement: the UK Cochrane Centre’s experience of using social media for communication about Cochrane Reviews and more! Chapman S, Millward H P2.071 Cochrane Eyes and Vision Group Reviews and Co-publications Wang X, Hawkins B, Dickersin K  2.072 Brazilian Cochrane Centre strategies for P disseminating the Cochrane methodology for systematic reviews Martimbianco ALC, Costa MB, Porfírio GJM, Silva V, Grande AJ, Torres MFS, Carvalho MR, Fioretti BTS, Torloni MR, Riera R, Atallah Î P2.073 Barriers to knowledge translation in Chinese doctors: a cross-sectional survey Huang Y, Li J, Chen J, Wang J

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

saturday 21 September

Saturday 21 September con’t.

P2.076 Cochrane Public Health group South Asian Satellite - Public Health Evidence South Asia (PHESA): Early experience Nair S, Saith R, Waters E, B U, Nair S P2.077 Should the PRISMA statement be fully qualified to report an updated meta-analysis? A case report He X, Wang Q, Li P P2.078 Logic model templates for systematic reviews of complex health interventions Rohwer A, Rehfuess E P2.079 Challenges of complex interventions: a worked example Horey D, Horvat L, Romios P P2.080 Development of a quality appraisal tool for case series studies Moga C, Guo B, Schopflocher D, Harstall C P2.081 Using a combined realist and socioecological approach to integrating quantitative and qualitative systematic review evidence in a health technology assessment setting Robertson C, Archibald D, Avenell A, Douglas F, Hoddinott P, van Teijlingen E, Boyers D, Stewart F, Boachie C, Fioratou E, ROMEO Project Group AT P2.082 What is the current situation of the published N-of-1 trial? Yang K, Yao D, Zhang F, He Y P2.083 IPD meta-analyses are important to improve evidence-based decisions in the geriatric population van de Glind E, Rhodius-Meester H, Reitsma J, Hooft L, van Munster B

67


 2.084 A practical taxonomy proposal for P systematic reviews of therapeutic interventions Bender R, Lerch C P2.085 Survey of the Reporting Characteristics of Systematic Reviews in Rehabilitation Gianola S, Gasparini M, Agostini M, Castellini G, Corbetta D, Gozzer P, Li L, Sirtori V, Taricco M, Tetzlaff J, Turolla A, Moher D, Moja L P2.086 Implementing a HTA-Unit in a University-Affiliated Child Welfare Agency: The Challenge of Adapting the Medical Model of HTA to the Social Services Context Bussières E, Beaumier I, Perron C P2.087 Intervention Now To Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): multiple integrated review method exemplar Hendry M, Whitaker R, Noyes J, Rycroft-Malone J, Booth A, Carter B, Edwards RT, Williams N, Craine N, Lyons M P2.088 Treatment of quasi-randomised trials in Cochrane Reviews Herbison P  2.089 Using GRADE to evaluate the quality of P evidence in systematic reviews about Chinese traditional medicine ao L, Wei D, Wang Q, Wang XQ, Wu QF, Sun LN, Yang KH, Chen YL P2.090 Evidence synthesis of implementation studies in health research: A systematic scoping review of methodological approaches Thompson Coon J, Whear R, Abbott R, Rogers M, Bethel A, Stein K P2.091 Development of an innovative theorybased instrument to assess the impact of continuing professional development activities on clinical practice Légaré F, Borduas F, Jacques A, Drolet R, Godin G, Luconi F, Rousseau M, Freitas A

saturday 21 September

Saturday 21 September con’t. P2.093 Improving practice: Rx for Change an intervention research database for healthcare decision-makers and researchers Grimshaw J, Hill S, Worswick J, Mayhew A, Fiander M, Lowe D, Taylor M, Wu J, Belanger D P2.094 The Canadian Association of Pediatric Surgeons Evidence-Based Resource: improving patient care and maximizing the use of research resources Nasr A, Wayne C, Chan E P2.095 Experiences and attitudes toward evidence-informed policy-making among Canadian research and policy stakeholders working at the interface of agri-food and public health Young I, Gropp K, Pintar K, Waddell L, Marshall B, Thomas K, McEwen SA, Rajic A P2.096 Effects of decision aids on the accuracy of patient knowledge of outcome probabilities: an investigation of sources of heterogeneity Gentles SJ, Walter SD, Stacey D, Bennett C P2.097 Profile of Overviews published by The Cochrane Library Costa M, Martimbianco A, Porfírio G, Silva V, Grande A, Torres MF, Carvalho M, Fioretti B, Riera R, Torloni MR, Atallah Á P2.098 The theory of planned behaviour applied to shared decision-making behaviours: a systematic review Thompson-Leduc P, Clayman M, Légaré F  2.099 Better values clarification methods for P better decisions Scherer LD, Angott AM, Ubel PA, Dickson M, Holtzman L, Exe N, Zikmund-Fisher BJ P2.100 Patient-centered care: Is there a state of the art? Holmes-Rovner M, Benares K, Kelly-Blake K, Mavis B, Patel N

P2.092 Rapid evidence reviews: the CADTH experience Mann J, Kamel C

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

68


P2.102 The Grading of Efficacy-Effectiveness in Clinical Trials (GEECT): a modified PRECIS tool El Dib R, Jorge E, Kamegasawa A, Daher S, Spagnuolo RS, Teixeira M, Pereira G, Volpato E, Módolo N, Betini M, Valle A, Corrêa I, Bazan R, A lmeida R, Weber S, Molina S, Yoo H, Villas Boas P, Mathew J, Braz L, Nascimento P P2.103 Is clinically significant decisional conflict prevalent in primary care? A scoping review Ferron Parayre A, Thompson-Leduc P, Robitaille H, Légaré F P2.104 Decision aids from current systematic reviews for the clinical encounter Agoritsas T, Brandt L, Heen AF, Kristiansen A, Alonso- Coello P, Akl EA, Neumann I, Tikkinen KA, Montori VM, Guyatt G, Vandvik PO P2.105 Online access to personal health information as a key component of shared decision-making: a pilot study in severe mental illness Menkes DB, Kidd J, Southey K, Orr M, Christini-Crawford D, Fitzgerald J P2.106 New teaching and research activities of the Brazilian Cochrane Centre Carvalho MR, Fioretti BTS, Torloni MR, Riera R, Martimbianco ALC, Grande AJ, Porfirio GJM, Costa MB, Torres MFS, Silva V, Costa CS, Silva EMK, Macedo CR, Melnik T, Puga MEDS, Atallah AN

saturday 21 September

Saturday 21 September con’t. P2.110 Translating one million words into two languages: process approach and lessons learnt from the translation of a comprehensive international guideline database Van de Velde S, Vanneste K, Bauwens T, Goossens C, Huyghe S, Fauquert B, Vanschoenbeek J, Heselmans A, Goossens M, Buysschaert J, Aertgeerts B, Vander Stichele R P2.111 Disseminating information on medicines and health interventions in Brazilian Portuguese using a internet-based resource: the Cemeds’ Blog Junqueira DRG, Cândido RCF, Moraes AVSM, Pádua CAM, Lima MG, Perini E P2.112 The Italian IN-DEEP project - Integrating and deriving evidence, experiences and preferences: developing research-based health information applicable to decisionmaking and self-management by people with multiple sclerosis Colombo C, Filippini G, Confalonieri P, Baroni I, Traversa S, Hill S, Synnot A, Battaglia M, Mosconi P P2.114 The DECIDE frameworks for going from evidence to recommendations and decisions Oxman A, Glenton C, Lewin S, Alonso P, Flottorp S, Davoli M, Rosenbaum S, Moberg J, Gulmezoglu AM, and other members of the DECIDE Collaboration

P2.107 Participants in the online course “Handsearching: Identifying and Classifying Controlled Trial Reports” Ervin A, Dickersin K  2.108 Teaching searching in an intensive P systematic review course: “how many citations should I expect to review?” Rosman L, Twose C, Li M, Li T, Saldanha I, Dickerson K

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

69


1200-1330

Lunch Break

saturday 21 September

Saturday 21 September con’t. Auckland 400 B

1330-1500 Concurrent Session D 1330-1500

Special Sessions Special Session 2.01 Patient-Centred Decision-Making: Using evidence from bedside to health policies Stacey D, Shrier I, Gauvin F, Boivin A, Légaré J

Québec 200 AB

Special Session 2.02 Scaling up/boosting the production of scientific evidence in low- and middle-income countries Coren E, Cuervo LG, Ciaponni A, Nair S, Kredo T, Waters L

Baltimore 303 B

1330-1500

Oral Sessions

Qualitative evidence

(previously scheduled Friday, 20 September, 1330-1500)

Oral Session O1.11

Capetown 304 B

Moderator: Karen New Integrating findings from a Cochrane Systematic Review of effectiveness and a Cochrane qualitative evidence synthesis: methods and lessons learnt Glenton C, Lewin S, Colvin C, Carlsen B, Noyes J, Swartz A, Rashidian A

1.

2. Assessing how much certainty to place in findings from qualitative evidence syntheses: the CerQual approach Lewin S, Glenton C, Munthe-Kaas H, Carlsen B, Colvin C, Noyes J, Rashidian A

3. Using qualitative research to explore heterogeneity in a Cochrane Review Glenton C, Carlsen B, Flottorp S, Jamtvedt G

4. Enhancing transparency in reporting the synthesis of qualitative research: the ENTREQ statement - discussion and debate McInnes E, Tong A, Flemming K, Oliver S, Craig J

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

70


Oral Session O2.01

Review Methods

1. Talking to Librarians: How to get the most out of library staff and make your Cochrane Review process easier and more successful Witteman W

2. Documenting the search process: an update of different methods? Mann M, Rader T, Stansfield C, Cooper C, Sampson M

3.

4.

Oxford 301 A

Moderator: Lisa Hartling

Incorporating the economic evidence in systematic reviews of interventions: an example from a systematic review in prophylaxis of respiratory syncytial virus infection Rojas MX, Rueda JD, Andabaka T Assessment of the evidence for diagnostic tests and strategies: a systematic review of available tools Mustafa RA, Wiercioch W, Falavigna M, Zhang Y, Prediger B, Cheung A, Ivanova L, Arevalo-Rodriguez I, Ventresca M, Santesso N, Brozek JL, Schünemann HJ, OBOTDDSG

Oral Session O2.02

Hamilton 301 B

Skill development

1.

saturday 21 September

Saturday 21 September con’t.

Moderator: Mona Nasser An environmental scan for training programs in medical writing and publishing and a systematic review of their effectiveness Galipeau J, Moher D, Cameron W, Campbell C, Hébert P, Hendry P, Palepu A, Skidmore B

2. Getting Cochrane into schools Struthers C, Noel-Storr A

3. Opportunities for knowledge translation skill development through online learning Dobbins M, Ciliska D, Yost J, Forsyth P, Chera S, Mackintosh J

4. Using Cochrane Reviews to Improve Critical Appraisal Skills and Clinical Decision-Making in Problem-based Learning Wu M, Tam K, Chang T, Lin Y, Wu C, Wong C

Oral Session O2.03

Lyon 202

Individual Participant Data

1. Development and Validation of a Novel Instrument for Assessing the Quality of Individual Patient Data Meta-Analysis Arora R, Chiappelli F

2. Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? Debray T, Moons K, Abo-Zaid GMA, Koffijberg H, Riley R

3.

Moderator: Karla Soares-Weiser

PLUGGED-IN (Providing Likeable and Understandable Guidelines using GRADE in the EMR with Direct links to INdividual patient data) phase 2 Brandt L, Kristiansen A, Vandvik PO, Guyatt G

4. Individual participant data meta-analysis to examine the accuracy of serum mesothelin for diagnosing malignant pleural mesothelioma Reitsma J, Hollevoet K

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

71


Oral Session O2.04

Singapore 206 A

New developments in training

1. Conducting a needs assessment for Cochrane Learning Pettersen K, Cowlard S, Urquhart B

2. If you plan it, will they come? Lessons learned about participant recruitment and retention for Cochrane webinars Ueffing E, McNair C, Cuervo LG

3. MetaLight: freely available online software for teaching and learning Meta-Analysis Thomas J, Graziosi S, Higgins S, Coe R, Torgerson C, Newman M

saturday 21 September

Saturday 21 September con’t. Moderator: Miranda Cumpston

4. Learning and teaching risk of bias using a mock trial with interactive voting technology Baker P, Francis D, Cathcart A

Oral Session O2.05

Keystone 206 B

Conducting risk of bias assessments

1. Risk of bias assessment of studies included in multiple Cochrane Reviews: agreement between different reviews Rada G, Rivera S, Capurro D

2. The value of author contact in determining risk of bias in included studies in a systematic review Atherton H, Sawmynaden P, Car J

3.

Moderator: Kristin Danko

Planning and reporting of subgroup analyses in randomized trials – between confidence and delusion Kasenda B, Sun X, von Elm E, Blümle A, Tomonaga Y, Bengough T, tegert M, Guyatt G, Briel M

4. Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool Corbett M, Higgins J, Woolacott N

1330-1500

Workshops 2.01 [Core] Introduction to meta-analysis: Meta-analysis of binary

and continuous outcomes – Part 2 Facilitators: McKenzie J

2.02 Methodological requirements for searching for studies for Cochrane Reviews: an update on the MECIR standards Facilitators: Lefebvre C, Noel-Storr A

Adelaide 302 B

2.03 [DTA Stream] Diagnostic test accuracy reviews: Introduction to meta-analysis Facilitators: Takwoingi Y, Deeks J

Melbourne 204 B

2.05 [Core] Interpreting results of Cochrane Reviews and Summary of Findings Tables Facilitators: Schünemann H

Dublin 205 A

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

Rome 304 A

72


saturday 21 September

Saturday 21 September con’t. 2.06 Enhanced interrogation techniques - making Archie cough up the answers you need (restricted) Facilitators: Champion C, Welsh E, Dooley L

Barcelona 204 A

2.07 Ensuring Cochrane Reviews Drive Improvement In The Design And Delivery of Health Services Facilitators: Grimshaw J, Lavis J

Freiburg 205 C

2.08 Using social media for effective communication with Cochrane stakeholders Facilitators: Owens N

São Paulo 205 B

2.09 Writing Complex Search Strategies Facilitators: Noel-Storr A, Fiander M ***PARTICIPANTS: Please bring your laptops to this session

Amsterdam 303 A

2.10 Going from evidence to dis-coverage decisions Facilitators: Parmelli E, Davoli M, Amato L, D’Amico R

Madrid 207

2.11 [Consumer Stream] Demystifying clinical trials and systematic reviews for the public Facilitators: McIlwain C, Struthers C, Parris K, Gyte G ***In computer lab; no need for personal laptops

Oslo 302 A

*[Consumer stream] = workshops that are particularly aimed at consumers [DTA stream] = suite of workshops all related to diagnostic test accuracy (DTA) [Core] = basic training workshops likely to be relevant to authors conducting a Cochrane intervention review; not advanced methods, or new methods still under discussion & development

1500-1530 1530-1700

Refreshment Break and Exhibitors

Ottawa 200 C

The Cochrane Collaboration Annual General Meeting

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

Québec 200 AB

73


1715-1830

saturday 21 September

Saturday 21 September con’t. Meetings Meeting

Restriction (If any)

Room

Adverse Effects Methods Group (AEMG) Meeting

Open

Melbourne 204 B

African Cochrane Network Meeting

Open

Stavanger 203

Bias Methods Group Annual Meeting

Open

Adelaide 302 B

Cochrane Innovations Board of Directors

Closed

Rome 304 A

Cochrane Mid-Year Meeting & Xlll Iberoamerican Cochrane Conference; 31 March - 5 April 2014 Panama City, Panama

Closed

Dublin 205 A

Cochrane Trainers’ Network Meeting

Open

Keystone 206 B

Complementary and Alternative Medicine Field Meeting

Open

Hamilton 301 B

Consumers and Communication Review Group Open Meeting

Open

Oxford 301 A

Diagnostic Tests Support Unit Meeting

Closed

Baltimore 303 B

Iberoamerican Cochrane Network

Open

Singapore 206 A

Italian Cochrane Network

Open

Freiburg 205 C

Methodological Investigation of Cochrane Reviews of (MICCI) Complex Interventions

Closed

Madrid 207

Register of Studies User Support Team Meeting

Closed

Barcelona 204 A

RevMan Advisory Committee

Closed

Cape Town 304 B

Systematic Reviews of animal studies in the context of translational medicine

Closed

Lyon 202

Tranexamic acid to reduce blood loss (EC11-341)

Closed

São Paulo 205 B

Web Team Meeting

Closed

Amsterdam 303 A

Wikipedia Editathon ***In computer lab; no need for personal laptops

Open

Oslo 302 A

Free Evening – Enjoy Québec City! Option: Fundraising Walk to benefit the Anne Anderson Award

Please join us in raising funds for the Anne Anderson Award. See page 22 for more information about the Fundraising Walk.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

74


t Territor ie s Northwes The Nahanni National Park Reserve includes 30,000 square km of northern wilderness rivers, canyons, gorges and alpine tundra. The park is centred on the valleys of the South Nahanni and Flat Rivers. The only access to the park is by air, and tourists often visit to go white water rafting or canoeing, participate in overnight hikes and to see the Virginia Falls (twice the height of Niagra Falls). There are legends of haunted valleys and lost gold throughout the reserve, which arose after the mysterious deaths of several prospectors. The Nahanni National Park Reserve became a UNESCO World Heritage Site in 1978.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

75


0700-1700

Registration/Information Desk Open

0700-0815

Meetings Meeting

Restriction (If any)

Room

Agenda and Priority Setting Methods Group Open Meeting

Open

Madrid 207

Consumers and Communication Review Group Editors’ Meeting - Part 2

Closed

Melbourne 204 B

Ear, Nose and Throat Disorders Review Group Annual Meeting

Open

Cape Town 304 B

Effective Practice and Organisation of Care Review Group Open Meeting

Open

São Paulo 205 B

Information Retrieval Methods Group Meeting

Open

Singapore 206 A

Methods Application and Review Standards Working Group

Closed

Barcelona 204 A

Non-Randomized Studies Methods Group (NRSMG)

Open

Lyon 202

Search Master Class for The Cochrane Library

Open

Rome 304 A

0700-0815

Poster Set-up 3

Ottawa 200 C

0830-1000

Plenary III: Better knowledge for better health: an Americas’ perspective

Québec 200 AB

The learning objectives of this plenary session are to ensure participants:

1.

sunday 22 September

Sunday 22 September

Understand current health care challenges and opportunities within the Americas.

2. Recognize the distinct health challenges faced by aboriginal peoples.

3. Understand how The Cochrane Collaboration can contribute more to this endeavour.

The diversity of health problems, health care systems and societies across the Americas raise challenges for evidence-informed health decision-making. During this session, our speakers will describe some of these challenges, opportunities to address them and discuss how The Cochrane Collaboration can contribute to this.

Chairs: Paul Fortin and Tianjing Li

Speakers: Dr Catherine L Cook, MD, MSc, CCFP, FCFP Associate Dean, First Nations, Métis and Inuit Health Knowledge for indigenous peoples

Dr Alan Bernstein, OC President and Chief Executive Officer, Canadian Institute for Advanced Research Better Knowledge for Global Health: A central role for The Cochrane Collaboration

Dr Luiz Augusto Cassanha Galvão Acting Assistant Director Pan American Health Organization Better Knowledge and Health for the Americas

Dr Tim Evans, DPhil, MD Director, Health Nutrition and Population, World Bank Knowledge for global health systems

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

76


1000-1030

Refreshment Break and Exhibitors

Ottawa 200 C

1030-1200

Poster Viewing 3

Ottawa 200 C

P3.001 The reporting of research design of diagnostic test accuracy (DTA) studies in abstracts of Cochrane Diagnostic Test Accuracy Reviews Hunt H, Zhelev Z, Hyde C P3.003 The DEPRESsion Screening Data (DEPRESSD) Registry: A protocol for a registry to support individual patient data meta-analyses of the diagnostic accuracy of depression screening tools Levis B, Thombs B P3.004 The assessment of reporting quality on systematic reviews or meta-analyses of diagnostic test published by Chinese authors Ge L, Liang L, Liu YC, An N, Shi XT, Xu JF, Tian JH P3.005 The Study of Reporting Quality of Randomized Controlled Trials in Systematic Reviews of Acupuncture Liu Y, Huang J, Zhang R, Mai Y, Zhao X, Sun W, Wei M, Li Y, Huo X, Ke W, Yang K P3.006 Has completeness and quality of systematic review and meta-analysis reporting in major radiology journals changed since publication of the PRISMA statement? Is completeness of reporting associated with study quality? Tunis A, McInnes M, Hanna R, Esmail K P3.007 Methodological quality of systematic reviews and meta-analyses on interventional in leading Chinese evidence-based medical journals Li Y, An N, Xu J, Ge L, Liang L, Shi X, Tian J P3.008 Quality Appraisal of Clinical Practice Guidelines on the Treatment of Hepatocellular Carcinoma or Metastatic Liver Cancer: A Systematic Review Wang Y, Li Y, Deng S, Wei S, Luo Q, Li X, Yu J

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

sunday 22 September

Sunday 22 September con’t.

P3.009 Interventions for Age-related Macular Degeneration: What is the quality of the evidence? Ssemanda E, Ugarte Gil C, Li T, Dickersin K P3.010 Assessment of the quality of reporting for treatment components in Cochrane Reviews of acupuncture Kim KH, Kang JW, Lee MS, Shin B, Lee JD P3.011 Assessment of the quality of clinical trials registries Wong C, Wu M, Tam K P3.012 Quality appraisal of clinical practice guidelines on glioma Tian H, Gou Y, Wang Z, Niu X, Dang W, Yang K P3.013 The use of Cochrane SR in the development of Clinical Practice Guidelines. The case of Syndromic Management of Sexually transmitted infections and other infections of the Genital Tract. 2012 Gaitan H, Torres M, Rodriguez A P3.015 Reducing unnecessary cervical cancer screening: achieving more by doing less Koster M, Schottinger J P3.016 Meeting end-user needs through rapid evidence reviews: a partnership case study Barker SJ P3.017 Summarizing evidence for policy: some limitations of rapid and systematic reviews Blanquaert I, Laberge A, Deck W, Dufort P, Rousseau J P3.018 What’s more important - timeliness or accuracy of results in providing evidence? Preliminary results on a research program on rapid reviews Tricco A, Antony J, Hutton B, Moher D, Ciliska D, Straus S

77


P3.019 Usability of Cochrane-based evidence summaries in point-of-care guidelines Jousimaa J, Alenius H, Kunnamo I P3.021 The Publishing Characteristics of Cochrane Reviews for Health Policy Research Xiu-xia L, Jia-hua Z, Yao-long C, Zong-jiu Z, Ke-hu Y P3.022 Analysing the Impact Factor of the Cochrane Database of Systematic Reviews (CDSR) Stewart G P3.023 Making Cochrane Reviews more clinically accessible: Cochrane Clinical Answers Pettersen K P3.024 Cultures of evidence among decisionmakers in non-health fields: systematic review Lorenc T, Tyner E, Petticrew M, Duffy S, Martineau F, Phillips G, Lock K P3.025 The limitation of word count in Chinese journals: a potential impediment for implementing the CONSORT statement Zhang Z, Wang X, Zhang Q, Tian J P3.026 A family of different dissemination products from one Cochrane Review Rosenbaum S, Glenton C, Lewin S P3.027 Moving from evidence to implementation for childhood vaccination communication strategies: synthesising programme experience from low-income countries Lewin S, Hill S, Ames H, Bensaude de Castro Freire S, Bosch-Capblanch X, Cliff J, Glenton C, Kaufman J, Lin V, Muloliwa A, Oku A, Oyo-Ita A, Rada G P3.028 Development of knowledge brokering intervention model based on a systematic review Ban J

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

sunday 22 September

Sunday 22 September con’t. P3.029 An updated review of the development of Evidence-based Pharmacy: definition, practice and research Liang Y, Zhang L, Liu Y, Song J P3.030 Engaging nurses in the work of The Cochrane Collaboration: a Field’s account Stern C, Pearson A P3.031 The PRISMA evaluate the reporting systematic reviews and meta-analyses’ abstracts of cost-effectiveness of pregnancy mortality Qiu J, Zhang S, Zhou Y, Yao Q, Song G, Yan B, Zhou R P3.032 How to explore user experience when developing communication products Rosenbaum S P3.033 A novel approach to presenting adverse effect results: a case study Dryden D, Sumamo Schellenberg E, Vandermeer B, Rowe B P3.035 Patient-important outcomes reported in randomized clinical trials (RCTs) of neuromuscular electrical stimulation (NMES) in mechanically ventilated patients: A systematic methodologic review Kho ME, Duffett MC, Koo KK, Dodek P, Herridge MS, Lamontagne F, Needham DM, Cook DJ P3.036 Are claims of interventional benefit in clinical trial abstract conclusions justifiable? A case report of pharmacological and complementary therapies for chronic asthma Toone R, Sinha I P3.037 Cross-over trials – are they doing it right? Are we doing it right? Dwan K

78


P3.038 Using bivariate meta-analysis and meta-regression to investigate the effects of exercise on pain and disability in osteoarthritis Uthman O, van der Windt D, Jordan J, Dziedzic K, Healey E, Jordan K, Foster N P3.039 Measurement Harmonization in Individual-Participant-Data Meta-analysis Galindo-Garre F, Hidalgo MD P3.040 Challenges in conducting a systematic review of predictors and moderators of outcome: an example in psychological therapies for OCD Knopp J, Knowles S, Bee P, Lovell K, Bower P P3.041 Statistical simulation to assess results of meta-analyses using post-intervention, change from baseline and mixed methods Silva V, Grande AJ, Porfírio GJM, Puga MES, Martimbianco ALC, Torres MFS, Costa MB, Carvalho MR, Fioretti BTDS, Costa CS, Peccin MS, Riera R, Torloni MR, Atallah Î P3.042 Which journals have cited Cochrane Systematic Reviews? Sun X, Ma J, Zhao Y, Tian J P3.043 Which is more generalizable, powerful and interpretable in meta-analyses, mean difference (MD) or standardized mean difference (SMD)? Takeshima N, Furukawa TA, Sozu T, Tajika A, Ogawa Y, Hayasaka Y P3.044 The feasibility and reliability of using restricted mean survival time in aggregate data meta-analysis of time-to-event outcomes Wei Y, Royston P, Tierney J, Parmar M P3.045 Comparison between Autocad and Draftsight in data extraction Li Z, Mi D, Yang K, Cao N, Tian J, Ma B, Liu Y P3.046 Why196 Cochrane Systematic Reviews were withdrawn in Cochrane Database of Systematic Reviews? Ma J, Sun X, Zhao Y, Tian J P3.047 Supplementary tables for systematic reviews of herbal medicine or acupuncture Cao H, Li X, Klupp N, Liu J

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

sunday 22 September

Sunday 22 September con’t. P3.048 A hybrid approach for automating citation screening process Zhang D, Lei J, Robinson K P3.049 Underreporting of conflicts of interest among authors of clinical drug trials: cross sectional study Rasmussen K, Schroll J, Gøtzsche PC, Lundh A P3.050 Publication bias in randomised trials of duloxetine for the treatment of major depressive disorder Maund E, Tendal B, Hróbjartsson A, Jørgensen KJ, Lundh A, Schroll JB, Gøtzsche PC P3.051 Publication bias in Clinical Trials on monoclonal antibodies: a cross-sectional study Marin dos Santps DH, Riera R, Atallah AN P3.052 Barriers and facilitators in the implementation of interventions to prevent publication bias Nussbaumer B, Kien C, van Noord M, Thaler K, Griebler U, Gartlehner G P3.053 Full publication of studies presented at biomedical meetings – updated systematic review of follow-up studies Scherer R, Meerpohl JJ, Schmucker C, Schwarzer G, von Elm E P3.054 Quantifying bias in randomized controlled trials in child health Hartling L, Hamm M, Dryden D, Vandermeer B P3.055 Completeness of outcome specification across Cochrane Systematic Reviews of three common eye conditions: Time to be more explicit! Saldanha I, Wang X, Li T, Dickersin K P3.056 Characteristics of the authors of acupuncture related Cochrane Systematic Reviews Fei Y, Chai Q P3.057 Would a timely analysis of secondary outcomes have led to an earlier identification of effective stroke rehabilitation interventions? Langhorne P, Editorial team

79


P3.058 Methodological Overview: Meta-analyses of Adverse Effects Data from Case-Control Studies as Compared to Other Observational Studies Golder S, Loke Y, Martin B P3.059 The PRISMA statement for reporting systematic reviews of China health policy He S, Zhao J, Zhang F, Tian J P3.060 The correlation analysis of PRISMA, AMSTAR and GRADE in systematic review Yao L, Wei D, Wang Q, Wang XQ, Sun LN, Liang FX, Yang KH, Chen YL P3.061 Development of the PRISMA Harms Extension Zorzela L, Moher D, Vohra S P3.062 Systematic reviews in health policy: method, practice and challenges Jia L, Meng Q, Yuan B P3.063 Modifiable factors influencing recruitment in clinical trials Oude Rengerink K, Hooft L, Bossuyt P, Mol BW P3.064 Combining systematic review methods with philosophical analysis for a research ethics review: a case study in bridging disciplines Wright J, Wilman E, Megone C, Gyte G, Duley L, Oliver S P3.065 Methodological challenges to assess effectiveness of treatments with retrospective studies: the case of localized prostate cancer Larocque B, Asselin G, Coulombe M, Rhainds M P3.067 Terminology confused: how to name network meta-analysis? Li L, Tian J, Yang K, Tian H, Sun R

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

sunday 22 September

Sunday 22 September con’t. P3.068 How can we improve trials assessing the effectiveness of Screening, Brief intervention, and Referral to Treatment (SBIRT) for substance use? Methodological issues encountered during a systematic review Young M, Stevens A, Galipeau J, Pirie T, Garritty C, Singh K, Yazdi F, Golfam M, Pratt M, Turner L, Porath-Waller A, Grimshaw J, Moher D P3.069 Variability and completeness of outcome reporting in studies for low back pain rehabilitation interventions: a survey of trials included in Cochrane Reviews Gianola S, Castellini G, Pecoraro V, Frigerio P, Moja L P3.070 From health to development: a growing centre of excellence in systematic reviewing Stewart R, Korth M, van Rooyen C, de Wet T P3.071 Identifying underlying mechanisms between intrinsic and variable prognosticators and clinical outcomes: A structural modelling approach Hermans F, Schuit E, Mol BW, Opmeer B P3.072 Reaching certainty: a descriptive study of “stable” Cochrane Reviews and coming to firm conclusions Bastian H, Hemkens L P3.073 Methodology of animal studies and impact on aggregating data: why meta-analyses might be inappropriate for preclinical studies Pecoraro V, Cappellini G, Ciccolallo L, Dall’Olmo L, Virgili G, Garattini S, Moja L P3.074 A strategy to increase partnerships between health care professionals and Cochrane Canada: Online peer review modules for dietitians Santesso N, Thirsk J, Vilis E, Arratoon C, Grimshaw J

80


P3.077 Social work and The Cochrane Collaboration: Qualitative interviews with Cochrane contributors of social work background Shepard L

P3.085 Using a search filter to improve literature searching efficiency for clinical question updating Amos, Q, Chan W, Tom G

P3.078 Working with knowledge users to improve evidence-based medicine prescribing and use: key informant interviews and the process of developing an international training collaboration Helis E, Colquhoun H, Mayhew A, Lowe D, Taylor M, Hill S, Belanger D, Worswick J, Grimshaw J

P3.086 Using social media and crowdsourcing to gather important publications for a scoping review about wikis and collaborative writing tools Archambault P, van de Belt T, Grajales F, F aber M, Kuziemsky C, Gagnon S, Bilodeau A, Rioux S, Fournier C, Nadeau C, Émond M, Aubin K, Gold I, Gagnon M, Turgeon A, Heldoorn M, Poitras J, Kremer J, Eysenbach G, Légaré F

P3.079 Involving Service Users and Clinicians to Identify Research Uncertainties of Preterm Birth: the James Lind Alliance Priority Setting Partnership Uhm S, Chivers Z, Crowe S, David AL, Dowling I, Duley L, Gale C, Gyte G, James CP, McNeill J, Turner MA, Shennan A, Oliver S

P3.087 Reporting methodological search filter performance comparisons: a review Harbour J, Fraser C, Lefebvre C, Glanville J, Beale S, Boachie C, Duffy S, McCool R, Smith L, Varley D

P3.080 Cochrane Reviews need to cope with the flood tide of innovations Weingart O P3.081 Feasibility scans could improve prioritization and selection of systematic review topics Bekhuis T, Stein C P3.082 Prioritisation for Evidence Aid: choosing systematic reviews for the Evidence Aid database Allen C, Kayabu B, Clarke M P3.083 A framework to identifying and characterise research gaps from systematic reviews Robinson KA P3.084 Validating prognosis search filters using relative recall based on prognosis systematic reviews Parker RM, Hayden JA, Tougas M

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

sunday 22 September

Sunday 22 September con’t.

P3.088 Finding the largest pool of relevant citations in MEDLINE using the Pearl Harvesting Information Retrieval Theory Sandieson R, Torabi N P3.089 Searching for unpublished data for Cochrane Reviews: cross-sectional study Schroll J, Bero L, Gøtzsche PC P3.090 Dual monitors to increase efficiency of conducting systematic reviews Wang Z, Asi N, Elraiyah T, Abu Dabrh AM, Undavalli C, Murad M P3.091 A numbers of randomized controlled trials reported in Chinese literature are not covered in MEDLINE Zhang L, Wang Y, Lei J, Yang K P3.092 Proposal to establish a Cochrane Diet and Nutrition Trials Register Durao S, Volmink J, van Binsbergen J P3.094 Evidence about colchicine for gout to be added to 17th WHO EML Lu J, Xu T, Li Y, Wu B

81


P3.095 International cooperation in the abstracts of the 20th Cochrane Colloquium Yang KH, Sun R, Shi CH, Tian JH, Li L, Tian HL, Wang Q

P3.104 Evidence-based guideline implementation within Primary Care Practices on Hypertension and Diabetes Stein AT, Sirena SA, Baldisserotto J, Kopitke L

P3.096 The attention of reporting in journals under the Chinese Medical Association: research on “instructions for authors” Li X, Li H, Yao Q, Bai Z, Yang K, Ding G

P3.105 Cochrane Journal Club: meeting the expectations of our growing membership Urquhart B, Cayley W, Clarke M

P3.097 An analysis of randomized controlled trials of tuberculosis prophylaxis and treatment in Africa Abrams A, Kredo T P3.098 Transferring knowledge: equity for health professionals in Ethiopia Hagstrom C, Kendall S, Pielechaty R P3.099 The Use of Cochrane Reviews for Decision-Making by a Local Public Health Department Ward M, Ciliska D P3.100 Do Cochrane Systematic Reviews help decision-makers from middle-income countries? Update of the Chilean experience Pantoja T, Herrera C, Soto M P3.101 High risk cancer screening in workers exposed to asbestos. Application of evidence through partnerships in managing injured workers. Martin C, Rothfels P, Lam S, Dunn C, Pelman G, Noertjojo K P3.102 Utilizing a logic model framework to evaluate patient navigation interventions on colorectal cancer screening time to diagnostic follow-up care: a study protocol McIntosh B, Kazanjian A

sunday 22 September

Sunday 22 September con’t.

P3.106 Easy access to information on evidence-based mental health interventions for children in Norway: The website “Ungsinn” (ungsinn.no) Martinussen M, Reedtz C, Eng H, Willy-Tore M P3.107 Designing a social media strategy for a Cochrane entity Thomas J, Mayoral J, Riis J, Owens N, Chapman S, Millward H, Welsh E, Irving C P3.108 Consumer participation on a Cochrane Review team Gunderson J, Brachaniec M, Rader T, Busch A P3.109 Café Scientifique – Public Outreach Tarbett L P3.110 The young doctor’s opinion on Evidence-based Health Care (EBHC) in Stellenbosch University’s medical curriculum Rohwer A, Young T P3.111 Knowledge translation: the number, coverage, and application of Cochrane Reviews in China Mao X, Jia P, Du L, Zhang M P3.112 Usefulness of Cochrane Systematic Reviews in Health Technology Assessments in Argentina Ciapponi A, Pichón-Riviere A, GarcíaMartí S, Glujovsky D, Bardach A, Alcaraz A, Augustovski F

P3.103 Evidence-Informed Healthcare Renewal Portal: the development of an online repository of policy-relevant documents addressing healthcare renewal in Canada Kowalewski K, Moat K

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

82


1200-1330 1200-1330

Lunch Break

Auckland 400 B

Meetings

Meeting

Restriction (If any)

Room

Prognostic Factor Systematic Reviews – PMG Working Group Meeting

Closed

Cape Town 304 B

Colloquium Policy Advisory Committee Business Meeting

Closed

Barcelona 204 A

1330-1500 Concurrent Session E 1330-1500

Special Sessions Special Session 3.01 Increasing access to trial data and the next generation of Cochrane Reviews: A panel and open floor discussion Stewart L, Dickersin K, Grimshaw J, Rovers M, Tierney J, Tovey D, Cullum N, Langhorne P

Baltimore 303 B

Special Session 3.02 Chair: Shemilt I Health Behaviour Change Godin G, Spence J, Marteau T, Waters E

Stavanger 203

1330-1500

Oral Sessions

Advanced Review Methods

Oral Session O3.01

Oxford 301 A

Moderator: David Moher

1. Waiting list may be a “nocebo” condition in psychotherapy trials Noma H, Honyashiki M, Shinohara K, Imai H, Churchill R, Hunot V, Caldwell D

2. Categorising Continuous Risk Factors: Issues and Implications Abdallah DY

3. A framework to interpret external validition studies of prediction models Debray T, Koffijberg H, Vergouwe Y, Nieboer D, Moons K, Steyerberg E

4. An ‘all-in-one’ meta-analysis model: Joint synthesis of multiple outcomes to compare multiple interventions Efthimiou O, Dimitris M, Andrea C, Georgia S

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

83

sunday 22 September

Sunday 22 September con’t.


Oral Session O3.02

Partner/knowledge user engagement

Moderator: Anne Lyddiatt

1.

Bridging the gap between science and policy at the agri-food and public health interface through a knowledge synthesis, transfer and exchange handbook Young I, Rajic A

2.

Partnering with Canadian Public Health departments to explore the impact of a tailored, collaborative approach to evidence-informed decision-making Dobbins M, DeCorby K, Traynor R, Greco L

3. Knowledge translation and partner engagement through a national workshop with interactive voting technology Baker P, Dobbins M

4.

sunday 22 September

Sunday 22 September con’t. Hamilton 301 B

Canadian Cochrane Centre Partners Forum: Strengthening partnerships to increase evidence-based decision-making Vilis E, McGovern L, McNair C, Schaafsma ME, Tarbett L, Ueffing E, Grimshaw J

Oral Session O3.03

Lyon 202

Statistical Methods: Advanced – Session 1

1. Higher-order asymptotics for random effects meta-analysis: An empirical evaluation Beyene J

2. A simple adaptation considerably improves the performance of the standard method for random effects meta-analysis IntHout J, Ioannidis JP, Borm GF

3.

4. A Bayesian approach facilitates interpretation of results in meta-analysis: the example of periodontal disease Brignardello-Petersen R, Carrasco-Labra A, Pintor F, Ulloa C, Tomlinson G

Oral Session O3.04

Singapore 206 A

Rapid Response

1. Rapid reviews to inform health policy decisions using Cochrane Systematic Reviews Kriz H, King V, Gerrity M, Thielke A, Little A

2. Applicability and usability of rapid systematic reviews for rapid guidance development in health care and policy settings Koster M, Garritty C, Gallagher C, Schünemann H, Norris S

3. Cochrane Response rapid reviews: What are they about, how to get involved and what’s in it for Cochrane Groups Becker L, Garritty C, Moher D, Ried J

4. Rapid reviews: one size fits all? Garrity C, Kamel C, King V, Stevens A, Kelly S

Moderator: Hans van der Wouden

Instrumental variable methods to adjust for treatment non-compliance and contamination in meta-analyses of randomized controlled trials Miladinovic B, Kumar A, Hozo I, Mhaskar R, Djulbegovic B

Moderator: Adrienne Stevens

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

84


Oral Session O3.05

Heterogeneity

1. Investigating clinical heterogeneity in systematic reviews Gagnier J

2. SAMURAI - A new statistical program for sensitivity analyses using unpublished but registered studies Gartlehner G, Kim NY, Bangdiwala SI, Thaler K

3. Hypertension, drug treatment, and sub-group analysis: a case for updating Cochrane Handbook? Gueyffier F

4.

Keystone 206 B

Moderator: Jim Wright

Does hierarchical meta-regression provide key insights for exploring the effectiveness of complex quality improvement interventions in diabetes? Ivers N, Trikalinos T, Dahabreh I, Tricco A, Moher D, Ramsay T, Yu C, Straus S, Grimshaw J

Oral Session O3.06

Shared decision-making

1. L’évaluation des outils d’aide à la pratique médicale de 1ère ligne : la perspective du transfert de connaissances. Ziam S, Boulet L, Côté G, Lauzier A

2.

sunday 22 September

Sunday 22 September con’t.

Québec 200 AB

Moderator: Bernard Burnand

Cochrane Review of interventions for improving adoption of shared decision-making by healthcare professionals: an update Légaré F, Stacey D, Turcotte S, Cossi M, Kryworuchko J, Graham I, Lyddiat A, Politi MC, Thomson R, Elwyn G, Donner-Banzhoff N

3. Shared Decision-Making Does Not Influence Physicians Against Clinical Practice Guidelines Guerrier M, Légaré F, Labrecque M, Rivest L

4. Sharing evidence with clinicians in ethically sound environment Tejani A, Adlparvar C, Jauca C

1330-1500

Workshops 3.01 Introducing the new Cochrane Handbook chapter on equity – methods for systematic reviews with a focus on equity Facilitators: Petticrew M, Welch V, Tugwell P, O’Neill J, Francis D, Pottie K

Amsterdam 303 A

3.02 [Core] Using MECIR standards in the interpretation and presentation of results in Cochrane Reviews of interventions – Part 1 Facilitators: Lasserson T, Trivella M

Adelaide 302 B

3.03 [DTA Stream] Advanced meta-analysis – dealing with heterogeneity and test comparisons Facilitators: Macaskill P, Takwoingi Y

Rome 304 A

3.04 Translating critical appraisal of a systematic review to meaningful peer review Facilitators: Wormald R, Dickersin K, Jørgensen KJ, Lindsley K

Melbourne 204 B

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

85


3.05 Extending the Risk of Bias Tool to allow for assessment of non-randomised studies, cluster-randomised trials and cross-over trials: A Cochrane Methods Innovation Fund Project Facilitators: Sterne J, Higgins J, Reeves B

Dublin 205 A

3.06 Helping Cochrane Reviews soar: a workshop to create a communication and dissemination strategy for every Cochrane Review Facilitators: Pentesco-Gilbert D, Jones B

Freiburg 205 C

3.07 Addressing missing participant data in systematic reviews: Dichotomous outcomes – Part I Facilitators: Akl E, Ebrahim S, Johnston B, Alonso P, Briel M, Guyatt G

Cape Town 304 B

3.08 [Core] Mastering the art of the plain language summary Facilitators: McIlwain C, Struthers C

Barcelona 204 A

3.09 [Consumer Stream] The wonders of randomisation - workshop for consumers Facilitators: Crowe S, Gyte G, Horey D

São Paulo 205 B

3.10 Quality in reporting adverse events and the PRISMA Harms Extension Facilitators: Zorzela L, Vohra S, Golder S

Madrid 207

3.11 Graphs to enhance understanding and improve interpretability of the evidence from network meta-analysis: a hands-on tutorial in STATA Facilitators: Chaimani A, Mavridis D, Salanti G ***In computer lab; no need for personal laptops

Oslo 302 A

sunday 22 September

Sunday 22 September con’t.

*[Consumer stream] = workshops that are particularly aimed at consumers [DTA stream] = suite of workshops all related to diagnostic test accuracy (DTA) [Core] = basic training workshops likely to be relevant to authors conducting a Cochrane intervention review; not advanced methods, or new methods still under discussion & development

1500-1530

Refreshment Break and Exhibitors

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

Ottawa 200 C

86


sunday 22 September

Sunday 22 September con’t. 1530-1700 Concurrent Session F 1530-1700

Special Sessions Special Session 3.03 Chairs: Becker L, Tugwell P Developing evidence in a responsive approach Oliver S, Hyde C, Thompson-Coon J, Whear R, Allen C, Clarke M, Moher D, Nasser M, Welch V, Li T, Crowe S

Baltimore 303 B

Special Session 3.04 Research issues in the evaluation and design of interventions to improve outcomes for patients with multimorbidity Boyd C, Smith S, Fortin M

Stavanger 203

1530-1700

Oral Sessions Oral Session O3.07

Oxford 301 A

Challenges in Review Methods

1. A discussion of the challenges in conducting a systematic review of adverse effects including randomized trials and non-randomized studies Furlan A, Irvin E, Carnide N, Munhall C, Loke Y, Marin T

2. Non-randomised studies in systematic reviews of intervention effectiveness: a content analysis of Cochrane Systematic Reviews Ijaz S, Mischke C, Ruotsalainen J

3. Cochrane Review authors’ reporting of blinding in included studies: A descriptive study Motaze V, Durãao S, Okwundu C

Moderator: Ian Shrier

Oral Session O3.08

Review Impact

1. Informing change: Cochrane Reviews helping to guide cancer prevention research priorities Zitzelsberger L, Belair M, Vilis E, Kerner J

2. Measuring impact of systematic reviews using individual participant data: evidence from clinical guidelines Vale C, Rydzewska L, Stewart L, Rovers M, Emberson J, Gueyffier F

3. The antenatal magnesium sulphate for fetal neuroprotection research cycle: beyond the meta-analysis Bain E, Middleton P, Crowther C

Hamilton 301 B

Moderator: Mala Mann

4. Evidence on Tap: Youth suicide prevention Bennett K, n/a TYSEOTT

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

87


Oral Session O3.09

Amsterdam 303 A

Future Tech

1. Future Tech: Linked data Mavergames C

2. Future Tech: IMS Thomas J, Riis J

3. Future Tech: Cochrane’s Web Presences (including The Cochrane Library) Mavergames C, Becker L

sunday 22 September

Sunday 22 September con’t. Moderator: Jordi Pardo Pardo

4. Future Tech: CRS Dooley G, Foxlee R

Oral Session O3.10

Statistical Methods: Advanced – Session 2

1. Sufficiently stable systematic reviews using random order cumulative meta-analysis Ramirez G

2. Use of outcome data hierarchies to deal with multiplicity in trials: survey of systematic reviews Page MJ, McKenzie JE, Green SE, Forbes A

3. An empirical comparison of univariate and multivariate meta-analysis for categorical outcomes Trikalinos T, Hoaglin D, Schmid C

4. A framework for individual participant data meta-analysis in the presence of missing data Debray T, Koffijberg H, Jolani S, Van Buuren S, Moons K

Oral Session O3.11

Global Health and Equity - Session 1

Moderator: Craig Lockwood

1.

Are men difficult to find? Identifying sex-specific studies in MEDLINE and Embase Stewart F, Fraser C, Roberston C, Archibald D, Alison A, ROMEO Project Group

2. Effectiveness of interventions on reducing inequities in maternal and child health in low- and middle-income settings Målqvist M, Trygg N, Qian X, Ng N, Thomsen S

3.

4. Integrating sex and gender analysis into systematic reviews Puil L, Tudiver S, Doull M, Welch V, Shea B, Boscoe M, Runnels V, O’Neill J

Lyon 202

Moderator: Jasvinder Singh

Singapore 206 A

An equity focused approach for systematic reviews: using community dialogue to interpret the implications of findings for safety and security of immigrant children and youth Pottie K, Dahal G, Georgiades C, Rader T, Hassan G

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

88


Oral Session O3.12

Keystone 206 B

Reporting evidence

1.

Moderator: Laura Amato Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Protocols (PRISMA-P) 2013 Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart L

2. Developing a checklist to assess quality of reporting of knowledge translation interventions using the WIDER Recommendations Albrecht L, Archibald M, Arseneau D, Scott SD

3. Do problems in the conduct and reporting of Cochrane Reviews limit the reliability of clinical conclusions? Alper B, Fedorowicz Z

4.

An overview of reports evaluating the quality or reporting of systematic reviews Turner L, Pussegoda K, Boutron I, Garritty C, Bjerre L, Altman D, Hróbjartsson A, Moher D

Oral Session O3.13

Knowledge Translation and Communicating the Evidence - Session 2

1.

Québec 200 AB

Moderator: Mary Catherine Lindberg The communication assessment checklist in health (CATCH): moving forward with research on the usability of health information resources Giguere A, Witteman H, Francine B, Grimshaw J, Genova J, Haynes B, Légaré F, Pons F, Bhattacharyya O, Grudniewicz A, Versloot J

2. Linking knowledge translation methods and tools to support evidence-informed public health Dobbins M

3. Formulating recommendations to increase appropriateness and efficiency in healthcare: the MAPAC initiative Solà I, Quintana M, Urrútia G, Bolíbar I, Gich I, Puig T, Balasso V, Bonfill X

4.

sunday 22 September

Sunday 22 September con’t.

Methods for the assessment of the effectiveness of treatment sequences for clinical and economic decision-making Lewis R, Wilkinson C, Sutton A, Woolacott N, Hughes D, Ruiz F, Williams N, Philips C

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

89


1530-1700

sunday 22 September

Sunday 22 September con’t. Workshops 3.12 Presenting evidence-based recommendations to patients and the public - what do people want and how should we provide it? Facilitators: Santesso N, Agoritsas T

Rome 304 A

3.13 [Core] Using MECIR standards in the conduct of systematic reviews with emphasis on associated Common Errors – Part 2 Facilitators: Trivella M, Beller E, Lasserson T, Cates C

Adelaide 302 B

3.14 [DTA Stream] Systematic reviews of diagnostic accuracy studies: interpreting results and drawing conclusions Facilitators: Scholten R, Davenport C, HYDE C

Cape Town 304 B

3.15 [Core] Start strong: choosing your review topic and writing your topic proposal Facilitators: Marin T, Couban R, Ueffing E, Furlan A

Melbourne 204 B

3.16 Comments on Cochrane Reviews: approaches to managing feedback Facilitators: Hilton J, Stewart G, Lasserson T

Barcelona 204 A

3.17 Summarising evidence for harms in systematic reviews Facilitators: Herxheimer A

São Paulo 205 B

3.18 Addressing missing participant data in systematic reviews: Continuous outcomes – Part 2 Facilitators: Ebrahim S, Akl E, Johnston B, Alonso P, Mustafa R, Guyatt G

Madrid 207

3.19 Searching and tracking in the Cochrane Register of Studies (restricted) Facilitators: Foxlee R, Dooley G, Littlewood A, Noel-Storr A, Salzwedel D ***In computer lab; no need for personal laptops

Oslo 302 A

3.20 [Consumer Stream] Stakeholder/consumer engagement in systematic reviews Facilitators: Marin T

Dublin 205 A

*[Consumer stream] = workshops that are particularly aimed at consumers [DTA stream] = suite of workshops all related to diagnostic test accuracy (DTA) [Core] = basic training workshops likely to be relevant to authors conducting a Cochrane intervention review; not advanced methods, or new methods still under discussion & development

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

90


1715-1830

sunday 22 September

Sunday 22 September con’t. Meetings

Meeting

AAOHNS Cochrane Scholars - introduction to systematic reviews

1800

Restriction (If any)

Room

Closed Hamilton 301 B

Canadian Network for Observational Drug Effect Studies Open (CNODES): Prospective meta-analysis of drug safety data from a distributed network

Oxford 301 A

CerQual approach: Assessing how much certainty to place in findings from qualitative evidence syntheses

Open

Adelaide 302 B

Chalmers Award Committee - Meeting 1

Closed

Dublin 205 A

Consumers Executive Meeting - Part 2

Closed

São Paulo 205 B

Fields Executive Meeting

Closed

Cape Town 304 B

Managing Editors’ Executive - Part 2

Closed

Barcelona 204 A

Ottawa Group Meeting

Open

Singapore 206 A

Musculoskeletal Review Group Open Meeting

Open

Amsterdam 303 A

Primary Health Care Field: Updates, Discussions & More

Open

Freiburg 205 C

Public Health Review Group Priority Setting Meeting

Open

Lyon 202

Research dissemination for impact

Closed

Keystone 206 B

Trials Search Co-ordinators’ Executive Meeting – Part 2

Closed

Madrid 207

Using ReGroup for Cochrane Reviews

Open

Stavanger 203

20th Anniversary Gala Cocktail hour 1800-1900 (fourth floor foyer) Gala Dinner 1900 Entertainment and Dancing 2100 until . . .

Hyderabad 400 A

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

91


Alberta Lake Minnewanka is a glacial lake located east of Banff National Park. In 1888, a summer resort village called Minnewanka was established by the lake that grew to include four avenues, three streets, hotels, restaurants and cruise boats. In 1941, a dam was built by the Calgary Power Company that raised the water level of Lake Minnewanka by 30 m (100 ft), flooding the entire town. Minnewanka is now a high altitude dive site that is18 km long, about 30 m deep and at an altitude of 1450 m (4750 ft). It is one of the best preserved examples of a submerged historic village in Canada.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

92


0700-1700

Registration/Information Desk Open

0700-0815

Meetings Meeting

0700-0815

Restriction (If any)

Room

Applicability and Recommendations Methods Group Meeting

Open

Madrid 207

Sexually Transmitted Infections Review Group Meeting

Open

São Paulo 205 B

Statistical Methods Group Meeting

Open

Cape Town 304 B

Trials Search Co-ordinators’ Executive Meeting – Part 3

Closed

Rome 304 A

Poster Set-up 4

monday 23 September

Monday 23 September

Ottawa 200 C

Please note today begins 15 minutes later than the previous four days

0845-1000

1st Annual Cochrane Lecture

Québec 200 AB

Sir Iain Chalmers, DSc

Coordinator, James Lind Initiative (via videocast)

Sir Iain Chalmers will show a film he recently made with Mark Starr demonstrating the Oxford Database of Perinatal Trials (ODPT – 1988-1993) and The Cochrane Collaboration Pregnancy and Childbirth Database (CCPC – 1993-1995), both of which were developed to provide the means for keeping systematic reviews up to date, and which the vast majority of people involved in The Cochrane Collaboration will never have heard of. These two publications were the predecessors of the Cochrane Database of Systematic Reviews. During his discussion Sir Chalmers will emphasize the need to meet the continuing challenge of keeping reviews up to date.

1000-1030

Refreshment Break and Exhibitors

Ottawa 200 C

1030-1200

Poster Viewing 4

Ottawa 200 C

P4.001 CRISP: online summaries of Cochrane Reviews for policy Turner T, Brennan S, Cossens L, McDonald S

P4.002 Reporting of interim analyses, stopping rules, and Data Safety and Monitoring Boards in protocols and publications of discontinued randomized trials Stegert M, Kasenda B, von Elm E, Briel M

P4.003 Systematic reviews on nutrition interventions relevant to low- and middle-income countries: descriptive assessment of methodological challenges Salam R, Welch V, Das J, Bhutta Z

“Keeping systematic reviews up to date: a continuing challenge”

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

93


P4.004 Is adequate reporting on health equity in systematic review equivalent to an equitable recommendation? A case report Shi C, Tian J, Wang Q, Yang K P4.006 La généralisation des résultats de méta-analyses dans les recommandations formulées par les organisations internationales Druetz T, Ridde V, Haddad S P4.007 Cochrane’s impact on child health guidance in three Western countries Thomson D, Sommerville M, Harting L P4.009 Critical Appraisal of Clinical Practice Guidelines for Treatment of Pancreatic Cancer Based on the Global Disease Burden Li CC, Li XL, Li YP, Chen Y, Wang L, Tan J P4.010 The Endocrine Society Guidelines: when the confidence cart goes before the evidence horse? Brito JP, Domecq JP, Murad MH, Guyatt GH, Montori VM P4.011 Publication and appraisal of methodological guidelines: the development of systematic reviews (SR) and meta-analyses of randomized clinical trials by the Department of Science and Technology of the Brazilian Ministry of Health (DECIT/MOH) Koury C, Vieira N, Elias F, Gadelha C, Calvalcanti A, Buehler A, Figueiró M, Berwanger O P4.012 Brain metastasis management: difficulties with integrating Cochrane Review evidence into guidelines Grant R, Quinn G, Jess C P4.013 Is replication research informing the results of systematic reviews in knowledge translation research? Curran J, Vachon B, Grimshaw J, Research R P4.014 Tools to evaluate the methodological quality of physical therapy trials. What items should we use from these tools? A factor analysis Armijo-Olivo S, Cummings G, Fuentes J, Saltaji H, Ha C, Chisholm A, Rowe B, Hartling L, Rogers T

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

monday 23 September

Monday 23 September con’t. P4.015 Network meta-analysis in Health Technology Assessments: how frequently used and how necessary are they? Ciapponi A, GarcíaMartí S, Glujovsky D, Bardach A, Alcaraz A, Pichon-Riviere A, Augustovski F P4.016 The growing trend of network metaanalyses topic appearance in medical literature Ciapponi A, Glujovsky D, GarcíaMartí S, Bardach A, Comandé D P4.017 Priority Setting Distinguishing Methodological Quality from Report Quality: Assessment Example of Systematic Reviews about Non-pharmacological Intervention for Depression with PRISMA and AMSTAR Wang J, Zhai J, Zhang S, Shang H P4.018 Development of a topic nomination and selection process with US Medicaid policy makers Kriz H, Thielke A, Betteridge S, King N, King V P4.019 An approach to deal with the absence of cohort studies in prognosis systematic reviews: a meta-analysis of cross-sectional studies El Dib R, Branco A, Kapoor A P4.020 Systematic review and methodological exploration of synthesis methods in public health evaluations of interventions Achana F, Hubbard S, Sutton A, Kendrick D, Cooper N P4.021 Validation of a quality assessment checklist for case series studies Guo B, Moga C, Schopflocher D, Harstall C P4.022 Assessment of methodological quality of systematic reviews of China health policy He S, Zhao J, Zhang F, Tian J P4.023 A QQAQ assessment of the methodological quality of systematic reviews of China health policy Zhao J, He S, Zhang F, Tian J P4.024 Methodological quality assessment of systematic reviews or meta-analysis of interventions on diabetic nephropathy Ge L, Ma JC, Zeng QL, Zhang F, Liang L, Shi XT, Liu YC, Tian JH

94


P4.025 A PRISMA assessment of the reporting quality of systematic reviews or meta-analysis of interventions on diabetic nephropathy An N, Ge L, Liu YC, Xu JF, Liang L, Ma JC, Wang J, Shi XT, Tian JH P4.026 Assessment of the quality of reporting in randomized controlled trials of acupuncture in the Korean literature using the CONSORT and STRICTA statements Kim KH, Kang JW, Choi J, Lee JD P4.027 A Systematic Assessment of the Quality of Systematic Reviews/Meta-analyses on Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma Wang Y, Luo Q, Li Y, Deng S, Li X, Wei S, Yu J P4.028 Systematic review of clinical practice guidelines on the diagnosis and management of thyroid nodule and cancer Tam K, Wu C, Huang T, Wu M P4.029 Low carbohydrate diets and cardiovascular health: an example of a rapid response with high quality reviews to inform public health promotion Naude CE, Schoonees A, Young T, Senekal M, Volmink J, Garner P P4.030 Reporting guidelines for reporting searches of network meta-analysis are needed Yang K, Li L, Tian H, Tian J, Sun R P4.031 Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study Bindslev JBB, Schroll J, Gøtzsche PC, Lundh A P4.032 The use of collaborative writing applications in healthcare education a scoping review van de Belt T, Grajales F, Faber M, Kuziemsky C, Gagnon S, Bilodeau A, Rioux S, Fournier C, Emond M, Nadeau C, Lalonde TM, Aubin K, Gold I, Gagnon M, Turgeon A, Heldoorn M, Poitras J, Eysenbach G, Kremer J, Légaré F, Archambault PM

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

monday 23 September

Monday 23 September con’t. P4.033 Wikis and collaborative writing applications in healthcare: results of a scoping review Archambault P, van de Belt T, Grajales F, Faber M, Kuziemsky C, Gagnon S, Bilodeau A, Rioux S, Fournier C, Nadeau C, Émond M, Aubin K, Gold I, Gagnon M, Turgeon A, Heldoorn M, Poitras J, Kremer J, Eysenbach G, Légaré F P4.034 Calculating confidence intervals for the absolute risk reduction taking uncertainties of relative risk and baseline risk estimates into account Bender R, Newcombe R P4.035 Translation and validation of The Cochrane Collaboration’s tool for assessing risk of bias into German Buchberger B, Katzer C, Huppertz H, Wasem J P4.036 The Norwegian electronic health library - helping Norwegian health professionals in accessing English language resources Rosenbaum S, Tjensvoll K, Eggen R P4.037 Chronically sick to chronically well: a realistic and concrete way to do things differently with evidence in the Canadian system! Laframboise F, Mireault J P4.038 Health Systems Evidence: the development of a “one-stop-shop” of health systems research evidence to support policy-making Moat KA, Wilson MG, Lavis JN, Hammill A, Boyko J, Grimshaw JM, Flottorp S P4.039 Comparison of two experiences of development of healthcare quality indicators Roqué M, Osorio D, Rigau D, Pardo H, Solà I, Bellmunt S, Escudero JR, Bonfill X P4.040 Advancing quality in health policy decision-making in the face of uncertainty: an integrated review to characterize and address uncertainty Brouwers M, Driedger M, Makarski J, Craigie S, Annable G

95


P4.041 The Publishing Characteristics of Cochrane Reviews for Nursing Research Zhang F, Zhou Z, Li X, Zhang J, Yang K P4.042 RCT databases - reducing research wastage from the systematic review process Nankervis H, Williams H, Thomas K, Delamere F P4.043 Technological solutions for enhancing efficiency and sustainability of data abstraction in systematic reviews Li T, Vedula S, Hadar N, Parkin C, Lau J, Dickersin K P4.044 Dealing with Publication Bias Salmond S, Jadotte Y P4.045 Risk of Bias Assessment in Cross-Sectional Genetic Research: The Impact of Genetic Polymorphisms on Methadone Response Dennis B, Bawor M, Sohani Z, Thabane L, Guyatt G, Samaan Z P4.046 Does the modified intentionto-treat reporting affect the estimate of the treatment effect in meta-analyses? A meta-epidemiological study Abraha I, Montedori A, Cozzolino F, Orso M, Luchetta L, De Florio R, Schünemann H, Germani A P4.047 Evidence of design-related bias among studies validating clinical prediction rule: a meta-epidemiological study Ban J P4.048 Randomised clinical trials with negative results: Is there an increase in their reporting? Martínez-Zapata MJ, Rigau D, Roqué M, Solà I, Vernooij R, Pardo H, Simon C, Gich I, Urrútia G

monday 23 September

Monday 23 September con’t. P4.050 Judging the impact of missing participant continuous data on risk of bias in systematic reviews of randomized trials Ebrahim S, Johnston B, Akl E, Mustafa R, Sun X, Walter S, Heels-Ansdell D, Alonso-Coello P, Guyatt G P4.051 Reporting bias in industry-sponsored spinal fusion studies of recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) Selph S, Fu R, McDonagh M, Peterson K, Tiwari A, Chou R, Helfand M P4.052 Assessing publication bias in systematic reviews and meta-analyses in the context of small n trials: application of a capture-recapture method Coronado-Montoya S, Kwakkenbos L, Thombs B P4.055 Development of user-friendly summaries for published systematic reviews and meta-analyses in agri-food public health Kerr A, Young I, Waddell L, Keay S, McEwen S, Rajic A P4.056 Does a Cochrane contributor facilitate the implementation of evidence-informed recommendations in practice Nabhan A P4.057 Putting the issues on the table: summarising outcomes from reviews of reviews to inform health policy Brunton G, Thomas J, Paraskeva N, Caird J, Rumsey N P4.058 Critically Appraised Topic (CAT) one-day workshop – ‘CAT in a Day’ Jordan J, Stevenson K, van der Windt D, Dziedzic K P4.059 Developing a conceptual framework for going from evidence to coverage decisions Davoli M, Amato L, Parmelli E, Pregno S

P4.049 Obtaining confidential protocols to increase the completeness and accuracy of risk of bias assessments for RCTs: an example from recombinant human bone-morphogenetic protein-2 (rhBMP-2) for spinal fusion Rodgers M, Brown J, Heirs M, Higgins J, Mannion R, Simmonds M, Stewart L

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

96


P4.060 Readability of Cochrane Breast Cancer Group plain language summaries Luis C, Jeffery G, Hickey B P4.061 Awareness and use of The Cochrane Library in internal medicine Letelier LM, Rivera S, Díaz A, Ewolt S, Acuña MP P4.062 Dissemination of effective physiotherapy treatments - analysing the relevance and usefulness of a large database of evidence summaries Claes E, Jans C, Meesen R, Deschutter F, Van de Velde S P4.063 What is the most appropriate knowledge synthesis method to conduct a review? A scoping review Tricco A, Kastner M, Soobiah C, Antony J, Cogo E, MacDonald H, Lillie E, Perrier L, Welch V, Horsley T, Straus S P4.064 Assessing generalizability of findings in systematic reviews of public health interventions: Methods of the US Community Preventive Services Task Force Thota A, Elder R, Hopkins D, Mercer S P4.065 The reporting characteristic of qualitative study: a review Shi C, Ren D, Wei H, Tian J, Yang K P4.066 How rare are adverse drug effects? Assessing the frequency of harm effects of drug treatments for the management of sciatica in primary care Junqueira DRG, Ferreira ML, Pinto RZ, Cândido RCF, Ferreira PH

P4.069 From summary to synthesis: A review of statistical synthesis and presentation methods used in complex reviews McKenzie J, Brennan S, Page M, Chau M, Kramer S, Bosch M P4.070 Using a theory driven mixed-method review to assess the benefits of complex environmental-health programmes. Cochrane Public Health Group review CD010351 Lovell R, Husk K, Cooper C, Garside R P4.071 Surgical trials and trial registries: a cross-sectional study of RCTs published in journals requiring trial registration in their author instructions Hardt JLS, Metzendorf M, Meerpohl JJ P4.072 Clinical trials of Traditional Chinese medicine need core outcome sets Zhang L, Zhang J, Zheng W, Xing D, Shang H P4.073 Generating empirical evidence to support methods for overviews of reviews Hartling L, Dryden D, Vandermeer B, Fernandes R P4.074 Scoping reviews: a valuable first step in knowledge synthesis Hartling L, Hamm M, Milne A P4.075 Characteristics of published scoping reviews: A scoping review of scoping reviews Pham M, Rajic A, Greig J, Scott M P4.077 Using a bibliometric approach for a clinical question that generates a large volume of literature Shaw SM, Skoretz S, Martino R

P4.067 Collating the knowledge base for the COMET (Core Outcome Measures in Effectiveness Trials) Initiative - a systematic review Gargon E, Gurung B, Paula W

P4.078 Building a Database of Validated Pediatric Outcomes: An Investigation of Compliance with Established Reporting Standards Adams D, Bhaloo Z, Hartling L, Vohra S

P4.068 Development of a question-driven framework for evidence rating in the area of communicable diseases – a project of the European Centre for Disease Prevention and Control (ECDC) de Carvalho Gomes H, Takla A, Sanchez-Vivar A, Jansen A, Harder T

P4.079 A user-friendly alert service of high-impact, pre-filtered literature for obstetrics and gynaecology Skidmore B, Bell H, LeBlanc N, Paquette S

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

monday 23 September

Monday 23 September con’t.

97


P4.080 A review of online evidence-based practice point-of-care information summary providers: an update Moja L, Gonzalez Lorenzo M, Tagliabue L, Banzi R P4.081 The CONSENSUS Study - Squamous Cell CarcinOma of the OropharyNx: Late PhaSECliNicalTrialS; Core OUtcomeS Tudur-Smith C, Young B, Jones TM P4.082 What’s in ‘Dr Cochrane’ for family physicians? Evaluation of an online Cochrane Learning programme with the Information Assessment Method (IAM) Urquhart B, Grad R, Pluye P, Shulha M, Granikov V P4.083 A study of evidence sources used in midwifery training and practice Alderdice F, McNeill J, Lasserson T, Clarke M P4.084 Strategies to fill knowledge gaps in health care - experiences from the Swedish Council on Health Technology Assessment (SBU) Jacobson S, Mowafi F, Tranaeus S, Heintz E P4.085 Sharing tacit knowledge to build capacity for knowledge translation: Lessons learned from pan-Canadian public health webinars Sears K, Chera S, Dobbins M, Forsyth P P4.086 Systematic Reviews and Meta-Analyses in Eyes and Vision: First Steps in Identifying Gaps in Ophthalmology Research Ssemanda E, Li T, Dickersin K P4.087 Finding research on websites – experiences and solutions from the field of international development Stansfield C, Dickson K, Stewart R, Vigurs C, Tripney J, Bangpan M, Oliver S, Hauari H P4.088 What’s in it and how do users find it? – Challenges of knowledge transfer through specialised registers of health promotion effectiveness Stansfield C, Brunton G, Kavanagh J P4.089 Searching for indirect evidence: advantages and challenges of extending the network of studies Sutton AJ, Abrams KR

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

monday 23 September

Monday 23 September con’t. P4.090 Search filter for retrieving overviews of systematic reviews in The Cochrane Library Silva V, Puga MES, Grande AJ, Porfírio GJM, Martimbianco ALC, Torres MFS, Costa MB, Carvalho MR, Fioretti BTDS, Costa CS, Peccin MS, Riera R, Torloni MR, Atallah Î P4.091 Interobserver reliability for application of tools for assessing quality and susceptibility to bias in observational studies Mota B, Bevilacqua JL, Silva V, Barrett J, Riera R P4.092 Evidence-based Physiotherapy: mapping Cochrane Systematic Reviews with practical implications for clinical practice Torres MF, Porfírio G, Silva V, Grande AJ, Martimbianco AL, Costa M, Carvalho M, Fioretti B, Costa C, Torloni MR, Riera R, Atallah Á P4.093 Mapping the Cochrane evidence in infectious diseases Almeida R, Cavalcante R, Ferreira-Filho S, Kim A, El Dib R P4.094 Do patient decision aids improve patient adherence? Considering definitions and measures when interpreting systematic review findings Selva A, Desroches S, Singh K, Bissonnette J P4.095 Screening for decisional conflict in clinical practice: validation of SURE Ferron Parayre A, Labrecque M, Rousseau M, Turcotte S, Légaré F P4.096 Challenges in SDM education: The heterogeneity of SDM training programs and the search for consensus on core competencies Légaré F, Drolet R, Stacey D, Moumjid-Ferdjaoui N, Härter M P4.097 Presentation of continuous outcomes in meta-analysis: a survey of clinicians’ understanding and preferences Johnston B, Bandayrel K, Friedrich J, Akl E, da Costa BR, Neumann I, Adhikari N, Alonso-Coello P, Crawford M, Mustafa R, Svendrovski A, Thabane L, Tikkinen K, Vandvik P, Guyatt G

98


P4.098 Permutation based resampling for deriving p-vlaues for pooled effect estimates in meta-analsyes Gagnier J, Beyene J P4.099 Consistency of outcome and statistical reporting of time-to-event data: The impact on Cochrane Reviews and meta-analyses in epilepsy Nolan SJ, Sutton L, Marson A, Tudur Smith C P4.100 Framing minimal important difference in measuring of quality of life: Absolute or Relative? Zhang Y, Zhang S, Thabane L, Zhou Q, Furukawa T, Johnston B, Guyatt G P4.101 The current situation of the publication of Cochrane Systematic Reviews Ma J, Sun X, Zhao Y, Tian J P4.102 Accuracy of blood pressure data abstraction from graphs Soufi S, Zhang X, Musini V

monday 23 September

Monday 23 September con’t. P4.107 Attitudes towards evidence based medicine among medical students of Universidad Nacional del Sur Medical School of Argentina Garcia Dieguez M, del Valle M, Jouglard E, Gazzoni C, Camila I, Sosa Ridolfi A, Lauronce M, Durante E P4.108 Training Cochrane Systematic Reviews: Challenges and benefits of online training Jahanfar S P4.109 Building Capacity of Indian Scientists in Conduct of Systematic Reviews: An Indian Council of Medical Research (ICMR) Initiative Sinha A, Thavraj V, Shah D, Sazawal S, David T, Tharyan P, Roy M P4.110 Current curriculum and training program of evidence-based health care (EBHC) for undergraduate students: Taiwan’s experience Huang Y, Yang Y, Lin C, Tsai S, Lin W, Tsai J

P4.103 The challenges of establishing and maintaining a multilingual clinical trials register Long L, Stern C, Pearson A P4.104 Effectiveness of a brief course in evidence-based medicine for knowledge of the best sources of information in health care among health care workers: first results of the beginning of evidence-based medicine in the Amazonian region Fonseca RMDM, Martins MDA, dos Santos CL, Pereira IV, Andriolo BNG, Atallah Î, Andriolo RB P4.105 Online capacity building in translating research into practice for Latin American researchers Villanueva EC, Tzanova M, Cuervo LG, Urrutia G, Ueffing E P4.106 Enhancing evidence-based health care (EBHC) knowledge and skills of medical student interns at Stellenbosch University’s Rural Clinical School in Worcester Rohwer A, Schoonees A, Engel M, Young T

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

99


1200-1330 1215-1330

Lunch Break

Auckland 400 B

Meet the Editors (open) (Please bring a lunch plate with you) What goes through the mind of an editor? What topics are they interested in publishing? Join editors from several key medical journals at an informal interactive session that explores how to get published, what to do if rejected and other topics including: > Attitudes towards joint publication of Cochrane Reviews > What reviews appeal to journal editors? > Word limits, table and figures

Lyon 202

monday 23 September

Monday 23 September con’t.

You will hear from editors from: > Journal of the American Medical Association > PLOS Medicine > Canadian Medical Association Journal > British Medical Journal > Journal of Clinical Epidemiology

1230-1330

Meeting Meeting

Chalmers Award Committee - Meeting 2

Restriction (If any)

Closed

Room

Barcelona 204 A

1330-1500 Concurrent Session G 1330-1500

Special Sessions Special Session 4.01 Chair: Ravaud P Translation of Cochrane summaries: a realistic and timely goal for the Collaboration? Ravaud P, Yvon F, Rada G

1330-1500

Oral Sessions

Quality of Guidelines

1. The quality of the evidence base for clinical pathway effectiveness: Room for improvement in the design of evaluation trials Rotter T, Kinsman L

2. Relative paucity of high-quality or moderate-quality evidence to inform World Health Organization guidelines on antiretroviral therapy Rutherford GW, Horvath T, Kennedy GE

3. Quality appraisal of clinical guidelines and consensus statements on computed tomography for coronary artery disease Yang P, Yao D, Tian JH, Lei JQ, Li JK

Oral Session O4.01

Québec 200 AB

Oxford 301 A

Moderator: Heather Colquhoun

4. Systematic reviews and Chinese guidelines: a cross-sectional study Yang K, Chen Y, Yuan B, Sun L, Yao L, Xiao X, Wei D, Wang Q

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

100


Oral Session O4.02

Statistical Methods - Network Meta-Analysis

Moderator: Rafael Perera 1. How to design future studies based on conditional power of network meta-analysis Nikolakopoulou A, Mavridis D, Salanti G

3. Evaluating the transitivity assumption when constructing network meta-analyses: lumping or splitting? Lindsley K, Cameron N, Wormald R, Li T, Dickersin K

monday 23 September

Monday 23 September con’t. Hamilton 301 B

4. Empirical evidence about inconsistency in complex networks of interventions Veroniki AA, Vasiliadis H, Higgins JP, Salanti G

Oral Session O4.03

Baltimore 303 B

GRADE and Summary of Findings Tables

Moderator: Mohammed Ansari 1. Harmonization of explanations for common judgments about the quality of evidence in Summary of Findings Tables Langendam M, Mustafa R, Santesso N, Carrasco A, Moustgaard R, Ventresca M, Heus P, Brozek J, Lasserson T, Schünemann H 2.

GRADE in Summary of findings tables: how to formulate informative footnotes on the assessment of the quality of evidence Langendam M, Mustafa R, Santesso N, Carrasco A, Moustgaard R, Ventresca M, Heus P, Brozek J, Lasserson T, Schünemann H

3. Interactive Summary of Findings tables Rosenbaum S, Oxman A, Morelli A, Rada G

4.

Upgrading the quality of evidence from RCTs? Examples from published Summary of Findings tables Langendam M, Mustafa R, Santesso N, Carrasco A, Moustgaard R, Ventresca M, Heus P Brozek J, Lasserson T, Schünemann H

Oral Session O4.04

Lyon 202

Mixed methods and realist reviews Moderator: Esther Coren 1. Promoting Health Literacy through Community Based Peer Support: a worked example of innovative methods in integrating qualitative and quantitative research in evidence synthesis Booth A, Harris J, Croot L, Springett J, Wilkins E

2.

The Mixed Methods Appraisal Tool for assessing studies with diverse designs: Example from a systematic mixed studies review on the key processes and outcomes of Participatory Research with Health Organizations Pluye P, Bush P, Macaulay A, Loignon C, Haggerty J, Granikov V, Repchinsky C, Parry S, Brown B, Bartlett G, Wright M, Pelletier J

3. An analysis of theory building in realist synthesis: perspectives from the literature Hunt H, Hardwick R

4. Configurational ‘qualitative’ synthesis for evidence-based policy and practice: breaking down the qualitative/quantitative divide Rees R, Sutcliffe K, Thomas J

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

101


Oral Session O4.05

Global Health and Equity - Session 2

1. How to address equity in guidelines: a review Shi C, Zhang L, Wang Q, Tian J, Guo Y, Yang K

monday 23 September

Monday 23 September con’t. Stavanger 203

Moderator: Davina Ghersi

2.

The importance of implementation evaluation. Case study of a review on preschool feeding programmes to improve the health of disadvantaged young children. Kristjansson E, Francis D, Liberato S, Benkhalti Jandu M, Welch V, Batel M, Greenhalgh T, Rader T, Noonan E, Shea B, Janzen L, Wells G, Petticrew M

3.

Assessing ethics and equity issues in systematic reviews and primary studies of nutrition interventions Welch V, Petticrew M, Tugwell P, Christie T, Moher D, Ueffing E, Nickerson J, Sculthorp M

4. Closing the health equity gap: a social determinants focus for population level Cochrane Reviews Doyle J, Waters E, Armstrong R

Oral Session O4.06

Editorial processes and supporting review authors

Moderator: Robert Dellavalle

1.

Project TAKE 5 - Transforming the Antecedent “Know-how” for Evidence Synthesis: 5 Factors to Consider when Conducting Systematic Reviews! Jadotte Y, Holly C, Salmond S

2.

Empty review reporting practices and policies: A survey of Cochrane Review Group editors and other key systematic review producers Montgomery P, Yaffe J, Morton M, Shepard L, Hopewell S

3. Barriers and facilitators to completing a Cochrane Review: A survey of authors in the African region Oliver J, Kredo T, Zani B

4.

1330-1500

Keystone 206 B

Proposal to improve the “Implications for Research” section of Cochrane Reviews Porfírio G, Martimbianco A, Torres MF, Grande A, Silva V, Costa C, Costa M, Fioretti B, Carvalho M, Parra M, Pesavento T, Torloni M, Riera R, Atallah üsup>1

Workshops 4.01 How to critically appraise qualitative research papers and prepare for data-extraction Facilitators: Hannes K

Adelaide 302 B

4.02 Workshop for Managing Editors and Assistant Managing Editors (restricted) Facilitators: Shah A, Dearness K, Ruotsalainen J

Rome 304 A

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

102


4.03 [DTA Stream] Grading the quality of evidence and preparing summary of findings tables for diagnostic tests Facilitators: Schünemann H

Melbourne 204 B

4.04 [Core] Investigating and Dealing with Bias in Cochrane Systematic Reviews Facilitators: Boutron I

Cape Town 304 B

4.05 Sharing participant-level clinical trial data in public repositories: what are implications for Cochrane Reviews? Facilitators: Krleza-Jeric K, Vision T, Groves T

Dublin 205 A

4.06 How to develop brief economic commentaries for Cochrane intervention reviews Facilitators: Shemilt I

Barcelona 204 A

4.07 Live the trial! An interactive method for learning and teaching trial design and risk of bias assessment Facilitators: Baker P, Francis D, Dobbins M

São Paulo 205 B

4.08 An introduction to systematic reviews of prognostic studies Facilitators: Hayden J, Moons K

Freiburg 205 C

4.09 [Consumer Stream] Consumer-led knowledge translation: leveraging patient networks to disseminate Cochrane Reviews Facilitators: Brachaniec M, Gunderson J, Rader T, Busch A

Madrid 207

4.10 Searching trials registers to identify studies for Cochrane Reviews (restricted) Facilitators: Glanville J, Lefebvre C ***In computer lab; no need for personal laptops

Oslo 302 A

4.11 [Core] Introduction to meta-analysis: Dealing with heterogeneity – Part 3 Facilitators: Salanti G, Veroniki AA, Mavridis D, Chaimani A

Amsterdam 303 A

monday 23 September

Monday 23 September con’t.

*[Consumer stream] = workshops that are particularly aimed at consumers [DTA stream] = suite of workshops all related to diagnostic test accuracy (DTA) [Core] = basic training workshops likely to be relevant to authors conducting a Cochrane intervention review; not advanced methods, or new methods still under discussion & development

1500-1530

Refreshment Break and Exhibitors

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

Ottawa 200 C

103


Closing Plenary IV: Even Better knowledge for better health: The next 20 years

The learning objectives of this plenary session are to ensure participants:

1.

2. Discover new models of community engagement that can better support societies’ needs.

3. Determine how The Cochrane Collaboration can better support societies’ needs.

Changes in technology and societies offer new opportunities to promote evidence-informed health decision-making. In this plenary we consider how technologies can advance the accessibility of health evidence, how social entrepreneurship can enable community engagement on health issues and how The Cochrane Collaboration will position itself to make the most of these opportunities to advance our mission.

Chairs: Isabelle Boutron and David Tovey

Speakers: Chris Mavergames, MLIS

1530-1700

Québec 200 AB

 Explore Web 3.0 and linked data opportunities to make health evidence more accessible to diverse knowledge users.

Director of Web Development, The Cochrane Collaboration The Future of Knowledge: #CochraneTech to 2020 (and beyond)

David Bornstein Author, How to Change the World: Social Entrepreneurs and the Power of New Ideas (Oxford University Press) Journalist, The New York Times The Cochrane Collaboration as an Engine for Social Innovation: How can Cochrane contributors leverage their work to advance system changes in healthcare?

Mark G Wilson, MA, DIP JOUR, M PHIL, MM, FCMI Chief Executive Officer, The Cochrane Collaboration From here to there, the next 20 years of The Cochrane Collaboration

1730-1900

monday 23 September

Monday 23 September con’t.

Meeting Meeting

Colloquium Debrief Meeting

thank you Restriction (If any)

Closed

Room

Barcelona 204 A

Thank you for joining us for this event; please remember to complete your evaluation!

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

104


Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

105


British Co lumbia Ogopogo is the name given to Canada’s most famous water monster reported to inhabit Okanagan Lake, British Columbia. Sightings of Ogopogo were first reported by First Nations people in the early 19th century and have continued to be reported ever since. Ogopogo is most commonly described as a 30-50 foot long creature with a horse-shaped head and the body of a serpent. The most popular area where sightings have occurred is just south of Kelowna in waters near Peachland.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

106


General Information Accreditation

The Office of the Vice-Dean of Education and Continuing Professional Development of Université Laval, Faculty of Medicine, is supported by the College of Physicians of Québec, the Committee on Accreditation of Canadian Medical Schools (CACMS), and the Accreditation Council for Continuing Medical Education (ACCME) of the United States and is authorized by these organizations to offer activities in medical education. The Office of the Vice-Dean of Education and Continuing Professional Development of Université Laval, Faculty of Medicine, will acknowledge category 1 credits in medical education to participants of the Cochrane congress (i.e. Cochrane Colloquium).

Breakfast

Please be aware that breakfast is not provided at the Colloquium. Please make other arrangements such as buying breakfast foods or arranging breakfast with your hotel. The first refreshment break served is at 1000. There is a café in the Convention Centre and many in the near vicinity.

Certificate of attendance

All Colloquium delegates will receive an electronic certificate of attendance via email when the Colloquium has ended.

Cochrane Library access

Wiley-Blackwell is offering free access to The Cochrane Library throughout all of Canada in September, October and November 2013.

Conference organizers

Colloquium organizers are wearing red polo shirts with the word, “Organizer” on the back. They will be located throughout the Colloquium venue as well as the registration desk. There are also additional volunteers in red t-shirts who can offer help.

Concierge service

The Québec City Convention Centre offers a concierge service to assist delegates with directions, transportation information, restaurant reservations, booking city tours, etc. The concierge desk is located on the second level in the main hallway.

Evaluation form

Kindly complete the evaluation form to help us improve future Colloquia.

Internet access

Wireless internet is freely available throughout the Québec City Convention Centre. You do not need a password or code to access the internet. There is also a computer room (Oslo 302 A) where you can access the internet. It is inaccessible when sessions are scheduled in this room; please do not disturb when in session. There is an additional small computer area for delegate use on the third floor in the foyer.

Lost and found

Please enquire about lost and found items at the registration desk on level four (main hallway).

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

107


General Information Messages

Delegates can check for messages left for them at the registration desk located on level four (main hallway).

Morning run club

Wake up your brain and body by joining us for a scenic run around the Plains of Abraham. Runs will start and finish outside the entrance of the Convention Centre (100 boulevard Rene-Levesque) each morning of the regular program (20-23 September) and will be ~5 kms (30 minutes) in length. No registration is required. Please meet at the Convention Centre entrance at 0630. Please contact Kristin Danko (mkdanko@ohri.ca) with any questions.

Name badges

Identification badges are required for admission to all sessions and meals. Please wear your badge at all times. Social event tickets must be presented to gain entry to each respective event. Name badges will be colour-coded based on registration category. The colour codes are as follows: Full Colloquium Orange Day 1 only Gold Day 2 only Blue Day 3 only Green Day 4 only Yellow Plenary Speakers Royal Blue Exhibitors Teal Media Dark Green Special Guest Purple Organizers and Volunteers Red

Poster sessions

Posters are on display in Ottawa 200 C throughout Saturday, Sunday, and Monday (21 – 23 September 2013). On Friday, 20 September, the Meet the Entities posters will also be on display in the same room. Posters will be changed at the beginning of each day to allow for three poster viewing sessions. Please refer to the Program at a Glance to find poster viewing times.

Program

Please note we have made an effort to provide a varied program throughout each day so all of our delegates can attend sessions suited to them. For example, each day will offer a mix of statistics, methods, knowledge translation, consumer issues, etc. to meet the diverse needs of our delegates.

Registration desk

The Registration Desk is located on the fourth level in the main hallway and will be staffed from 0700 to 1700 on Friday, Saturday, Sunday and Monday (20-23 September 2013 inclusive). Registration will be open from noon to 1530 on Thursday, 19 September.

Simultaneous translation

Simultaneous interpretation between French and English will be provided all day in the plenary session room (Québec 200 AB) only. Sessions will be delivered in English, unless otherwise indicated. Headsets can be acquired outside the plenary room in foyer 200.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

108


General Information Special Sessions

Special sessions provide an opportunity to explore themes relevant to The Cochrane Collaboration in greater depth. The format of the sessions will vary, but the emphasis will be on discussing various key and emerging issues in systematic reviews and evidence-based health care.

And remember . . .

Please ensure your mobile phone and any other electronic devices are in silent mode or switched off before entering sessions as a courtesy to speakers and other delegates.

Disclaimer

The Organizing Committee of The Cochrane Collaboration Colloquium 2013 and its constituent members acting as organizers (known collectively as ‘the Organizers’) cannot accept any liability for death, injury, any loss, cost or expense suffered by any person (including accompanying persons or partners or attendant caregivers), if such loss is caused or results from the act, default or omission of any person other than an employee or agent of the Organizers. In particular, the Organizers cannot accept any liability for losses arising from the provision or non-provision of services provided by hotel companies or transport operators. Nor can the Organizers accept liability for losses suffered by reason of war including threat of war, riots and civil strife, terrorist activity, natural disasters, weather, fire, flood, drought, technical, mechanical or electrical breakdown within any premises visited by delegates and/or partners in connection with the meeting, nor losses suffered by reason of industrial disputes, governmental action, registrations or technical problems which may affect the services provided in connection with the meeting. The Organizers are not able to give any warranty that any particular individual will appear as a speaker or panelist. Registrants, speakers and guests of the Colloquium consent to being photographed filmed and/or recorded throughout the event, including social events. Registrants consent to the use of any such image, film or recording being used at the discretion of the Organizers.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

109 109


Local attractions Things to do and places to see . . . Québec City is known for its natural, cultural and historical attractions and is one of the most beautiful cities in Canada. The Conference Centre and its surrounding hotels are just a short walk or cab ride away from many of the city’s must-see attractions. Québec City Tourism has put together several suggestions for how you might spend your free time. Please visit the concierge desk at the Convention Centre if you need more details on the places mentioned below and other attractions. Helpful information can also be found on the Québec City Tourism website: quebecregion.com/en

Fortifications of Québec

Why go to China when you can walk a great wall right here! Québec is the only fortified city in North America north of Mexico, with close to 4.6 km of walls and imposing gates to explore. Discover beautiful cityscapes and see how Québec’s defenses developed under the French and English regimes. Cannons, loopholes, the Esplanade Powder Magazine, a star-shaped Citadel, Artillery Park, and fortresses are all part of this outstanding tour!

Old Québec/Dufferin Terrace

Visitors to Old Québec soon see why UNESCO designated it a world heritage treasure! You’ll love Château Frontenac (the world’s most photographed hotel), the centuries-old architecture, and the historic sites. The friendly atmosphere and affable locals add to the European charm. Whatever the time of year, you’ll find horse-drawn carriages, street entertainers, singers, and artists, particularly at Old Québec’s own open-air art gallery, Rue du Trésor. High atop Cape Diamond, stroll along the Dufferin Terrace overlooking the St Lawrence River and the surrounding area. Or come watch the ice making its way down the river in winter.

St Lawrence River/Vieux-Port de Québec

The St Lawrence River—a massive presence cutting clean across the Québec area—cannot be overlooked. Gateway to America, it has been a part of the city’s economic landscape for over 400 years. Harbour and trade activities and the ever-growing number of cruise ships docking in the Vieux-Port de Québec testify to its importance. A public market, park, bike path and shows also bring the Vieux Port to life and help make this river-washed place truly idyllic. Near the bridges that span the River, the Aquarium du Québec not only provides an outstanding view of the majestic waterway, but also presents the marine mammals and species that inhabit it. Close by, the Promenade Samuel-De Champlain is also worth a gander: the River flowing at your feet is simply spectacular!

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

110


Local attractions Montmorency Falls Park

This natural phenomenon is definitely not to be missed! At 83 metres high (30 metres higher than Niagara Falls) Montmorency Falls can be seen from all the way across the St Lawrence River in Lévis! But the best views are from Parc de la Chute-Montmorency, where you can feel the full force—and spray—of the falls for yourself. Take a gondola ride or walk the trails to the very top of the falls. In winter the spray freezes at the foot of the falls to form a huge “sugar loaf,” another intriguing Québec City attraction.

Plains of Abraham

The scene of the 1759 battle between generals Wolfe and Montcalm, the Plains of Abraham are the heart and lungs of Québec City. Discover one of the world’s largest and finest urban parks. The Plains are perfect for all kinds of activities (walking, cycling, picnicking, cross-country skiing, and more) or simply meeting up with friends. It was here that hundreds of thousands of fans rocked to Paul McCartney and Céline Dion as part of Québec City’s 400th anniversary celebrations, and it is here that Québec’s national holiday is celebrated every 24 June. Musée national des beaux-arts du Québec—renowned for its exhibits and collection of Québec art—is only a short walk away.

Parliament Hill

The province’s Parliament Hill has never been so popular! Québec’s National Assembly convenes here in the Parliament Building, a marvelous architectural treasure! The gorgeous Fontaine de Tourny was awarded a gold medal at the Paris World Fair in 1855. Today, it stands as a legacy of Québec City’s 400th anniversary celebrations, turning heads with its 43 jets, water-themed sculptures, and beautiful nighttime lighting. Nearby Observatoire de la Capitale also turns visitors giddy with excitement with its tremendous views of Québec City and area from a height of 221 m!

Wendake

Enter the fascinating world of the Huron-Wendat First Nation and embark on a history tour that will take you back to the 17th century. The ancestral site of Wendake is a window onto aboriginal culture! Dance shows and legends will whisk you deep into this people’s imagination, while Musée huron-wendat and various craft stores invite you to learn more about the nation’s culture and traditional know-how. A short walk through scenic natural surroundings leads visitors to Kabir Kouba Falls by Rivière Saint-Charles, and sampling the game featured in traditional Huron cuisine is the perfect way to round out your voyage of discovery.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

111


Visitor information Québec City is like no other city in Canada. It is known for its gorgeous landscapes, historic architecture and European feel. The fall is the city’s most beautiful time of year as the landscape transforms into a sea of stunning autumn colours.

Banks, currency & credit cards

The currency used is the Canadian Dollar (CAD). Banks and exchange bureaus will change money and travellers cheques, as will some hotels. Normal banking hours are from 1000 to 1500, Monday through Friday, with extended hours on Thursday, Friday and Saturday at some locations. Major credit cards are widely accepted and ATMs are plentiful.

Disabled access

The law requires new buildings to provide access for people with disabilities, but check when booking. All venues of the Colloquium will have wheelchair access. If you are unsure please visit the registration desk.

Drinking water

Québec City’s tap water is clean and safe to drink.

Driving and rental cars

Traffic drives on the right side of the road in Canada. You will need to provide a valid driver’s licence (in English) from your home country or an International Driver’s Permit to rent a vehicle. Minimum rental age varies from 21 to 25.

Electricity

Québec’s electrical current is 60 cycles, 110 volts. An adapter is needed for electrical appliances using another type of current, such as the 220-volt European system.

Emergency numbers

Health info 811 (daily, 24 hours/day, answering service provided by qualified nurses)

Québec Provincial Police 418-623-6262 or 418-310-4141

Other 24 hour emergencies: 911 Police, fire and ambulance

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

112


Visitor information Language

French is the official language in Québec and is used by more than 90 per cent of its population. English is widely spoken in tourist areas such as restaurants, hotels and boutiques.

Personal safety

Canada is one of the world’s safest destinations, but basic safety precautions should be taken. Canada has a relatively low crime rate, but please take sensible precautions such as keeping valuables out of sight and locking doors and vehicles, even in remote locations. Avoid walking around empty or poorly lit areas. It is advisable to carry only the money you will need for each day. You must pay attention in crowded places, such as public transport or department stores, as is expected in any major city.

Public Transport

Québec City offers an efficient and relatively inexpensive public transportation system. Bus tickets are $3.00 each, or $7.00 for a day pass, and can be purchased directly on the bus from the driver. The Écolobus (Québec City’s environment-friendly bus service) travels to many popular tourist destinations, such as the Chateau Frontenac, Parliament Hill, and the Musée de la civilisation. It runs from 0600-2400.

Smoking

The Tobacco Law forbids smoking in all public buildings, including bars and restaurants.

Taxes

The federal tax on goods and services (GST) is 5% and applies to most goods and services in Canada. The provincial sales tax (PST) is 9.975% and is charged on the selling price, not including the federal tax, and applies to most goods and services purchased in Québec.

Tipping

It is rare for gratuities to be automatically included on the average restaurant bill. The standard tip is 15-20 per cent of the bill before tax – 15 per cent for good service and 20 per cent for exceptional. When it comes to tipping in your hotel or other service-oriented businesses such as taxi drivers or hair dressers, the choice is really up to you. Most of these people will not expect to receive tips but will really appreciate them.

Weather

September weather is perfect for walking through the streets of Old Québec and exploring its many unique shops and markets. The average temperature in September is 12˚C, ranging from 7˚C -17˚C. The city generally experiences an Indian summer (a term used to describe a string of warm, sunny days) from mid/late September to early/mid-October.

Wireless internet

Wireless internet is freely available at the Québec City Convention Centre during the conference.

More information such as restaurant suggestions can be found on the Colloquium website at colloquium.cochrane.org/getting-together.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

113


Yukon The Bluefish Caves are an archaeological site in Northern Yukon that reveals the oldest evidence of human habitation in North America. Excavations have discovered stone and bone tools as well as butchered animal remains. The tools, such as mircroblades and wedge-shaped cores, are in context with the bones of extinct horse species, suggesting human occupancy between 15,000-10,000 years ago.

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

114


Rue

ra o nç is

O ue st

DE

de La

la

Rue

De

Saint-Jos eph

Salle

Reine

du

Est

eau Mgr-Caz

r

du Chalutie

Est

F Rue

du

2

Sa

Prince -

e

Édouard

du

Est

Signaï enod De Maz

Colbert

March F.-G.and

Philip pe-Do

TER

rval

Sutherland V auba

des

Trois-Mâtss

Grands-V ents

aute

Marée-H

des

de la Côte

des

sse Pota

Richelieu

440

de

Prairies

la

Pas. sous le Coteau

Parc de l'Artillerie McMahon

AG

E

Gare du Palais

4 Rue

De Saint-Vallier E. Côte Dinan

UL

R de ue l’E stu

JohnGoudie

SAIN T-PA

Gare-du-P alais Place de la Gare

3

de l'Arsenal

8

e

air

lila Cou rd Ru e

de u ie tel-D l'Hô

Charle voix

AVENUE

alais du P

Ga rn ea u

Deligny

O. -Robitaille

St-Stanislas

de

qu br i Fa la

scarpe

e De

de

Place de l' e l'Hôtel-de-Ville

B

ME HONORÉ -

Ste-Angèle

ua de

A venue

Panet

le Sainte-Ursu

s

Place d'Armes

i

Sa

artin

m-M

aha

U

Q

-

Avenue

Cartier

De

uisAvenue Lo nt Saint-Laure

Avenue Turnbull

RCIER

du Parloir

Côte

de

v T ra

r sie er

s

ÉC HA

du P o

e

9

Sain Anto tine

rche

Mon tagn e

Salaberry

Avenue

A venue Galipeault

Avenue

lm alm ntcal Dee Montc

A

Av e

Taché

alnéérral Géén du G rs du urs ou C Co

Place George-V Est

D'Auteuil

500 mètres

la r iviè

re

5

ge

Bun

S ai nt C har les

au Oue rne Ga ue

nu

Pl. George-V Ouest

Route principale

Autoroute

Gare

Terminus d’autobus interurbain

Stationnement

Tél. : 418-641-6290

Information touristique

LÉGENDE

Place-Royale

440

175

Écluse (Lock)

Agora

Vieux-Port

Rue Isidore-Thibaudeau Rue du Don-de-Dieu Rue du Marché-Finlay

ARC l-de-Sa c H N AI Place de Paris M PL

Pl. Royale Sou du C s-le-Fo rt u

de Barr la icad e

Pl. de la FA FAO O

Bassin Louise

E s t uai re d

I N TAN DR É

A

AI S nt -P a

ul Côte Dam du C bou olrgès

Porte Prescott

Parc Montmorency

Po r t

S o us M Re -le La gr- m -Ca va De p l d e la Vieil Hébert le-U nive rsité

Funiculaire

de s

rts pa

eAn ne

E 7 Sa int

Mont-Carme l Parc des Parc Go Gouverneurs

t

50 m = 164 ft.

S ve

n ai

Quartier ain ai n Petit Champlain

u Fle 250

Abr

Place du Marché-duVieux-Port Vieux-Port de rie te ote Cô Can la

Elgin

Saint-Jean

Ch. des Coo k Écossais

Donnacona

Vieux- 6 Québec Saint-Louis

des Ursulines du Corpsde-Garde

rs eu ern uv Go

Saint-D enis

De Brébeuf

- Genev iève

Parc du Cavalierdu-Moulin Av. Sain te ve

nu e

Citadelle

s

RD VA

de

Côte

1

e

Sainte-Anne

Porte McWilliam St-Jean Place D'Youville

Côte de l'E

hine

Porte St-Louis

Place de l’AssembléeNationale

Daup Porte Kent Parc de l'Esplanade

D

du

enad Prom

Carleton

n

B

Martin-Pêche ur

Vieux-Québec

Roi

Est

t

des Soeursde-la-Charité

Octave

EST

an

Saint-Joachim

Est

Saint e Marguerite de Xi’an

r

Carré Lépine SaintVallie

D'

AB R

AH AM ade lein e -M

SAINT-JEAN Rue

EST

Centre des congrès

C Joly-deLotbinière

EST

ia m -D ux

n ue Ave

a pCa

Esc. des Glacis

Quartier Saint-Roch Ru int-Franç ois

eph

Saint-Jos

CH

Fleurie

AREST Pl. de l’U.du-Québec De Saint e-Hélène

Jardin de Saint-Roch

des

Ste

175 CÔ De TE l

Saint-Réa

Richelieu

RUE

D'Aiguillon

Saint-Gabriel Sain

Lavigueur

VictorRevillon

Place JacquesCartier

des Commissa ires

Est

BOULEVAR D

EST Est

Côte Bad elaar d

Tourelle

DORCHES

la

Roi

ges

tre-Damedes-An

No

T-

De Sain te-Hé lène

SAIN

de

RUE

St-Crépin

Rue

Rue

Arago

VALL Chris IER toph e-C olom b

st

-F St e

S

Saint-Olivier Rue Rue

Rue Burton

t- Patr Augustines ic k Rue du MarchéRenéBerthelot Jalbert

RENÉ - LÉVESQUE

Prévost

du Bon-Paste ur

Colline Parlementaire mable

Parc de la Francophonie

du

Place George-V

. Av

des Goélands

Cap Diamant

ES -L

21st Cochrane Colloquium / 21e Colloque Cochrane

d es Com miss aires O

La

Bd Charest O

te

Rue

Lockwell

Place du Faubourg

Rue

Quartier

N

T-JEA

SAIN

De

De m ers

St-Josep h O

t let Centre des congrès de Québec vio

1 Restaurant Chez L'Autre 2 Versa Restaurant - Bar 3 L'Aviatic Club 4 Charbon Steakhouse 5 Le Café du Monde 6 La Crémaillère 7 Le Pain Béni 8 Portofino Bistro Italiano 9 Musée de la Civilisation A Hôtel Château Laurier Québec B Hilton Québec Est

Saint-Jean-Baptiste azie Rue Crém

D

Parc de l’AmériqueFrançaise

Saint-A

D‘Artigny

A Laurier

ALLÉE

G Wilfrid -

rio Onta

du

Parvis

du

Escalier du Cap-Blanc

Vallière

E UL BO

1 km = 0.6 mi

Bell

- Gauvrea u

ur

de Rando la nnée de la D rav e

BD

JE AN

0

ar cy

-C

C Hôtel Delta Québec BOULEVAR uve

onne De Mais

175

- VI George

Jardin Jeanne-d'Arc

ue Aven

Rue des Sapeurs

nt

Po i

D Hôtel Palace Royal Fraser

GRANDE

u Est

Parc des Champs-de-Bataille

e

Avenue

r nea

u Aven

s De Bernière

Ga

plain Cham

CHAMPLAIN

Te de c rmina rois l ière s

la

de

ad e

E Hôtel Clarendon F TRYP Québec Hôtel PUR Aberdeen

rs

Av en

e

Ontario

Rue

Ch ou ina

ai

en

Da up hi

du

Qu

Pr om

as

en t

-L au r

G Hôtel Loews Le Concorde rsde deun SaunSa

Avenue

Briand

BOULEV ARD

DAL

HO USIE

Na d e vig s ate urs

n Sau lt-a u Sain t - P -Matel ot ierre

rd

Ri ou x

Th int

om

Mé de la nag erie

M

tie

Sa Ch du P am eti pla tin

Notr e-Da la me

92

ua i

Q

ffer

Fo rt

Sa Hamel Fe int rla -F telav nd Fa ien mi lle du

Lega ré Ch ris

s

du

Sa in Tré so r

in

Ja rd in

Ru e

AI N

M PL

Grisons

de s

Rue de la Terrasse des Carrières Dufferin Te

rra sse

Du

PONT SAMSON des Bains

Ch P.-O au . ve au

Saint-Nicolas

l'AncienChantier Va is du seau -R xoi

des

e

de la Port

Glacis des

Saint-Roc h de l'Éperon

inique d e ll e

la

de Rue

COURONNE LA

DE RUE

elme Saint-Ans

de la Voie-d'Eau

D'Youville

e

des Pont Menuisiersrs Laberge Rue Sagard s

Jérôm

Av. Daulac Letellier Chapelle Côte Sainte-Geneviè ve

Rue

Saint-Augustin

De Magellan

Rue

Sainte-Marie AntonioBarrette

Saint-Dom Côte de la C it a

des Zouaves

Chevro tière

De La

aine

Sainte-Claire De Lorn e Berthel ot

rgues

J.-J. Bertrand

Louis-A. Taschereau des Parlementaires

Scott De Seneze

Caron

des Voltigeur s

Lange llie ier Richa rdBurke

Turge on Nazair Fortie er Horatio Nelson -

Monseigne

orge - VI Ge

Haldimand

CH A

de l'A mérique

-Franç

aise

- Font Claire

Boulle evarrd d a b e rr y

al

Na r Be cisse llea u

Rue d e

Yvon-Guillou


Floor plans

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

116


Floor plans

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santĂŠ

117


Cochrane South Asia is privileged to host the 22nd Cochrane Colloquium in the charming city of Hyderabad in India. The year 2014 heralds the 21st anniversary of The Cochrane Collaboration’s pioneering global initiative. We celebrate Cochrane’s rite of passage into its prime with a Colloquium that we hope will challenge, stimulate, and empower us to face our responsibilities as global leaders in research synthesis for better health. The 2014 Cochrane Colloquium will focus on ‘Evidence-Informed Public Health: Opportunities and Challenges’, a theme that is apt for the setting of the Colloquium in India and South Asia. We hope that September 2014 will see history, geography, altruism, pragmatism and good science meld seamlessly to help improve the health of the millions of people in the region and around the world. The 400-year-old city of Hyderabad, built by the Qutub Shahi kings, is steeped in a rich historical, cultural and architectural heritage and is home to the glistening towers of many global IT giants. Blending the ancient and the modern in perfect harmony, Hyderabad, the jewel of the Deccan, offers you a life-changing experience of the vibrant democracy that is Incredible India like no other Indian city can.

The Hyderabad International Convention Centre (HICC), the Colloquium venue, is situated in Hyderabad’s HITEC city, and has state-of-the-art conference facilities. The conference hotel is attached to the HICC, and there are over 25 other hotels in the vicinity, as well as service apartments and guest houses, which will provide options to suit a range of budgets and preferences. HICC is a 45-minute drive by a dedicated expressway from the Rajiv Gandhi International Airport that is well connected to major international destinations in Europe, Asia, and the Middle East, and—through these hubs—to the rest of the world. The weather in September should be pleasant after the monsoons, which marks the beginning of the tourist season in India. Swagatham! We welcome you warmly to the planet called India, the land of a thousand Gods, where every guest is treated like a god. See you in Hyderabad!

Charminar, Famous monument

Better Knowledge for Better Health | Un meilleur savoir pour une meilleure santé

118


21st Cochrane Colloquium Program  

Full program for the 21st Cochrane Colloquium in Quebec City, 19-23 September 2013.

21st Cochrane Colloquium Program  

Full program for the 21st Cochrane Colloquium in Quebec City, 19-23 September 2013.

Advertisement